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ABSTRACT
Background: Weight status is one of the factors that influence healthy ageing. It is 
often assessed with anthropometric measures such as body mass index (BMI) and waist 
circumference (WC), which indicate underweight or excess fat. Both are associated with 
adverse health outcomes in adults. The first paper of this thesis investigates whether this 
association is consistent over calendar time, to check for possible influences of improved 
healthcare procedures over time. In old age, this association is unclear. Using several 
anthropometric measures, the subsequent five papers examine the impact of weight status 
and development of weight status on coronary heart disease (CHD), mortality, and quality 
of life (QoL) among the elderly and during ageing.
Methods: A meta‐regression analysis of 31 international cohort studies (n=389,212) was 
used to estimate the multivariable adjusted relative risk (RR) of CHD for an increased BMI and 
whether the RR was different between calendar periods (i.e. studies that started before 1985 
and studies that started after 1985) taking account of the age of the population. Associations 
of BMI and changes in eight anthropometric measures with all‐cause and cause‐specific 
mortality in old age were studied by means of multivariable Cox regression analyses using 
data from the Survey in Europe on Nutrition and the Elderly: a concerted action study including 
70–77‐year‐olds (n=1,061–1,970). Moreover, the association of WC with all‐cause and cause‐
specific mortality was studied by means of a meta-analysis of 29 international cohort studies 
including 65–74‐year‐olds (n=58,609). For an ageing population, we used the Doetinchem 
Cohort Study including 20–70‐year‐olds (n=3,408–4,135) and three to four repeated measures 
of weight and height over a period of 10 to 15 years. In this study population, we used a 
multivariable regression analysis to examine the association of changes in weight and long‐
term BMI patterns with QoL (measured by the SF‐36 questionnaire).
Results: After simultaneous inclusion of calendar period and age of the population in the 
model, the meta‐regression analysis showed no difference in the RR of CHD in the association 
with a high BMI between calendar periods. However, a 10‐year increment in population 
age lowered the 1.28 [95%confidence interval (CI): 1.22–1.34] RR of CHD for a five‐BMI‐unit 
increment by 29% (95%CI: ‐55 to ‐5). Among the elderly, BMI was associated with all‐cause 
mortality, cardiovascular disease (CVD) mortality, and mortality due to causes other than 
CVD, cancer, and respiratory diseases (p<0.05). A BMI below 24 kg/m2 and above 30 kg/m2 
were the thresholds at which risks of cause‐specific mortality were increased by 10%. WC was 
associated with all‐cause, CVD, cancer, and respiratory disease mortality (p<0.05). At the levels 
for abdominal obesity (102 cm, men; 88 cm, women), the risk of all‐cause and CVD mortality 
was not significantly increased, or only modestly. A risk of 2.0 (clinically relevant) for all‐cause 
and CVD mortality was associated with a WC of 132 and 123 cm in men, and 116 and 105 cm in 
women, respectively. By using a combination of WC and BMI categories with the combination 
of a small WC (94 cm, men; 80 cm, women) and a healthy weight (20.0–24.9 kg/m2) as the 
reference, we observed the highest all-cause and CVD mortality risk of approximately 2.0 for 
underweight (<20.0 kg/m2; in combination with a small WC), and abdominal obesity within 
healthy ranges of BMI. Changes in BMI and WC were not associated with all‐cause and CVD 
mortality, except for a decrease in WC ≥3.1 cm in the association with all‐cause mortality 
(1.52, 95%CI: 1.01–2.31). Similarly, a decrease in weight ≥3.2 kg was associated with a 1.48 
(95%CI: 0.99–2.20) increased all‐cause mortality risk. Moreover, both a decrease and an 
increase in mid‐upper arm circumference (MUAC) were associated with all‐cause mortality 
and CVD mortality. A decrease of ≥1.6 cm and 0.6–1.6 cm in MUAC was associated with a 1.81 
(95%CI: 1.17–2.79) and a 1.66 (95%CI: 1.10–2.49) all‐cause mortality risk. An increase of ≥1.3 
cm in MUAC was associated with a 1.52 (95%CI: 1.00–2.31) all‐cause mortality risk and a 1.94 
(95%CI: 1.00–3.75) CVD mortality risk. In an ageing population, we found that weight gain, 
especially weight gain of >6 kg, resulted in a decline in QoL. Weight loss (>2 kg) did not result 
in large changes in QoL. However, both weight gain and weight loss were adversely associated 
with changes in QoL as compared to a stable weight (changes ≤2 kg). From examination of 
long‐term BMI patterns, the lowest QoL was observed for the ‘persistent obesity (≥30 kg/
m2)’ pattern. The BMI patterns, ‘persistent obesity’, ‘developing overweight (25.0–29.9 kg/m2)’, 
‘developing obesity’, and ‘switching between BMI categories’ scored 1.8–11.6 points (p<0.05) 
lower on QoL than the ‘persistent healthy weight (18.5–24.9 kg/m2)’ pattern. The BMI pattern 
‘persistent overweight’ generally did not differ from the ‘persistent healthy weight’ pattern. 
These findings were consistent among age groups.
Conclusions: Although the risk of CHD in the association with BMI attenuated with 
increasing age, we found associations of BMI and WC with all‐cause and cause‐specific 
mortality among the elderly. These anthropometric measures can be used as single 
predictors of mortality for the elderly, but higher cut‐off points for BMI and WC to indicate 
underweight and excess fat should be considered. Moreover, a combination of these two 
anthropometric measures can be recommended, as that would provide more information 
of the body composition than one anthropometric alone. With regard to assessing changes 
in body composition, MUAC might be recommended for the elderly. Furthermore, a stable 
weight is best for health maintenance among all ages, provided this stable weight does 
not fall within the extreme values of weight, i.e. too light or too heavy. In all, our results 
underscore the value of anthropometric measures in the management of weight and the 
importance of the maintenance of a stable weight during ageing.
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Ageing
Along with the decrease in mortality rates, the life expectancy in developed countries has 
steadily increased over the past two centuries.1 Over the last decades in particular, the 
cardiovascular disease (CVD) mortality rates strongly decreased,2-4 possibly because of early 
diagnosis, more effective (surgical) treatment, improved risk reduction by pharmaceutical 
treatment, and preventive measures with regard to lifestyle.2,5,6 This development, together 
with low fertility, has resulted in ageing of the population1 as illustrated by the 4% increase 
in the proportion of persons aged 65 years and older in Europe between 1999 and 2009.7 
Although in the elderly population the prevalence of CVD, cancer, diabetes, and osteoporosis 
has increased over time, the life expectancy of the elderly with morbidity and comorbidity 
has concurrently increased because of improved healthcare and early diagnosis.1,8 These 
processes, i.e. the ageing of the population and the increase in the prevalence of chronic 
diseases, are expected to proceed even further.2,8,9 Therefore, it is important to examine 
factors that may facilitate healthy ageing. Weight status is one of those factors, as both 
overweight and underweight are associated with adverse health outcomes.10-13 
Anthropometric measures 
Anthropometric measures, such as body weight, body mass index (BMI, kg/m2), and waist 
circumference (WC, cm) are used to assess weight status in order to predict health risks. BMI is 
often used in clinical practice and reflects total body weight in relation to height. Individuals 
can be classified according to their weight and height into underweight, normal (or ‘healthy’) 
weight, overweight, and obese (Table 1.1). This classification has been adopted in the World 
Health Organization (WHO) guidelines since 1995 and is based on the association of BMI with 
mortality.14 WC classifications have been proposed by Lean and colleagues.15 including two action 
levels: 1) prevent further weight gain and 2) lose weight (also known as ‘abdominal obesity’) 
(Table 1.1). The WHO has adopted both classifications of BMI and WC in their guidelines.16,17
Table 1.1 Classification of BMI and WC according to the WHO guidelines
BMI Men and women WC Men Women
Underweight <18.5 kg/m2
Normal weight 18.5–24.9 kg/m2 Small waist <94 cm <80 cm
Overweight 25.0–29.9 kg/m2 Action level 1 94–101 cm 80–87 cm
Obesity ≥30.0 kg/m2 Action level 2 ≥102 cm ≥88 cm
11
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WC reflects abdominal fat mass, which has a high correlation with visceral fat,18 and is less 
influenced by muscle and bone mass. Other measures of abdominal fat are waist-to-hip 
ratio (WHR) and waist-to-height ratio (WHtR), of which the cut-off points to indicate an 
increased health risk are a WHR of ≥0.90 in men and ≥0.85 in women17 and a WHtR of >0.5 
for both sexes.19  
Other anthropometric measures are the triceps skinfold thickness (TSF, mm), mid-upper 
arm circumference (MUAC, cm), and corrected arm muscle area (CAMA, cm2). These are 
generally used to assess nutritional status, mainly with regard to under-nutrition and thus 
underweight. TSF reflects the subcutaneous fat mass, and MUAC reflects bone, muscle, 
and subcutaneous fat mass. With these measures, the muscle mass of the arm, CAMA, can 
be calculated; this is important as a loss of muscle mass is a strong indicator of prevalent 
diseases. For these measures, the cut-off points that indicate increased risks are below 1–2 
mm for TSF, 24 cm for MUAC, and 10 cm2 for CAMA.14
Impact of weight status on health 
The prevalence of overweight and (ab dominal) obesity has increased worldwide since 1980 
across all ages.10,20-22 Overweight and (abdominal) obesity are associated with cardiovascular 
diseases, an increased mortality risk, and lower quality of life (QoL).10,17,20-25 The prevalence 
of underweight in adults 20 years and older is low in the Netherlands, as well as in many 
other developed countries, and seems to be stable around 2–3% since 1980.26,27 However, 
the prevalence of underweight is higher in Dutch elderly individuals in e.g. hospitals (10%) 
and nursing homes (15%) and in elderly individuals living at home (8%).28 Underweight 
(measured by BMI), a low MUAC, TSF, and CAMA are associated with a lower QoL, more 
pain, and increased mortality risks, especially in older ages.29-35 Thus, both overweight and 
underweight are associated with adverse health outcomes, including mortality. 
In adults, the association between BMI and (cause-specific) mortality and between WC and 
(cause-specific) mortality is clear, i.e. high levels of BMI (>25 kg/m2) and high levels of WC 
(>102 cm, men; >88 cm, women) are associated with increased (cause-specific) mortality 
risks.11,36-42 However, in elderly individuals, the impact of a high BMI and a high WC on the 
risk of mortality is not consistent.11,41,43-46 With regard to BMI, several studies concluded 
that overweight (25–29.9 kg/m2) among the elderly (≥65 years) was not associated with 
(cause-specific) mortality and that obesity (≥30 kg/m2) only modestly increased the risk of 
mortality, or that the risk started to increase significantly from 31–32 kg/m2 and over.43,44 
However, a pooled analysis of 57 prospective studies did find an increased (cause-specific) 
12
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mortality risk in persons above the age of 70 years with a BMI of 25–50 kg/m2.11 With regard 
to WC, a few studies showed no association or even an inverse association with either 
all-cause or CVD mortality,45,46 whereas another study showed a positive association with 
CVD mortality.41 Thus, the associations between BMI and mortality and WC and mortality 
in elderly individuals seem unclear. 
There might be different reasons for this. Firstly, the body composition changes with ageing: 
i.e. elderly individuals have a higher total fat mass (because of an age-dependent loss of 
lean body mass) than young adults; elderly individuals have more visceral fat than young 
adults for a given WC, as fat redistributes to the more central region; subcutaneous fat 
on the extremities transforms to visceral and ectopic fat; and elderly individuals shrink in 
height, causing an increase in their BMI, while body weight stays the same.18,47-49 Therefore, 
the weight status of elderly individuals might relate differently to health than the weight 
status of young adults. Secondly, during the life course, individuals who are susceptible to 
the adverse effects of obesity have probably died before reaching old age. This is the so-
called survival effect.47 Thirdly, if obesity is developed at an old age, the remaining life span 
is relatively short to expose its adverse effects on health.47 Finally, when elderly individuals 
fall ill, overweight might provide a metabolic buffer as previously reported in older people 
with chronic conditions.50 Because of these factors, the applicability of the currently used 
cut-off points of BMI with regard to both overweight and underweight and the cut-off point 
of WC with regard to abdominal obesity (Table 1.1) in the elderly are under discussion.51,52 
Further exploration of the applicability of these cut-off points in elderly individuals is needed 
and is highly relevant for clinicians and public health. 
So far, only a few studies have examined the impact of BMI and WC on the association with 
mortality in elderly populations separately and jointly. These studies reported stronger 
associations for WC with mortality when analysed jointly with BMI than when WC was 
analysed separately.53,54 In the model with WC and BMI, BMI had even an inverse association 
with mortality.53,54 Thus, the roles of WC and BMI in association with mortality seem different. 
Because the interpretation of WC and BMI as a continuous variable are –as yet– difficult to 
translate to practical use, further research including combinations of the currently used 
WC and BMI categories is needed as these have not been rigorously examined among the 
elderly.45,54 
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Changes in weight status and health
Besides insight into initial weight status and health among the elderly, it is important to 
consider weight history over a longer period and assess the potential impact of changes 
in body weight. Several studies have examined changes in weight in the association with 
mortality and QoL.55-58
Weight loss over a short as well as over a long period is known to be associated with an 
increased mortality risk.57-62 For weight gain, the association with mortality is less consistent. 
In adults, weight gain over a long period (11–41 years) was associated with an increased 
mortality risk.59-61 In elderly individuals, weight gain, often assessed over a relatively short 
period (e.g. 3–6 years), seemed not to be associated with mortality,57,58 although in persons 
with overweight or obesity and in particular in the longer term, an increased mortality risk 
was evident.62 However, little is known about changes in different anthropometric measures 
with respect to mortality; this is of importance since in elderly individuals changes in body 
weight can depend on several factors, e.g. changes in body fluid by oedema, dehydration, 
or changes in fat mass, or muscle mass. Therefore, more research is needed on mortality and 
changes measured with different anthropometric measures within one elderly population. 
For QoL, many studies have examined the cross-sectional association with weight status 
and showed consistent results.63 From intervention studies we know that weight loss is 
beneficial for QoL in obese adults.63 However, an important aspect for healthy ageing is the 
impact of overweight and obesity determined in the longer term. Longitudinal studies on 
both young and older adults have observed negative associations between their weight 
gain and QoL compared to persons with a stable weight, whereas for weight loss the 
results were inconsistent.55,56,64-66 However, these longitudinal studies failed to examine the 
associations in the longer term, in men and women separately, or on all aspects of QoL, 
and/or used self-reported weight, or used only two measurements to define changes in 
weight over time.55,56,64-66 Thus, to gain more insight into long-term changes in weight over 
individuals’ life course, further research is needed in a general population with repeated 
measurements of weight, carried out by trained personnel over a longer period of time.  
Objective
The focus of this PhD research is to examine the impact of weight status, using several 
anthropometric measures, on coronary heart disease (CHD), mortality, and QoL in old age 
and during ageing. 
14
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Methodology and outline of the thesis
To examine the objective of this thesis, data were used from longitudinal cohort studies, 
including populations from the United States, Australia, Europe, and specifically from the 
Netherlands. Data on demography, lifestyle, and QoL were obtained by questionnaires or 
interviews. Anthropometric measurements were in almost all cohort studies measured 
by trained personnel and were repeated over time. Furthermore, data were available on 
diseases, date of death, and cause of death. The general descriptives of these studies are 
presented per chapter in Table 1.2.
Chapter 2 describes the relative risk of CHD in association with BMI, and whether this 
relative risk is different between studies that started before or in 1985 and after 1985. In 
addition, this chapter describes how age of the population and follow-up period influences 
this relative risk. This was examined by means of a meta-regression analysis including 
international cohort studies. 
Chapter 3 describes the association between BMI and cause-specific mortality in an elderly 
European population, and Chapter 4 describes the association between WC and cause-
specific mortality (taking account of BMI) in an elderly Western population by means of a 
meta-analysis including international cohort studies. Furthermore, both chapters explore 
the cut-off points of BMI and WC classifications for use in elderly populations. 
Chapter 5 describes the association of changes in eight different anthropometric measures 
and mortality due to all-causes and due to cardiovascular diseases in an elderly European 
population and explores which measure might be applicable for the detection of body 
compositional changes in old age. 
In Chapters 6 and 7, data from an adult population are used to examine the longitudinal 
association between changes in weight and changes in QoL, and the association between 
long-term BMI patterns (i.e. persistent healthy weight (reference pattern), developing 
overweight, persistent overweight, developing obesity, persistent obesity, and switching 
between BMI categories) and QoL. 
Chapter 8 discusses the main findings and concludes with the implications for public 
health and clinical practice. 
15
G
eneral introduction
Chapter 1
Ta
bl
e 
1.
2 
St
ud
y 
in
fo
rm
at
io
n 
pe
r c
ha
pt
er
Ch
.
St
ud
y
Ye
ar
(s
) o
f 
as
se
ss
m
en
t
N
um
be
r o
f 
pa
rt
ic
ip
an
ts
Ag
e 
at
 
ba
se
lin
e
Ex
po
su
re
M
ea
su
re
d/
Se
lf-
re
po
rt
ed
Fo
llo
w
-u
p 
pe
rio
d
O
ut
co
m
es
N
um
be
r 
of
 c
as
es
2
M
et
a-
an
al
ys
is
 
(n
co
ho
rt
 s
tu
di
es
=3
1)
19
57
–1
99
6
38
9,
21
2
20
–9
4 
ye
ar
s
BM
I (
kg
/m
2 )
M
 (n
=2
7)
       
       
       
S 
(n
=4
)
1–
35
 y
ea
rs
In
ci
de
nc
e 
of
 o
r 
m
or
ta
lit
y 
fr
om
 C
H
D
 
8–
3,
50
3
3
SE
N
EC
A
 s
tu
dy
19
88
–1
98
9
1,
97
0
70
–7
7 
ye
ar
s
BM
I (
kg
/m
2 )
M
10
 y
ea
rs
M
or
ta
lit
y 
du
e 
to
      
      
      
 
A
ll-
ca
us
es
 
CV
D
 
Ca
nc
er
   
   
   
   
   
   
   
   
   
 
Re
sp
ira
to
ry
 d
is
ea
se
           
    
O
th
er
 c
au
se
s
75
1 
       
       
       
29
6 
       
       
      
17
2 
       
       
       
 
41
      
      
      
      
 
64
4
M
et
a-
an
al
ys
is
 
(n
co
ho
rt
 s
tu
di
es
=2
9)
19
79
–2
00
7
58
,6
09
      
      
      
   
52
,6
39
     
     
     
   
50
,8
45
       
       
       
  
36
,2
67
65
–7
4 
ye
ar
s
W
C 
(c
m
), 
BM
I (
kg
/m
2 )
M
 (n
=2
7)
       
       
       
  
S 
(n
=2
)
4–
7 
ye
ar
s
M
or
ta
lit
y 
du
e 
to
 
A
ll-
ca
us
es
 
CV
D
    
    
    
    
    
    
    
    
    
    
  
Ca
nc
er
   
   
   
   
   
   
   
   
   
 
Re
sp
ira
to
ry
 d
is
ea
se
 
4,
79
8  
        
     
1,
55
0 
       
      
1,
64
3  
         
       
21
6
5
SE
N
EC
A
 s
tu
dy
19
88
–1
98
9
19
93
1,
06
1
70
–7
7 
ye
ar
s
Ch
an
ge
 in
 w
ei
gh
t (
kg
), 
BM
I (
kg
/m
2 ),
 W
C 
(c
m
), 
W
H
R,
 W
H
tR
, M
U
AC
 (c
m
), 
TS
F 
(m
m
), 
CA
M
A
 (c
m
2 )
M
6 
ye
ar
s
A
ll-
ca
us
e 
m
or
ta
lit
y  
        
    
CV
D
 m
or
ta
lit
y
27
4 
     
     
     
10
3
6
D
CS
19
95
–1
99
9       
20
00
–2
00
4       
20
05
–2
00
9
4,
13
5
26
–7
0 
ye
ar
s
Ch
an
ge
 in
 w
ei
gh
t (
kg
)
M
10
 y
ea
rs
Ch
an
ge
 in
 q
ua
lit
y 
of
 li
fe
n.
a.
7
D
CS
19
89
–1
99
4         
19
95
–1
99
9        
20
00
–2
00
4        
20
05
–2
00
9
3,
40
8
20
–6
6 
ye
ar
s
BM
I p
at
te
rn
M
15
 y
ea
rs
Q
ua
lit
y 
of
 li
fe
n.
a.
A
bb
re
vi
at
io
ns
: B
M
I: 
bo
dy
 m
as
s 
in
de
x,
 C
A
M
A
: c
or
re
ct
ed
 a
rm
 m
us
cl
e 
ar
ea
, C
H
D
: c
or
on
ar
y 
he
ar
t d
is
ea
se
, C
VD
: c
ar
di
ov
as
cu
la
r d
is
ea
se
s, 
D
CS
: D
oe
tin
ch
em
 C
oh
or
t S
tu
dy
, 
M
U
AC
: m
id
-u
pp
er
 a
rm
 c
irc
um
fe
re
nc
e,
 n
.a
.: 
no
t a
pp
lic
ab
le
, S
EN
EC
A
: S
ur
ve
y 
in
 E
ur
op
e 
on
 N
ut
rit
io
n 
an
d 
th
e 
El
de
rly
: a
 c
on
ce
rt
ed
 a
ct
io
n,
 T
SF
: t
ric
ep
s 
sk
in
 fo
ld
, W
C:
 w
ai
st
 
ci
rc
um
fe
re
nc
e,
 W
H
R:
 w
ai
st
-t
o-
hi
p 
ra
tio
, W
H
tR
: w
ai
st
-t
o-
he
ig
ht
 ra
tio
.
16
General introductionChapter 1
References
1.  Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. 
Lancet. 2009;374(9696):1196–1208.
2 . van Duin C, de Jong G, Stoeldraaijer L, Garssen J. Bevolkingsprognose 2010–2060: model en 
veronderstellingen betreffende sterfte. CBS Bevolkingstrends: Statistisch kwartaalblad over de 
demografie van Nederland. 2011;59(2e kwartaal):28–41.
3.  Uemura K, Pisa Z. Trends in cardiovascular disease mortality in industrialized countries since 
1950. World Health Stat Q. 1988;41(3–4):155–178.
4. O’ Flaherty M, Allender S, Taylor R, Stevenson C, Peeters A, Capewell S. The decline in coronary 
heart disease mortality is slowing in young adults (Australia 1976–2006): a time trend analysis. 
Int J Cardiol.2012;158(2):193–198.
5. Tuns tall-Pedoe H, Vanuzzo D, Hobbs M, Mahonen M, Cepaitis Z, Kuulasmaa K, et al. Estimation of 
contribution of changes in coronary care to improving survival, event rates, and coronary heart 
disease mortality across the WHO MONICA Project populations. Lancet. 2000;355(9205):688–700.
6. The w orld health report 2002: Reducing risks, promoting healthy life. Geneva: World Health 
Organization, 2002.
7. Europ e in figures. Eurostat yearbook 2010. Luxembourg: European Union, 2010. 
8. van  der Lucht F, Polder JJ. Van gezond naar beter: Kernrapport Volksgezondheid Toekomst 
Verkenning 2010.Bilthoven: RijksInstituut voor Volksgezondheid en Milieu, 2010.
9. Oeppe n J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029–
1031.
10. Branc a F, Nikogosian H, Lobstein T. The challenge of obesity in the WHO European Region and the 
strategies for response.Denmark: World Health Organization, 2007.
11. Whitl ock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and 
cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. 
Lancet. 2009;373(9669):1083–1096.
12. Yan LL , Daviglus ML, Liu K, Pirzada A, Garside DB, Schiffer L, et al. BMI and health-related quality 
of life in adults 65 years and older. Obes Res. 2004;12(1):69–76.
13. Lean ME , Han TS, Seidell JC. Impairment of health and quality of life using new US federal 
guidelines for the identification of obesity. Arch Intern Med. 1999;159(8):837–843.
14. Physical status: the use and interpretation of anthropometry. Geneva: World Health Organization, 
1995.
15. Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight 
management. Bmj. 15 1995;311(6998):158–161.
16. Clinical  guidelines on the identification, evaluation, and treatment of overweight and obesity in 
adults--The evidence report. National Institutes of Health. Obes Res Sep 1998;6 Suppl 2:51S–209S.
17
G
eneral introduction
Chapter 1
17. Waist circ umference and waist–hip ratio: Report of a WHO expert consultation, Geneva, 8–11 
December 2008. Geneva: World Health Organization, 2011.
18. Lemieux S, P rud’homme D, Bouchard C, Tremblay A, Despres JP. A single threshold value of waist 
girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am 
J Clin Nutr. 1996;64(5):685–693.
19. Browning LM,  Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening 
tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global 
boundary value. Nutr Res Rev. 2010;23(2):247–269.
20. Eiben G, Dey D K, Rothenberg E, Steen B, Bjorkelund C, Bengtsson C, et al. Obesity in 70-year-old 
Swedes: secular changes over 30 years. Int J Obes (Lond). 2005;29(7):810–817.
21. Finucane MM, St evens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, 
and global trends in body-mass index since 1980: systematic analysis of health examination 
surveys and epidemiological studies with 960 country-years and 9.1 million participants. 
Lancet.2011;377(9765):557–567.
22. Janssen I, Shiel ds M, Craig CL, Tremblay MS. Prevalence and secular changes in abdominal 
obesity in Canadian adolescents and adults, 1981 to 2007–2009. Obes Rev. 2011;12(6):397–405.
23. Petursson H, Sigur dsson JA, Bengtsson C, Nilsen TI, Getz L. Body configuration as a predictor of 
mortality: comparison of five anthropometric measures in a 12 year follow-up of the Norwegian 
HUNT 2 study. PLoS One. 2011;6(10):e26621.
24. Han TS, Tijhuis MA , Lean ME, Seidell JC. Quality of life in relation to overweight and body fat 
distribution. Am J Public Health. 1998;88(12):1814–1820.
25. Blokstra A, Vissink P, Venmans LMAJ, Holleman P, van der Schouw YT, Smit HA, et al. Nederland de 
Maat Genomen, 2009–2010, Monitoring van risicofactoren in de algemene bevolking.Rijksinstituut 
voor Volksgezondheid en Milieu (RIVM): Bilthoven, 2011.
26. CBS. Lengte en gewic ht van personen, ondergewicht en overgewicht vanaf 1981. 2012; http://
statline.cbs.nl/StatWeb/publication/?DM=SLNL&PA=81565NED&D1=a&D2=0&D3=5-12&D4=
0&D5=0,10,20,30&HDR=T&STB=G1,G2,G3,G4&VW=T, Accessed 24/03/2013.
27. WHO. Global database on body mass index.  http://apps.who.int/bmi/index.jsp. Accessed 
24/03/2013.
28. Gezondheidsraad. Ond ervoeding bij ouderen. Den Haag: Gezondheidsraad, 2011; publicatienr. 
2011/32.
29. Flegal KM, Graubard  BI, Williamson DF, Gail MH. Excess deaths associated with underweight, 
overweight, and obesity. Jama. 2005;293(15):1861–1867.
30. Renzaho A, Wooden M,  Houng B. Associations between body mass index and health-related 
quality of life among Australian adults. Qual Life Res. 2010;19(4):515–520.
31. Heim N, Snijder MB, De eg DJ, Seidell JC, Visser M. Obesity in older adults is associated with an 
increased prevalence and incidence of pain. Obesity (Silver Spring). 2008;16(11):2510–2517.
18
General introductionChapter 1
32. Wijnhoven HA, van Bokho rst-de van der Schueren MA, Heymans MW, de Vet HC, Kruizenga HM, 
Twisk JW, et al. Low mid-upper arm circumference, calf circumference, and body mass index 
and mortality in older persons. J Gerontol A Biol Sci Med Sci. 2010;65(10):1107–1114.
33. Wannamethee SG, Shaper A G, Lennon L, Whincup PH. Decreased muscle mass and increased 
central adiposity are independently related to mortality in older men. Am J Clin Nutr. 
2007;86(5):1339–1346.
34. Miller MD, Crotty M, Gile s LC, Bannerman E, Whitehead C, Cobiac L, et al. Corrected arm muscle 
area: an independent predictor of long-term mortality in community-dwelling older adults? J 
Am Geriatr Soc. 2002;50(7):1272–1277.
35. Enoki H, Kuzuya M, Masuda  Y, Hirakawa Y, Iwata M, Hasegawa J, et al. Anthropometric 
measurements of mid-upper arm as a mortality predictor for community-dwelling Japanese 
elderly: the Nagoya Longitudinal Study of Frail Elderly (NLS-FE). Clin Nutr. 2007;26(5):597–604.
36. Pischon T, Boeing H, Hoffma nn K, Bergmann M, Schulze MB, Overvad K, et al. General and 
abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359(20):2105–2120.
37. Arnlov J, Ingelsson E, Sunds trom J, Lind L. Impact of body mass index and the metabolic 
syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 
2010;121(2):230–236.
38. van Dam RM, Li T, Spiegelman  D, Franco OH, Hu FB. Combined impact of lifestyle factors on 
mortality: prospective cohort study in US women. Bmj. 2008;337:a1440.
39. Calle EE, Rodriguez C, Walker -Thurmond K, Thun MJ. Overweight, obesity, and mortality from 
cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–1638.
40. Zhang C, Rexrode KM, van Dam R M, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, 
cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 
2008;117(13):1658–1667.
41. Baik I, Ascherio A, Rimm EB, Gi ovannucci E, Spiegelman D, Stampfer MJ, et al. Adiposity and 
mortality in men. Am J Epidemiol. 2000;152(3):264–271.
42. Simpson JA, MacInnis RJ, Peeters A, Hopper JL, Giles GG, English DR. A comparison of adiposity 
measures as predictors of all-cause mortality: the Melbourne Collaborative Cohort Study. Obesity 
(Silver Spring). 2007;15(4):994–1003.
43. Heiat A, Vaccarino V, Krumholz HM . An evidence-based assessment of federal guidelines for 
overweight and obesity as they apply to elderly persons. Arch Intern Med. 2001;161(9):1194–1203.
44. Janssen I, Mark AE. Elevated body  mass index and mortality risk in the elderly. Obes Rev. 
2007;8(1):41–59.
45. Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE. Weight, shape, and mortality risk in older 
persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk 
of death. Am J Clin Nutr. 2006;84(2):449–460.
46. Reis JP, Macera CA, Araneta MR, Lind say SP, Marshall SJ, Wingard DL. Comparison of overall 
obesity and body fat distribution in predicting risk of mortality. Obesity (Silver Spring). 
2009;17(6):1232–1239.
19
G
eneral introduction
Chapter 1
47. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of 
obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005;29(9):1011–
1029.
48. Hughes VA, Roubenoff R, Wood M, Fronte ra WR, Evans WJ, Fiatarone Singh MA. Anthropometric 
assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr. 2004;80(2):475–
482.
49. Cartwright MJ, Tchkonia T, Kirkland JL. Aging in adipocytes: potential impact of inherent, depot-
specific mechanisms. Exp Gerontol. 2007;42(6):463–471.
50. Romero-Corral A, Montori VM, Somers VK,  Korinek J, Thomas RJ, Allison TG, et al. Association 
of bodyweight with total mortality and with cardiovascular events in coronary artery disease: 
a systematic review of cohort studies. Lancet. 2006;368(9536):666–678.
51. Flicker L, McCaul KA, Hankey GJ, Jamrozik K, Brown WJ, Byles JE, et al. Body mass index and 
survival in men and women aged 70 to 75. J Am Geriatr Soc. 2010;58(2):234–241.
52. Heim N, Snijder MB, Heymans MW, Deeg DJ, S eidell JC, Visser M. Optimal cutoff values for high-
risk waist circumference in older adults based on related health outcomes. Am J Epidemiol. 
2011;174(4):479–489.
53. Guallar-Castillon P, Balboa-Castillo T, Lop ez-Garcia E, Leon-Munoz LM, Gutierrez-Fisac JL, Banegas 
JR, et al. BMI, waist circumference, and mortality according to health status in the older adult 
population of Spain. Obesity (Silver Spring). 2009;17(12):2232–2238.
54. Janssen I, Katzmarzyk PT, Ross R. Body mass  index is inversely related to mortality in older 
people after adjustment for waist circumference. J Am Geriatr Soc. 2005;53(12):2112–2118.
55. Fine JT, Colditz GA, Coakley EH, Moseley G, M anson JE, Willett WC, et al. A prospective study of 
weight change and health-related quality of life in women. Jama. 1999;282(22):2136–2142.
56. Leon-Munoz LM, Guallar-Castillon P, Banegas JR , Gutierrez-Fisac JL, Lopez-Garcia E, Jimenez FJ, 
et al. Changes in body weight and health-related quality-of-life in the older adult population. 
Int J Obes (Lond). 2005;29(11):1385–1391.
57. Lee CG, Boyko EJ, Nielson CM, Stefanick ML, Bau er DC, Hoffman AR, et al. Mortality risk in 
older men associated with changes in weight, lean mass, and fat mass. J Am Geriatr Soc. 
2011;59(2):233–240.
58. Newman AB, Yanez D, Harris T, Duxbury A, Enright PL, Fried LP. Weight change in old age and 
its association with mortality. J Am Geriatr Soc. 2001;49(10):1309–1318.
59. Hu FB, Willett WC, Li T, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical 
activity in predicting mortality among women. N Engl J Med. 2004;351(26):2694–2703.
60. Lee IM, Paffenbarger RS, Jr. Change in body weight and longevity. Jama. 1992;268(15):2045–2049.
61. Breeze E, Clarke R, Shipley MJ, Marmot MG, Fletcher AE. Cause-specific mortality in old age in 
relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of 
male civil servants. Int J Epidemiol. 2006;35(1):169–178.
20
General introductionChapter 1
62. Bamia C, Halkjaer J, Lagiou P, Trichopoulos D, Tjonn eland A, Berentzen TL, et al. Weight change 
in later life and risk of death amongst the elderly: the European Prospective Investigation into 
Cancer and Nutrition-Elderly Network on Ageing and Health study. J Intern Med. 2010;268(2):133–
144.
63. Fontaine KR, Barofsky I. Obesity and health-related q uality of life. Obes Rev. 2001;2(3):173–182.
64. Burns CM, Tijhuis MA, Seidell JC. The relationship bet ween quality of life and perceived 
body weight and dieting history in Dutch men and women. Int J Obes Relat Metab Disord. 
2001;25(9):1386–1392.
65. Kozak AT, Daviglus ML, Chan C, Kiefe CI, Jacobs DR, Jr. , Liu K. Relationship of body mass index 
in young adulthood and health-related quality of life two decades later: the Coronary Artery 
Risk Development in Young Adults study. Int J Obes (Lond). 2011;35(1):134–141.
66. Verkleij SP, Adriaanse MC, Wendel-Vos GC, Schuit AJ. Lon gitudinal relation between weight 
change and quality of life in a community-based population: a prospective cohort study. Eur J 
Public Health. 2013;23(2):285–290.
Obesity (Silver Spring). 2013;21(5):865–880.
2
Influence of calendar period on 
the association between BMI and 
coronary heart disease: 
a meta-analysis of 31 cohorts
Ellen L de Hollander, Rik P Bogers, Hendriek C Boshuizen, 
Annika Rosengren, Martin J Shipley, Paul Knekt, Pierre Ducimetière, 
Alessandro Menotti, Lisette CPGM de Groot, Wanda JE Bemelmans, 
for the BMI-CHD collaboration investigators
22
Calendar period, body mass index and coronary heart diseaseChapter 2
Abstract
Objectives: The association between obesity and coronary heart disease (CHD) may have 
changed over time, for example due to improved pharmacological treatment of CHD 
risk factors. This meta-analysis of 31 prospective cohort studies explores the influence 
of calendar period on CHD risk associated with body mass index (BMI). 
Design and Methods: The relative risks (RRs) of CHD for a five-BMI-unit increment 
and BMI categories were pooled by means of random effects models. Meta-regression 
analysis was used to examine the influence of calendar period (>1985 v ≤1985) in 
univariate and multivariate analyses (including mean population age as a covariate). 
Results: The age, sex and smoking adjusted RR [95% confidence intervals (CI)] of CHD for 
a five-BMI-unit increment was 1.28 (95%CI: 1.22–1.34). For underweight, overweight and 
obesity, the RRs (compared to normal weight) were 1.11 (95%CI: 0.91–1.36), 1.31 (95%CI: 
1.22–1.41) and 1.78 (95%CI: 1.55–2.04), respectively. The univariate analysis indicated 
a 31% (95%CI: -56 to 0%) lower RR of CHD associated with a five-BMI-unit increment 
and a 51% (95%CI: -78 to -14%)) lower RR associated with obesity in studies starting 
after 1985 (n=15 and n=10, respectively) compared to studies starting in or before 1985 
(n=16 and n=10). However, in the multivariate analysis, only mean population age was 
independently associated with the RRs for a five-BMI-unit increment and obesity [-29% 
(95%CI: -55 to -5%) and -31% (95%CI: -66 to 3%), respectively] per 10-year increment 
in mean age). 
Conclusion: This study provides no consistent evidence for a difference in the association 
between BMI and CHD by calendar period. The mean population age seems to be the 
most important factor that modifies the association between the risk of CHD and BMI, 
in which the RR decreases with increasing age. 
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Introduction
The prevalence of both overweight and obesity has increased worldwide over the past 
decades, especially after the 1980s in Europe and the USA.1-3 This is a major concern because 
obesity is associated with increased mortality, disability, decreased quality of life, high health 
care costs, and morbidity including coronary heart disease (CHD).1,4
Despite the rise in the prevalence of obesity, CHD mortality rates have declined since the 
1960s–1970s in Western Europe, Australia and the USA.5,6 This decline can be explained by 
major improvements in coronary treatments and CHD management since the mid 1980s 
and by changes in risk factors – even in overweight and obese persons – such as a decrease 
in the prevalence of smoking, and in blood pressure and cholesterol levels.7-10 Additional in 
this period, the lifestyle approach was advocated within healthcare procedures to combat 
CHD.11,12 Because of all these developments, we expected that the risk of incidence and 
mortality of CHD associated with being overweight or obese has decreased over time.
The impact of time on CHD risk associated with obesity in adults has not been examined in 
a large meta-analysis before. Knowledge of time-dependent shifts in CHD risk associated 
with obesity not only provides indirect ‘evidence’ for improved health care procedures in 
the obese, but is also important for forecasting future deaths from chronic diseases, as 
presented in leading publications.13,14 This in turn is fundamental for underpinning the 
needs for policies on obesity and CVD management. 
The present meta-analysis, including 31 prospective cohort studies from various countries, 
comprising 389,212 persons, examined the influence of calendar period (the year in which 
the study started) on the association between BMI and CHD, adjusted for age, sex and 
smoking. The analysis took additional study characteristics (i.e. mean age of the population 
and length of follow-up) into account that have been proposed to influence the association 
between body weight and CHD.15,16 To test for the impact of changes in risk factors over time 
(induced by treatment developments), we additionally examined the influence of calendar 
period on the association between BMI and CHD in a subset of 21 cohort studies with 
additional adjustments for physical activity, blood pressure and cholesterol. We expected 
that the influence of calendar period would be attenuated by adjusting for CHD risk factors.
Methods
Data sources, study selection and data extraction were previously described in detail.17 Briefly, 
studies were identified by a PubMed/Medline search until 2007 by using the following search 
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strategy: obesity, body mass index, BMI, or overweight in either the title or in the Medical 
Subject Heading (MeSH) and either coronary heart disease in the title or coronary disease in 
MeSH, plus either prospective or cohort. Also, we examined reference lists of identified articles, 
and got suggestions through colleagues. Eligible studies were prospective cohort studies 
conducted in healthy, mainly Caucasian populations. Seventy cohort studies were identified 
and 62 investigators were contacted of whom 31 agreed to participate. The 31 cohort studies 
had data available on BMI, age, sex and smoking and CHD incidence or mortality. Eighteen 
studies used mortality from CHD and 13 studies used incidence of CHD (both fatal and 
non-fatal events) as their endpoint. Twenty-one studies had extra data available on physical 
activity, blood pressure and cholesterol. The investigators from the participating cohort 
studies were requested to calculate hazard ratios (further on called relative risks (RR)) of CHD 
for BMI and their 95% confidence intervals (95%CIs) with systematic adjustments for age, sex 
and smoking, and if available also for physical activity, blood pressure, and cholesterol levels.
Data synthesis
In this study, we examined the influence of calendar period on the pooled RR for BMI as a 
continuous variable (i.e. risk per five units increase in BMI; n=31) as well as for BMI-categories 
(i.e. categories underweight (<18.5 kg/m2; n=17), overweight (25.0–29.9 kg/m2; n=20) and 
obesity (≥30.0 kg/m2; n=20), as compared to the reference category (18.5–24.9 kg/m2)). For 
the 10 studies which only provided RRs for BMI categories, the RRs were transformed to 
their continuous form for each set of adjustments by applying the method of Greenland 
and Longnecker,18 using the numbers of cases as observed rather than their fitted values.19 
The adjusted RRs for BMI were plotted to visualize variation in results between studies.
Calendar period was calculated by using the baseline year of each cohort study. Recruitment 
and data collection at baseline took in most cohort studies more than one year. Therefore, 
baseline year was defined as the mean of the first year and last year in which baseline 
measurements were conducted. The studies were then divided into two strata to examine 
whether the pooled RRs differed by calendar period (≤1985 and >1985). The 1985 cut-
point chosen, corresponded with the period when major changes occurred regarding the 
management of CHD and the increase in advocating lifestyle approaches within healthcare 
procedures.7-12 Furthermore, the influence of other important study characteristics on the 
association between BMI and CHD, i.e. age of the population (defined as the mean age of 
the population at baseline) and length of follow-up (defined as the mean length in years 
the population was followed to their endpoint) were examined. 
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Statistical analysis
Descriptive statistics were used to describe the main characteristics of the cohort studies, 
i.e. baseline year, mean age of the population and length of follow-up. 
The age, sex and smoking adjusted log RRs for BMI as a continuous and categorical 
variable were pooled by means of a random effects model,20 using the MIXED procedure 
in SAS (version 9.1). The pooled RR and the 95% confidence interval was estimated by 
exponentiating the results from this model. Heterogeneity of RRs between cohort studies 
was tested using chi-squared tests. 
To determine sensitivity of the results, meta-analyses with 30 studies (continuous BMI) and 
with 16 and 19 studies (BMI categories) were performed, leaving repeatedly each individual 
study out of the pooled risk. Further, to check for potential bias due to misclassification 
of BMI based on self-reported weight and height, analyses were repeated after excluding 
cohorts with self-reported BMI. This meant exclusion of four studies in the analysis for 
continuous BMI, overweight and obesity and three studies for underweight. Publication 
bias was investigated using a funnel plot.
To examine the influence of calendar period (>1985 v ≤1985), age of the population and 
length of follow-up (expressed per 10-year increment), a meta-regression analysis (including 
the random effects model) was used. In this meta-regression analysis, the age, sex and 
smoking adjusted log RR of the studies was regressed onto the study characteristics. This 
was done by using a univariate (i.e. calendar period, age and length of follow-up in separate 
models) and a multivariate analysis (i.e. calendar period and age of the population adjusted 
for each other). Calendar period and length of follow-up were not simultaneously entered 
into the model to prevent multicollinearity since baseline year and length of follow-up were 
highly correlated (Pearson’s r=-0.86; p<0.001). Similar models were used for the categories 
underweight, overweight and obesity.
These analyses were then repeated in a subset of cohort studies (continuous BMI: n=21, 
underweight: n=12, overweight and obesity: n=14) with log RRs additionally adjusted for 
physical activity, blood pressure and cholesterol.
The influence of study characteristics is reported as a percentage change of the RR of CHD 
associated with BMI by the study characteristic term. To give insight in how the percentage 
change was calculated, we present the following hypothetical example:
Suppose the regression coefficients for the log(RR) are 0.3 for the intercept and -0.1 for the 
calendar period effect. In that case, the RR of studies starting before and in 1985 is e0.3=1.35 
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and the RR for studies starting after 1985 is e(0.3 + -0.1)=1.22. This gives a percentage change 
of ((1.22-1)-((1.35-1))/(1.35-1)x100%=-37%. To indicate whether the influence of a study 
characteristic was statistically significant, the accompanying 95% confidence intervals 
(95%CI) are presented. 
Results
Characteristics of cohorts
Table 2.1 presents the characteristics of the study populations, comprising a total of 389,212 
persons. During follow-up in total 20,652 CHD events were observed. Some studies provided 
RRs for a longer length of follow-up than in the original articles. The cohorts used for analysis 
regarding BMI categories are marked in Table 2.1.
Table 2.2 presents the descriptive statistics of baseline year, age of the population and length 
of follow-up. For the earlier studies (≤1985), age of the population was lower in comparison 
with the later studies (>1985). The length of follow-up was longer for the earlier studies. 
Relative risks of CHD associated with BMI
For the 31 studies, the age, sex and smoking adjusted RR of CHD was increased for a five-
BMI-unit increment, overweight and obesity (Table 2.3). Underweight was not associated 
with the risk of CHD [RR 1.11 (95%CI: 0.91–1.36)]. After adjustment for physical activity, 
blood pressure and cholesterol, the RRs for a five-BMI-unit increment, overweight and 
obesity were lower but still significant as reported previously.17 
There was substantial heterogeneity between study results of the 31 cohorts (p<0.001; 
Figure 2.1) and between the study results for each BMI category (p<0.05; not shown). The 
sensitivity analysis indicated no strong influence by individual studies as the change in RR 
of CHD associated with BMI ranged maximally from -0.08 to 0.06 when single studies were 
excluded. Exclusion of studies that used self-reported BMI resulted in somewhat lower RRs 
in the remaining cohorts concerning increasing BMI, underweight, overweight and obesity 
[respectively, 1.26 (95%CI: 1.20–1.32); 1.09 (95%CI: 0.84–1.42); 1.26 (95%CI: 1.18–1.35); 1.66 
(95%CI: 1.45–1.91)].
The funnel plot suggested that studies with higher estimates of relative risk were not 
overrepresented, suggesting that there was no publication bias using the 31 cohorts 
27
Calendar period, body m
ass index and coronary heart disease
Chapter 2
Ta
bl
e 
2.
1 
Ch
ar
ac
te
ris
tic
s 
of
 s
tu
di
es
 in
cl
ud
ed
 in
 th
e 
po
ol
ed
 a
na
ly
si
s
St
ud
y
%
 
m
al
e
Ag
e 
ra
ng
e
Ba
se
lin
e 
ye
ar
(s
)
M
ed
ia
n 
or
 m
ea
n 
fo
llo
w
-u
p(
yr
)
%
 
Cu
rr
en
t 
sm
ok
er
s
N
o.
 a
va
ila
bl
e 
fo
r a
na
ly
si
s
N
o.
 
ca
se
s
D
es
cr
ip
tio
n 
of
 e
nd
po
in
t
Au
st
ra
lia
n 
N
at
io
na
l H
ea
rt
 
Fo
un
da
tio
n 
Ri
sk
 F
ac
to
r 
Pr
ev
al
en
ce
 S
tu
dy
21
cd
49
20
–7
0
19
89
–1
99
0
8.
3
24
9,
09
9
76
de
at
h 
fr
om
 C
H
D
: I
CD
-9
 c
od
es
 4
10
–4
14
Bu
ss
el
to
n 
H
ea
lth
 S
tu
dy
22
49
40
–7
5
19
66
–1
98
1
10
34
3,
89
1
18
7
de
at
h 
fr
om
 C
H
D
: I
CD
-9
 c
od
es
 4
10
–4
14
Ca
er
ph
ill
y 
co
ho
rt
 S
tu
dy
23
,2
4b
10
0
47
–6
7
19
84
–1
98
8
12
44
2,
16
0/
2,
35
7
39
8
fa
ta
l 
an
d
 n
o
n
-f
at
al
 e
ve
n
ts
: 
d
ea
th
 f
ro
m
 
CH
D
; c
lin
ic
al
 n
on
-f
at
al
 (
de
fin
ite
 a
cu
te
) 
M
I; 
el
ec
tr
oc
ar
di
og
ra
ph
ic
 M
I
D
ub
bo
 s
tu
dy
 o
f A
us
tr
al
ia
n 
el
de
rly
25
b
44
60
–9
4
19
88
13
15
2,
80
5
96
8
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s:
 h
os
pi
ta
lis
at
io
n 
or
 
de
at
h 
IC
D
-9
-C
M
 c
od
es
 4
10
–4
14
EC
CI
S 
st
ud
y2
6
10
0
40
–5
9
19
89
–1
99
2
5
38
4,
85
0
73
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s: 
de
fin
ite
 M
I; s
ud
de
n 
co
ro
na
ry
 d
ea
th
; c
as
es
 ju
dg
ed
  
of
 c
or
on
ar
y 
or
ig
in
 a
lt
ho
ug
h 
m
an
ife
st
ed
 o
nl
y 
as
 h
ea
rt
 
fa
ilu
re
, a
rr
hy
th
m
ia
 a
nd
 b
lo
ck
s
Fi
nn
is
h 
M
ob
ile
 C
lin
ic
 H
ea
lth
 
Ex
am
in
at
io
n 
Su
rv
ey
27
cd
53
30
–6
9
19
67
–1
97
2
22
34
30
,7
65
3,
31
9
de
at
h 
fr
om
 C
H
D
: I
CD
-8
 c
od
es
 4
10
–4
14
Fi
nn
is
h 
Tw
in
 C
oh
or
t 
St
ud
y2
8,
29
ad
50
24
–6
0
19
81
19
.7
30
15
,1
27
15
5
d
ea
th
 f
ro
m
 C
H
D
: 
IC
D
-8
 4
10
–4
14
, 
IC
D
9 
41
0–
41
4,
 IC
D
10
 I2
1–
25
Fl
et
ch
er
 C
ha
lle
ng
e3
0c
d
72
20
–8
9
19
92
4.
8
24
10
,2
01
11
0
de
at
h 
fr
om
 C
H
D
G
ub
bi
o 
Po
pu
la
tio
n 
St
ud
y3
1
45
35
–7
4
19
83
–1
98
5
6
35
2,
96
3
12
6
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s: 
de
fin
ite
 M
I; s
ud
de
n 
co
ro
na
ry
 d
ea
th
; c
as
es
 j
ud
ge
d 
of
 c
or
on
ar
y 
or
ig
in
 a
lt
ho
ug
h 
m
an
ife
st
ed
 o
nl
y 
as
 h
ea
rt
 
fa
ilu
re
, a
rr
hy
th
m
ia
 a
nd
 b
lo
ck
s
Io
w
a 
W
om
en
’s 
H
ea
lth
 
St
ud
y3
2a
cd
0
55
–6
9
19
86
15
.8
15
32
,0
11
/3
0,
74
1
1,
12
1
de
at
h 
fr
om
 C
H
D
Ita
lia
n 
Ru
ra
l A
re
as
33
b
10
0
40
–5
9
19
60
35
61
1,
62
2
21
4
de
at
h 
fr
om
 C
H
D
: d
ef
in
ite
 fa
ta
l M
I; 
ot
he
r f
or
m
s 
of
 fa
ta
l i
sc
he
m
ia
; s
ud
de
n 
de
at
h 
fr
om
 C
H
D
Ta
bl
e 
2.
1 
co
nt
in
ue
s o
n 
ne
xt
 p
ag
e
28
Calendar period, body mass index and coronary heart diseaseChapter 2
Ta
bl
e 
2.
1 
Co
nt
in
ue
d
St
ud
y
%
 
m
al
e
Ag
e 
ra
ng
e
Ba
se
lin
e 
ye
ar
(s
)
M
ed
ia
n 
or
 m
ea
n 
fo
llo
w
-u
p(
yr
)
%
 
Cu
rr
en
t 
sm
ok
er
s
N
o.
 a
va
ila
bl
e 
fo
r a
na
ly
si
s
N
o.
 
ca
se
s
D
es
cr
ip
tio
n 
of
 e
nd
po
in
t
Ku
op
io
 Is
ch
ae
m
ic
 H
ea
rt
 
D
is
ea
se
 R
is
k 
Fa
ct
or
 S
tu
dy
34
d  
(K
IH
D
)
10
0
42
–6
1
19
84
–1
98
9
10
.6
31
1,
59
7
15
5
fa
ta
l 
an
d
 n
on
-f
at
al
 e
ve
n
ts
: 
d
ef
in
it
e 
an
d 
pr
ob
ab
le
 a
cu
te
 M
I; 
pr
ol
on
ge
d 
ch
es
t 
pa
in
 
ep
is
od
es
M
al
m
ö 
Pr
ev
en
tiv
e 
Pr
oj
ec
t3
5d
 
(M
PP
)
10
0
27
–6
1
19
74
–1
98
4
17
.7
49
22
,0
25
1,
72
7
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s:
 a
cu
te
 M
I (
IC
D
 c
od
e 
41
0)
; d
ea
th
 fr
om
 c
hr
on
ic
 C
H
D
 (I
CD
 c
od
es
 4
12
 
an
d 
41
4)
M
an
re
sa
 C
at
al
on
ia
 s
tu
dy
36
10
0
30
–5
9
19
68
18
.5
67
1,
05
9
13
5
fa
ta
l 
an
d 
no
n-
fa
ta
l 
ev
en
ts
: f
at
al
 M
I; 
ot
he
r 
de
at
h,
 su
dd
en
 o
r n
on
-s
ud
de
n,
 p
re
su
m
ed
 d
ue
 
to
 C
H
D
 (I
CD
A
 4
10
–4
13
, 7
95
, 4
27
.0
, 4
27
.2
 a
nd
 
42
7.
9)
; n
on
-fa
ta
l M
I
M
el
bo
ur
ne
 C
ol
la
bo
ra
tiv
e 
Co
ho
rt
 S
tu
dy
37
cd
41
27
–7
5
19
90
–1
99
4
5.
6
11
41
,1
19
32
3
de
at
h 
fr
om
 C
H
D
M
ul
tif
ac
to
r P
rim
ar
y 
Pr
ev
en
tio
n 
St
ud
y3
8c
d  (
M
PP
S)
 
G
öt
eb
or
g
10
0
47
–5
5
19
70
–1
97
3
22
.0
50
7,
37
1
1,
68
8
fa
ta
l a
nd
 n
on
-f
at
al
 e
ve
nt
s:
 d
ea
th
 f
ro
m
 C
H
D
 
(IC
D
-8
/9
 c
od
es
 4
10
–4
14
); 
no
n-
fa
ta
l M
I
N
H
A
N
ES
 I 
Ep
id
em
io
lo
gi
c 
Fo
llo
w
-u
p 
St
ud
y3
9c
d (
N
H
EF
S)
44
25
–7
4
19
71
–1
97
5
20
45
5,
13
9/
5,
07
8
54
3
de
at
h 
fr
om
 C
H
D
: I
CD
-9
 c
od
es
 4
10
–4
14
.9
N
ijm
eg
en
 C
oh
or
t S
tu
dy
40
cd
48
20
–5
2
19
77
–1
97
8
18
58
5,
89
8
26
8
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s: 
M
I; a
ng
in
a 
pe
ct
or
is
N
or
w
eg
ia
n 
Co
un
tie
s 
St
ud
y4
1c
d
51
35
–4
9
19
74
–1
97
8
26
45
43
,8
96
1,
56
4
de
at
h 
fr
om
 C
H
D
: I
C
D
-8
/9
 c
od
es
 4
10
–4
14
, 
IC
D
-1
0 
co
de
s 
I2
1–
25
; s
ud
de
n 
de
at
hs
 (
IC
D
-8
 
co
de
s:
 7
82
.4
, 7
95
; I
CD
-9
 c
od
es
: 7
98
.1
–7
98
.2
; 
IC
D
-1
0 
co
de
s:
 R
96
)
N
ur
se
s’ 
H
ea
lth
 S
tu
dy
42
ac
d
0
34
–5
9
19
80
20
28
76
,6
15
1,
99
6
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s:
 d
ea
th
 fr
om
 C
H
D
; 
no
nf
at
al
 M
I; 
su
d
d
en
 d
ea
th
 w
it
hi
n 
1 
h 
of
 
on
se
t o
f s
ym
pt
om
s 
in
 w
om
en
 w
ith
 n
o 
ot
he
r 
pl
au
si
bl
e 
ca
us
e 
ot
he
r t
ha
n 
CH
D
29
Calendar period, body m
ass index and coronary heart disease
Chapter 2
Pe
rt
h 
Co
ho
rt
43
,4
4c
d
52
20
–9
0
19
79
–1
99
4
14
.4
25
9,
72
7
18
7
de
at
h 
fr
om
 C
H
D
PR
IM
E 
st
ud
y4
5b
10
0
50
–5
9
19
91
–1
99
3
5
28
9,
75
7
31
7
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s: 
M
I; d
ea
th
 fr
om
 C
H
D
; 
an
gi
na
 p
ec
to
ris
Ro
m
e 
Ra
ilr
oa
d 
Co
ho
rt
46
b
10
0
40
–5
9
19
62
25
66
72
6
88
de
at
h 
fr
om
 C
H
D
: d
ef
in
ite
 f
at
al
 M
I; 
su
dd
en
 
de
at
h 
fr
om
 C
H
D
; c
as
es
 ju
dg
ed
 o
f C
H
D
 o
rig
in
 
al
th
ou
gh
 m
an
ife
st
ed
 o
nl
y 
as
 h
ea
rt
 f
ai
lu
re
, 
ar
rh
yt
hm
ia
 a
nd
 b
lo
ck
s
Sc
ot
tis
h 
H
ea
rt
 H
ea
lth
 
St
ud
y4
7c
d
51
40
–5
9
19
84
–1
98
7
7.
6
39
10
,2
62
17
1
fa
ta
l a
nd
 n
on
-fa
ta
l e
ve
nt
s: 
M
I; 
co
ro
na
ry
 a
rt
er
y 
su
rg
er
y;
 d
ea
th
 fr
om
 C
H
D
SE
N
EC
A
48
cd
48
70
–
10
0
19
88
–1
98
9
10
18
1,
19
6
55
de
at
h 
fr
om
 C
H
D
: I
CD
 4
10
–4
14
Sw
ed
is
h 
A
nn
ua
l L
ev
el
-o
f-
Li
vi
ng
 S
ur
ve
y4
9a
cd
 (S
A
LL
S)
51
35
–7
4
19
88
–1
98
9
11
.7
27
5,
19
6
37
3
fa
ta
l a
nd
 n
on
-f
at
al
 e
ve
nt
s:
 IC
D
-9
 4
10
–4
14
, 
IC
D
10
 I2
0–
I2
5
U
S 
Ra
ilr
oa
d 
co
ho
rt
46
b
10
0
40
–5
9
19
57
–1
95
9
25
60
2,
41
5
48
1
de
at
h 
fr
om
 C
H
D
: d
ef
in
ite
 f
at
al
 M
I; 
su
dd
en
 
de
at
h 
fr
om
 C
H
D
; c
as
es
 ju
dg
ed
 o
f C
H
D
 o
rig
in
 
al
th
ou
gh
 m
an
ife
st
ed
 o
nl
y 
as
 h
ea
rt
 f
ai
lu
re
, 
ar
rh
yt
hm
ia
 a
nd
 b
lo
ck
s
Ve
nt
im
ig
lia
 d
i S
ic
ili
a 
H
ea
rt
 
St
ud
y5
0  (
VH
S)
43
20
–6
9
19
89
8
17
83
5
8
de
at
h 
fr
om
 C
H
D
: d
ef
in
ed
 M
I; 
su
dd
en
 d
ea
th
W
es
te
rn
 A
us
tr
al
ia
n 
A
bd
om
in
al
 A
or
tic
 A
ne
ur
ys
m
 
St
ud
y5
1,
52
cd
10
0
65
–8
4
19
96
1.
2
11
12
,1
94
24
0
de
at
h 
fr
om
 C
H
D
W
hi
te
ha
ll 
St
ud
y5
3,
54
cd
10
0
40
–6
4
19
67
–1
96
9
33
41
17
,4
75
3,
50
3
de
at
h 
fr
om
 C
H
D
: I
CD
-8
 c
od
es
 4
10
–4
14
Zu
tp
he
n 
El
de
rly
 S
tu
dy
55
cd
10
0
64
–8
4
19
85
10
.3
33
57
5
83
de
at
h 
fr
om
 C
H
D
: I
CD
-9
 c
od
es
 4
10
–4
14
A
bb
re
vi
at
io
ns
: C
H
D
, C
or
on
ar
y 
H
ea
rt
 D
is
ea
se
: I
CD
, I
nt
er
na
tio
na
l C
la
ss
ifi
ca
tio
n 
of
 D
is
ea
se
 (-
8,
 -9
, -
10
 in
di
ca
te
 th
e 
re
vi
si
on
 n
um
be
r; 
CM
 C
lin
ic
al
 M
od
ifi
ca
tio
n)
; M
I, 
m
yo
ca
rd
ia
l i
nf
ar
ct
io
n;
 N
H
A
N
ES
, 
N
at
io
na
l H
ea
lth
 a
nd
 N
ut
rit
io
n 
Ex
am
in
at
io
n 
Su
rv
ey
; P
RI
M
E,
 P
ro
sp
ec
tiv
e 
Ep
id
em
io
lo
gi
ca
l S
tu
dy
 o
f M
yo
ca
rd
ia
l I
nf
ar
ct
io
n.
a B
od
y 
m
as
s 
in
de
x 
ba
se
d 
on
 s
el
f-r
ep
or
t o
f t
he
 p
ar
tic
ip
an
ts
.  
b N
o 
re
su
lts
 a
va
ila
bl
e 
fo
r b
ot
h 
th
e 
ca
te
go
rie
s 
m
od
er
at
e 
ov
er
w
ei
gh
t (
bo
dy
 m
as
s 
in
de
x,
 2
5.
0–
29
.9
 [c
al
cu
la
te
d 
as
 w
ei
gh
t i
n 
ki
lo
gr
am
s 
di
vi
de
d 
by
 h
ei
gh
t i
n 
m
et
er
s 
sq
ua
re
d]
) a
nd
 o
be
si
ty
 (b
od
y 
m
as
s 
in
de
x,
 ≥
30
.0
).
c C
oh
or
t u
se
d 
fo
r a
na
ly
si
s 
re
ga
rd
in
g 
un
de
rw
ei
gh
t.
d C
oh
or
t u
se
d 
fo
r a
na
ly
si
s 
re
ga
rd
in
g 
ov
er
w
ei
gh
t a
nd
 o
be
si
ty
.
30
Calendar period, body mass index and coronary heart diseaseChapter 2
Table 2.2 Mean (range) study characteristics
Baseline year Age of 
population (yr)
Length of 
follow-up (yr)
Studies in the body mass index analyses
All studies (n=31)a 1981 (1958–1996) 51.5 (35.0–73.0) 15.0 (1.2–35.0)
Studies ≤1985 (n=16) 1973 (1958–1985)* 48.1 (35.0–71.1)* 20.8 (6.0–35.0)*
Studies >1985 (n=15) 1989 (1986–1996) 55.1 (43.4–73.0) 8.9 (1.2–15.8)
Studies in the overweight and obesity analyses
Total (N=20)a 1983 (1969–1996) 51.0 (35.0–73.0) 15.2 (1.2–33.0)
Studies ≤1985 (n=10) 1976 (1969–1985)* 47.1 (35.0–71.1) 21.3 (15–33.0)*
Studies >1985 (n=10) 1989 (1986–1996) 54.8 (43.4–73.0) 9.0 (1.2–15.8)
*Significant difference between calendar period strata: p<0.05.
a The mean study characteristics did not change substantially in the subset of studies used in the model with additional adjustments 
for physical activity, blood pressure and cholesterol, although the range was slightly reduced with approximately 4 years in 
baseline year and follow-up period.
Figure 2.1 Relative risks of coronary heart disease per increment of 5 kg/m2, adjusted for age, sex 
and smoking. Horizontal lines indicate 95% confidence intervals.
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(Appendix 1; see publication: http://onlinelibrary.wiley.com/doi/10.1002/oby.20043/
abstract).  
Infl uence of calendar period and other factors on the relative risk of CHD 
for BMI
The relationships between study characteristics and the RR of CHD associated with BMI as a 
continuous and categorical variable are graphically displayed in Appendix 2 (see publication; 
http://onlinelibrary.wiley.com/doi/10.1002/oby.20043/abstract).
Table 2.3 presents the percentage changes in the RR of CHD associated with BMI by calendar 
period, age of the population and length of follow-up for the univariate and multivariate 
meta-regression analyses. Because underweight was not associated with CHD, the influences 
of the study characteristics were not examined for this category. Table 2.4 presents the 
RRs of CHD associated with continuous and categorical BMI stratified by calendar period.
Relative risks adjusted for age, sex and smoking
The difference in the RR of CHD for a five-BMI-unit increment and obesity between calendar 
periods, that was observed in the univariate analysis [-31% (95%CI: -56 to 0%) and -51% 
(95%CI: -78 to -14%), respectively] (Table 2.3, 2.4), was no longer observed in the multivariate 
analysis (Table 2.3). However, in the multivariate analysis, age of the population still (near) 
significantly lowered the RR by 29% (95%CI: -55 to -5%) and 31% (95%CI: -66 to 3%) 
respectively for each ten-year increase in age of the population (Table 2.3). No interaction 
effect between calendar period and mean age was found. 
Length of follow-up (only examined in the univariate analysis) had a significant influence 
on the RR associated with a five-BMI-unit increment [+25% (95%CI: 0 to 52%)] and with 
obesity [+53% (95%CI: 9 to 109%)] (Table 2.3). 
We repeated these analyses in a subset of studies (n=13; n=6 ≤1985; n=7 >1985) with a 
length of follow-up between 10–19.9 years in order to reduce correlation between baseline 
year and length of follow-up (Pearson’s r=-0.48; p= 0.10) and overlap in time period. In this 
subset, the results for calendar period and age of the population were similar (data not 
shown). 
Also, to take both baseline year and length of follow-up into account together with age 
of the population, we repeated the analyses with the variables age of the population and 
half of the follow-up length added up to baseline year. Then, calendar period had not an 
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influence on the association between BMI and CHD in the univariate or multivariate analysis, 
while the influence of age of the population remained the same (data not shown).
Relative risks additionally adjusted for physical activity, blood pressure and 
cholesterol
When the RRs were additionally adjusted for physical activity, blood pressure and cholesterol, 
the univariate analysis indicated no longer a significant influence of calendar period on the 
associations between a five-BMI-unit increment and CHD and obesity and CHD, but the 
percentage changes remained in the same order of magnitude [-36% (95%CI: -78 to 15%) 
and -51% (95%CI: -96 to 10%), respectively] (Table 2.3, 2.4). Age of the population remained 
significant for the association between a five-BMI-unit increment and CHD [-44% (95%CI: 
-90 to -4)], but not for overweight and obesity (Table 2.3).
The multivariate analysis indicated that age of the population did not significantly influence 
the association between overweight or obesity and CHD, but a trend was still visible for 
the association between a five-BMI-unit increment and CHD [-40% (95%CI: -105 to 6%)] 
(Table 2.3). 
Length of follow-up had no longer a significant influence on the association between a 
five-BMI-unit increment and CHD and obesity and CHD (Table 2.3).
Table 2.4 Relative risks (RR) of CHD per five BMI-unit increment, overweight and obesity stratified 
by calendar period (>1985 v ≤1985)
BMI measure of interest Model (nstudies) Pooled RR (95%CI)*
Calendar period ≤1985 Calendar period >1985
Continuous 5-BMI-unit increment 1 (n=31) 1.33 (1.27–1.41) 1.23 (1.16–1.31)
2 (n=21) 1.19 (1.13–1.24) 1.12 (1.04–1.20)
Overweight 1 (n=20) 1.35 (1.23–1.48) 1.25 (1.11–1.42)
2 (n=14) 1.17 (1.10–1.24) 1.18 (1.03–1.35)
Obesity 1 (n=20) 2.05 (1.75–2.40) 1.51 (1.26–1.81)
2 (n=14) 1.57 (1.39–1.78) 1.28 (1.04–1.58)
Model 1: the RRs are adjusted for age, sex and smoking at baseline.
Model 2: Model 1 with additional adjustment physical activity, blood pressure and cholesterol at baseline.
*Calculated from the univariate meta-regression analysis including calendar period, see explanation in text and Table 2.3 for the 
percentage difference between calendar periods.
34
Calendar period, body mass index and coronary heart diseaseChapter 2
Because we used two endpoints, we examined whether there was a difference between 
incidence and mortality regarding the RR of BMI (categories). We found no differences and 
also the influence of calendar period, follow-up period or mean age on the RR did not differ 
by the endpoint used in the analyses (data not shown).
Discussion
In this meta-analysis of 31 cohorts worldwide including 389,212 mainly Caucasian persons 
and 20,652 CHD events, we explored the hypothesis whether the RR of CHD associated with 
BMI is lower in later studies compared to earlier studies. Further, we took other important 
study characteristics, i.e. age of the population and length of follow-up into account. By 
taking these study characteristics into account and carrying out extra analyses with RRs 
adjusted for CHD risk factors, we found no longer a difference in the RR of CHD associated 
with BMI between calendar periods. The most important and consistent cohort characteristic 
influencing the association between BMI and CHD was age of the population.
Strengths and limitations
The strength of our analysis lies in the large number of cohorts including populations from 
various countries and the systematic adjustments for relevant cohort variables (i.e. length 
of follow-up and age of the population). No indication of publication bias was found, as 
was discussed also in a previous publication.17 
Another strength of our meta-analysis is that we were able to account for CHD risk factors 
(i.e. physical activity, blood pressure and cholesterol) which could influence the change in 
the association between BMI and CHD over time. 
Several limitations should be addressed. First, we did not use studies with a baseline year in 
the 21st century. This limited our time span to examine the influence of calendar period and 
to give insight on recent developments of the association between BMI and CHD. Second, 
length of follow-up was found to be a strong confounder, but was also strongly correlated 
with baseline year and associated with the RR of CHD for BMI (categories). However, in a 
previous analysis of data from the NHANES study, adjustment for length of follow-up did 
not affect the outcome of the trend of decreasing RRs of all-cause mortality for obesity 
over time.13 Third, for some studies the RRs for categories of BMI were transformed to RRs 
for BMI as a continuous variable, which may have introduced some inaccuracy. Finally, we 
did not adjust for important confounders such as dietary variables or weight (loss) history 
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because these were not available in most studies although those have been shown to be 
related to BMI and CHD.56,57 Nevertheless, in the Nurses’ Health Study (the largest included 
study) adjustment for diet had virtually no impact on the association between BMI and 
risk of CHD.42
Findings in the context of the literature
We found increased RRs of CHD for a five-BMI-unit increment, overweight and obesity of 
1.28, 1.31, and 1.78, respectively. The accompanying RRs with the additional adjustments 
were 1.16, 1.17 and 1.49, respectively. This corresponds well with relative risks found in 
other studies.58-61
With regard to time-dependent changes in the association between obesity and health 
risks, a previous meta-analysis found in overweight and obese elderly an RR of total 
mortality of 0.47 (95%CI: 0.40–0.55) and 0.66 (95%CI: 0.51–0.71), using 5 cohorts starting 
in or after 1990.62 In 13 and 15 cohorts starting before 1990, they found respectively an 
RR of 1.00 (95%CI: 0.96–1.04) and 1.02 (95%CI: 0.98–1.07).62 In the National Health and 
Nutrition Examination Surveys (NHANES I, II and III), a similar trend of decreasing RR of 
total mortality in obese US adults (≥25 years) was found.13 Our results also indicated an 
association between calendar period and the RR of CHD for (increasing) BMI and obesity, 
but not when study characteristic mean age of the population was taken into account. In 
addition, we expected that the influence of calendar period would be attenuated by the 
additional adjustments for physical activity, blood pressure and cholesterol, because of the 
hypothesis that the blood pressure and cholesterol profile in persons were unfavourable 
at baseline in studies starting before 1985 compared to studies starting after 1985 due to 
improvements of treatment of CHD risk factors and lifestyle. However, after the additional 
adjustments in the univariate analysis, the magnitude of the percentage changes on the 
RRs for a five-BMI-unit increment and obesity remained in the same order as for the age, 
sex and smoking adjusted RRs. 
In summary, we did not find a clear difference between calendar periods in the association 
between BMI and CHD. This suggests that earlier studies may not be ruled out for use in 
predictive models forecasting future deaths of chronic diseases. However, as discussed 
before, length of follow-up and age of the population might have confounded our results, 
since these factors were different between calendar periods. Therefore, we cannot conclude 
beyond doubt that there is no difference between calendar periods. To examine changes by 
calendar period more thoroughly, a meta-analysis should be performed with similar study 
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characteristics to exclude this kind of confounding. Also, systematic adjustments including 
information on medication use should be considered to test our hypothesis.
Nevertheless, our study yields sufficient evidence to draw the conclusion that age of 
the population is an important factor modifying the association between BMI and CHD. 
Throughout all analyses, we found a significant influence of age of the population on the 
association between BMI and CHD, except in the univariate and multivariate analyses with 
CHD and overweight and obesity adjusted for the additional CHD risk factors. These exceptions 
can easily be explained by the low number of included studies with an old population (n=1), 
which in turn made it less accurate to regress the log RR on age for the higher age ranges. 
All together, our results stress the importance of taking age of a population into account in 
predictive models forecasting future deaths attributable to overweight and obesity. 
The decrease in RR of CHD for a five-BMI-unit increment with each 10 year increment of 
age was comparable to previous studies who found a decreasing trend in the RR of CHD 
associated with BMI with increasing age.58,63 An explanation for the reduction in RR at 
higher BMI levels with increasing age is complicated. In the elderly, the value of BMI as 
an indicator of body fatness is reduced because of the higher total fat mass (because of 
an age-dependent loss of lean body mass), fat redistribution and age-related decline in 
height.64 Unintentional age-related weight loss which might be caused by (un)diagnosed 
illnesses can confound the association between BMI and risk of disease/mortality in the 
elderly.64 Also, the ones susceptible for the consequences of obesity might have died earlier 
in life, while the remaining obese elderly persons survived.64 Furthermore, several studies 
reported that the lowest mortality from all-causes or CVD in elderly persons lies within the 
overweight category, which indicates that a BMI of 18.5–24.9 kg/m2 is not appropriate for 
the elderly65-67 and therefore another anthropometric measure such as waist circumference, 
waist-hip ratio, body fat or lean body mass might be more useful.68,69
In conclusion, we found no consistent evidence for a difference in the association between 
BMI and the risk of CHD by calendar period, but we cannot conclude beyond doubt that no 
difference exists. Further research, that excludes the possible influence of follow-up length, 
is needed to clarify this. A clear finding of our study is, however, that age of the population 
was consistently associated with the RR of CHD for BMI. In older populations, the RR of CHD 
associated with BMI is lower than in younger populations. Therefore, for models used to 
predict mortality and prevalence of CHD in general populations, for example as used by 
the WHO, data from earlier studies may not be ruled out completely, but applying an age 
specific approach can be highly recommended.
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Abstract
Objectives: To assess the association between Body Mass Index (BMI) and cause-specific 
mortality in older adults and to assess which BMI was associated with lowest mortality. 
Design: Prospective study. 
Setting: European towns. 
Participants: 1,970 older adults, aged 70–77 years from the SENECA (Survey in Europe 
on Nutrition and the Elderly: a concerted action) study.
Measurements: BMI, examined in 1988/1989, and mortality rates and causes of death 
during 10 years of follow-up. 
Results: Cox proportional hazards model including both BMI and BMI2, accounting 
for sex, smoking status, educational level and age at baseline showed that BMI was 
associated with all-cause mortality (p<0.01), cardiovascular mortality (p<0.01) and 
mortality from other causes (p<0.01), but not with cancer or respiratory mortality 
(p>0.3). The lowest all-cause mortality risk was found at 27.1 (95%CI: 24.1–29.3) kg/m2, 
and this risk was increased with statistical significance when higher than 31.4 kg/m2 
and lower than 21.1 kg/m2. The lowest cardiovascular mortality risk was found at 25.6 
(95%CI: 17.1–28.4) kg/m2, and was increased with statistical significance when higher 
than 30.9 kg/m2. 
Conclusions: In this study, BMI was associated with all-cause mortality risk in older 
people. This risk was mostly driven by an increased cardiovascular mortality risk, as no 
association was found for mortality risk from cancer or respiratory disease. Our results 
indicate that the WHO cut-off point of 25 kg/m2 for overweight might be too low in old 
age, but more studies are needed to define specific cut-off points. 
45
BM
I and m
ortality in old age
Chapter 3
Introduction
Two concurring trends in our ageing populations are health problems associated with old 
age and an increased prevalence of overweight.1 In the general population overweight has 
been associated with several diseases,1 such as cardiovascular diseases (CVD) and certain 
types of cancer. These diseases are highly prevalent in older people and are one of the 
main causes of death. However, the impact of weight status at old age on mortality and 
especially on (cause-specific) mortality remains unclear. 
To provide further insight into the association between weight status and all-cause mortality 
in the elderly, a meta-analysis based on 32 studies was carried out. This study concluded that 
overweight (BMI: 25–30 kg/m2) in the elderly did not increase the risk of all-cause mortality 
and that obesity increased this risk only modestly.2 However, these results do not necessarily 
mean that weight status at old age is an unimportant risk factor for mortality. First, it could 
be hypothesized that overweight increases the risk of CVD mortality, while it decreases the 
relative risk of other causes of death, on average resulting in no increased all-cause mortality 
risk. Secondly, because of the use of weight status categories, which have been shown to 
be restrictive in the elderly,3,4 it remains unclear at which BMI measurement the mortality 
risk is increased. For example, if the mortality risk is lowest around a BMI of 25 kg/m2, thus 
at the higher end of the WHO healthy weight range and at the lower end of the overweight 
range, the mortality risk would be similar in both the normal and overweight category. 
Thirdly, since many studies show a U- or J-shaped association between BMI and mortality 
risk at an old age,5-7 it is of importance to investigate both sides of the BMI distribution to 
see at which BMI measurement the mortality risk increases. 
The aim of this study was to assess the association between BMI and cause-specific mortality 
in elderly people (70–77 years) in a European population. The secondary aim was to assess 
which BMI is associated with the lowest mortality and at which BMI the cause-specific 
mortality risk starts to increase. Both a high and a low BMI were considered as potential 
risk factors for increased all-cause and cause-specific mortality.
Methods
Study population
The SENECA (Survey in Europe on Nutrition and the Elderly: a concerted action) study is a 
prospective study investigating whether diet and lifestyle influence the health of elderly 
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people in various European countries. At baseline, participants were selected from an 
age- and sex-stratified sample of inhabitants from the following towns: Hamme, Belgium; 
Roskilde, Denmark; Haguenau, France; Romans, France; Iraklion, Greece; Monor, Hungary; 
Padua, Italy; Rome, Italy; Culemborg, the Netherlands; Vila Franca de Xira, Portugal; Betanzos, 
Spain; Yverdon, Switzerland; Burgdorf, Switzerland; Bellinzona, Switzerland; Marki, Poland. 
All citizens of these towns born between 1913 and 1918 were eligible for enrolment in 
the study. The only exclusion criteria were: living in a psychogeriatric nursing home, not 
being able to speak the country’s language fluently, not being able to answer questions 
independently.
Participation rates varied between towns from 34% to 62%.8 The follow-up period lasted 
from the baseline examination in 1988–1989 until April 30, 1999. Participants for whom 
data was missing for survival time (n=27) or BMI (n=227) were excluded from analyses. 
Furthermore, in three study centres (Monor, Burgdorf and Bellinzona) no information 
about cause of death was collected and therefore all people from these centres were also 
excluded (n=156). Subsequently, subjects for whom data was missing on the confounders 
age (n=6) and education level (n=4) were also excluded. The excluded group (n=420) differed 
somewhat from the study population. These subjects were on average 1.0 year older, had 
a 1.0 point higher BMI and had a higher mortality rate (50% vs. 38%, p<0.001) than the 
included subjects. The age and BMI difference was mainly introduced by excluding the 
three study centres mentioned earlier, because they only included the 1913 and 1914 birth 
year cohorts. However, the higher mortality rate was not caused mainly by excluding the 
three study centres. The total study population consisted of 1,970 subjects. All participants 
gave written informed consent. Approval of the study was obtained from the participating 
SENECA centres.
Health and vital status
Baseline information on smoking, educational level, chronic diseases, and alcohol use was 
obtained through questionnaires. A high level of education comprised secondary or higher 
education, while a low level of education comprised primary education only or illiteracy. 
Food consumption data was collected by trained personnel using the modified dietary 
history method.9 The Mediterranean diet score10 was calculated and dichotomized into a 
low quality (score <4) and high quality diet (score ≥4) and alcohol use was divided into 
abstainers and users, as described elsewhere.11 Household, sports, and leisure-time physical 
activities were estimated using a validated questionnaire.12 Physical activity was classified 
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in the total study population by sex-specific tertiles. Body weight was measured to the 
nearest 0.5 kg on a calibrated scale. Subjects were weighed in the morning after breakfast 
and after emptying their bladder; they wore light underclothing. Height was measured to 
the nearest 0.1 cm while the subjects were standing upright with no shoes on. Body mass 
index (BMI) was calculated by dividing body weight (in kg) by the square of height (m2).
Information on the vital status and causes of death was collected in 1999–2000. Information 
on cause of death was obtained through death certificates from towns in which deaths of 
participants occurred or, if this data was not available, via a medical doctor or first-degree 
relative. One experienced clinical epidemiologist coded the causes of death by using the 
9th revision of the World Health Organization International Classification of Disease (ICD-
9).13 We grouped deaths into four major categories, corresponding with the main causes 
of death among the elderly: cardiovascular disease (CVD), cancer, respiratory disease and 
other causes. In cases where there were multiple causes of death, cancer was prioritized 
above CVD, and CVD was prioritized above the other causes of death. The cause of death 
was unknown for 23.7% out of the total number of deaths.
Statistical analyses
Survival time was computed from the date of a participant’s baseline examination until the 
date of death for decedents, or until April 30, 1999, for survivors.
The major characteristics of the study population were given as frequencies or mean ± SD. 
We used Chi-square tests (categorical variables) or Student’s t-tests (continuous variables) 
to compare the characteristics of subjects over BMI categories.
We used a Cox proportional hazards model to investigate the association between BMI and 
all-cause, and cause-specific mortality. To examine whether the associations between BMI 
categories and mortality in this elderly population are comparable to previous literature,2,6 
we first calculated Hazard Ratios (HR) for BMI categories: <20 kg/m2, 25–30 kg/m2 and ≥30 
kg/m2 compared to the reference category: 20–25 kg/m2, adjusted for the confounders: sex, 
smoking status (current smoker/former/never), education level (high/low), age at baseline.
Hypothesizing that mortality risks are increased at both the lower and higher end of the 
BMI distribution, together with the aforementioned confounders, we analysed BMI as a 
continuous variable using a Cox regression model including BMI and BMI2. Also, from a 
previous study in men (40–69 years), this method was shown to explain more variability in 
mortality than when only the linear term was included or when the WHO classification was 
48
BMI and mortality in old ageChapter 3
used.14 U-shaped associations between BMI and mortality were significant when p<0.05 
for the test that regression coefficients for BMI and BMI2 were 0. 
In the case of a parabolic relation existing between BMI and mortality, we calculated the BMI 
associated with the minimum risk of death by: -b/2a, where ‘a’ represents the coefficients of 
the quadratic term (BMI2) and ‘b’ the coefficient of the linear term (BMI). We also determined 
the BMI ranges at which the mortality risk was increased by <10%, 10–20% or >20%. We 
chose an interval of 10–20% because the BMI at which mortality risks are significantly 
increased highly depends on the number of deaths; with larger numbers of deaths the 
confidence intervals become smaller, thus narrowing the optimum BMI range. The results 
were graphically displayed together with 95% confidence intervals.
Interactions between variables were considered for inclusion in the continuous model 
when p<0.05. However, interaction terms did not reach significance in any of the models. 
Because sex showed no interaction with either BMI or BMI2, stratification of the results by 
sex was not necessary. The proportional hazards assumption was checked for all models 
and no major violations of this assumption were found. 
Sensitivity analyses were performed to assess the robustness of the results. We repeated the 
analyses with extra adjustments for diet, physical activity and alcohol use, and in a subgroup 
in which the first 2 years of follow-up were excluded, in a subgroup with no major diseases 
(CVD, cancer or respiratory problems) at baseline and in a subgroup of non-smokers.
Data were analysed using the SAS System for Windows (release 9.1.3) (SAS Institute Inc, Cary, 
North Carolina). Mortality risk was considered significantly increased if the 95% confidence 
interval (95%CI) did not include 1. All p-values are 2-sided. 
Results
Table 3.1 presents the baseline health and lifestyle characteristics of the participants 
according to BMI category. Sex, smoking status, educational level, physical activity and 
alcohol use were not evenly distributed among the BMI categories. People within the 
highest BMI categories had a chronic disease at baseline more often (p<0.01): with diabetes, 
hypertension and arthritis being more common in people with a BMI ≤30 kg/m2. In contrast, 
respiratory problems were more common in people with the lowest BMI category, while 
osteoporosis was most common in people with a BMI between 20 and 25 kg/m2. Table 3.2 
shows the total number of deaths from each cause in SENECA participants during 10 years 
of follow-up.
49
BM
I and m
ortality in old age
Chapter 3
Ta
bl
e 
3.
1 
Ba
se
lin
e 
ch
ar
ac
te
ris
tic
s 
of
 S
EN
EC
A
 p
ar
tic
ip
an
ts
 (n
 (%
))
To
ta
l
BM
I <
20
 k
g/
m
2
BM
I 2
0–
25
 k
g/
m
2
BM
I 2
5–
30
 k
g/
m
2
BM
I ≥
30
 k
g/
m
2
p 
(C
hi
2 )
n 
(%
)
1,
97
0
83
 (4
)
61
4 
(3
1)
85
7 
(4
3)
41
6 
(2
1)
Ag
e,
 m
ea
n 
(S
D
), 
y
73
 (1
.9
) 
73
 (1
.8
)
73
 (1
.8
)
73
 (2
.0
)
73
 (1
.9
)
0.
52
*
Se
x 
m
al
e
97
9 
(5
0)
31
 (3
7)
31
4 
(5
1)
47
4 
(5
5)
 
16
0 
(3
8)
<0
.0
1
Sm
ok
in
g
<0
.0
1
N
ev
er
1,
04
2 
(5
3)
41
 (4
9)
29
4 
(4
8)
43
7 
(5
1)
27
0 
(6
5)
Fo
rm
er
57
9 
(2
9)
18
 (2
2)
18
5 
(3
0)
28
3 
(3
3)
 
93
 (2
2)
Cu
rr
en
t
34
9 
(1
8)
24
 (2
9)
13
5 
(2
2)
13
7 
(1
6)
53
 (1
3)
H
ig
h 
ed
uc
at
io
n 
64
5 
(3
3)
40
 (4
8)
23
4 
(3
8)
28
1 
(3
3)
90
 (2
2)
<0
.0
1
D
ie
t†
 (M
ed
ite
rr
an
ea
n 
sc
or
e 
≥4
) 
77
3 
(4
3)
31
 (4
2)
25
0 
(4
4)
32
4 
(4
1)
16
8 
(4
6)
0.
54
Ph
ys
ic
al
 a
ct
iv
ity
†
H
ig
h 
58
7 
(3
3)
19
 (2
6)
19
2 
(3
4)
28
1 
(3
6)
10
5 
(2
9)
0.
05
Lo
w
59
7 
(3
3)
28
 (3
8)
17
5 
(3
1)
24
1 
(3
1)
14
6 
(3
9)
0.
02
A
lc
oh
ol
 u
se
†  (
ab
st
ai
ne
rs
)
65
4 
(3
7)
32
 (4
4)
20
1 
(3
6)
26
0 
(3
3)
16
1 
(4
4)
<0
.0
1
Ch
ro
ni
c 
di
se
as
e 
pr
es
en
t a
t b
as
el
in
e
1,
51
6 
(7
7)
64
 (7
7)
45
4 
(7
4)
64
8 
(7
6)
35
0 
(8
4)
<0
.0
1
Is
ch
em
ic
 h
ea
rt
 d
is
ea
se
32
3 
(1
6)
8 
(1
0)
92
 (1
5)
14
7 
(1
7)
76
 (1
8)
0.
16
St
ro
ke
43
 (2
)
2 
(2
)
8 
(1
) 
23
 (3
)
10
 (2
)
0.
34
Ca
nc
er
36
 (2
)
2 
(2
)
12
 (2
)
18
 (2
)
4 
(1
)
0.
51
Re
sp
ira
to
ry
 p
ro
bl
em
s
21
9 
(1
1)
17
 (2
0)
72
 (1
2)
89
 (1
0)
41
 (1
0)
0.
04
D
ia
be
te
s
16
2 
(8
)
4 
(5
)
32
 (5
)
82
 (1
0)
44
 (1
1)
<0
.0
1
H
yp
er
te
ns
io
n
41
3 
(2
1)
6 
(7
)
10
2 
(1
7)
18
4 
(2
1)
12
1 
(2
9)
<0
.0
1
A
rt
hr
iti
s
64
1 
(3
3)
27
 (3
3)
18
2 
(3
0)
25
3 
(3
0)
17
9 
(4
3)
<0
.0
1
In
fla
m
m
at
or
y 
bo
w
el
 d
is
ea
se
13
7 
(7
)
7 
(8
)
54
 (9
)
47
 (5
)
29
 (7
)
0.
10
Ch
ro
ni
c 
liv
er
 d
is
ea
se
34
 (2
)
2 
(2
)
10
 (2
)
17
 (2
)
5 
(1
)
0.
74
O
st
eo
po
ro
si
s
48
 (2
)
1 
(1
)
25
 (4
)
14
 (2
)
8 
(2
)
0.
02
O
th
er
 d
is
ea
se
67
4 
(3
4)
26
 (3
1)
20
3 
(3
3)
29
6 
(3
5)
14
9 
(3
6)
0.
74
BM
I: 
Bo
dy
 M
as
s 
In
de
x
* 
A
N
O
VA
 
†  B
as
ed
 o
n 
th
e 
nu
m
be
r o
f p
er
so
ns
 u
se
d 
in
 th
e 
se
ns
iti
vi
ty
 a
na
ly
se
s 
in
cl
ud
in
g 
th
e 
ex
tr
a 
co
va
ria
te
s 
(n
=1
,7
88
): 
di
et
, p
hy
si
ca
l a
ct
iv
ity
, a
lc
oh
ol
 u
se
.
50
BMI and mortality in old ageChapter 3
All-cause mortality
We found no association for any of the BMI categories and all-cause mortality (p>0.3) (Table 
3.3). However, for BMI as a continuous variable, we did find a significant association with 
all-cause mortality (p<0.01). The lowest mortality risk was found at a BMI of 27.1 (95%CI: 
24.1–29.3) kg/m2 and the mortality risk was significantly increased above 31.4 kg/m2 or 
below 21.1 kg/m2 (Figure 3.1a).
Cause-specifi c mortality
For cause-specific mortality across BMI categories, we only found a significantly increased 
CVD mortality risk for the category ≤30 kg/m2 [1.39 (95%CI: 1.00–1.92)] and a significantly 
increased risk of mortality from other causes for the category <20 kg/m2 [2.75 (95%CI: 
1.00–7.52)] (Table 3.3).
In the analyses with BMI as a continuous variable, we found a significant association between 
BMI and CVD mortality (p<0.01). For CVD, the lowest mortality risk was found at a BMI of 
25.6 (95%CI: 17.1–28.4) kg/m2 and the CVD mortality risk was significantly increased above 
BMI 30.9 kg/m2 (Figure 3.1b). 
BMI was not significantly associated with cancer mortality (p=0.75) (Figure 3.1c), nor with 
respiratory mortality (p=0.36) (Figure 3.1d). BMI was significantly associated with other 
mortality (p<0.01), with the lowest mortality risk at a BMI of 27.4 (95%CI: 22.7–30.2) kg/m2. 
The other mortality risk was significantly increased at a BMI above 32.9 kg/m2 and below 
17.7 kg/m2 (Figure 3.1e).
Table 3.2 Cause of death and number of deaths in older adults aged 70–77y (n=1,970) during 10y 
follow-up (1988/89–1999)
Cause of death ICD-9 code No. (%) of deaths
Cardiovascular disease 390–459 296 (39.4)
Cancer 140–239 172 (22.9)
Respiratory disease 460–519 41 (5.4)
Other cause of death* All other numbers 64 (8.5)
Unknown cause of death No code assigned 178 (23.7)
Total 751 (100)
 ICD-9: International Classification of Diseases, 9th Revision
* The category ‘other’ mainly comprised injury, ill-defined causes, and diseases of the digestive system.
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Figure 3.1 Multivariate adjusted hazard ratios for risk of mortality from all-cause mortality (A), 
cardiovascular disease (B), cancer (C), respiratory disease (D), and other deaths (E) in older adults 
aged 70–77y by Body Mass Index. In panel A–E solid lines indicate hazard ratios and dashed lines 
indicate 95% confidence intervals. All models were adjusted for sex, smoking and education level.
The BMI values at which none of the cause-specific mortality risks was significantly increased 
ranged from 17.7 to 30.9 kg/m2. The BMI range at which none of the cause-specific mortality 
risk was increased by more than 20%, was between 23.0 and 31.9 kg/m2 (Table 3.4). The 
BMI range at which the mortality risk for all specific causes was increased by less than 10% 
lay between 24.2 and 30.1 kg/m2.
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Sensitivity analyses
Adjusting for diet, physical activity and alcohol use (n=1,788) hardly affected the shape of 
the BMI-mortality association. Only the HR’s at both ends of the curves were slightly higher 
(max. 0.3) for all-cause and CVD mortality compared to our main results (Figure 3.2). For 
mortality from other causes, however, the HRs at both ends of the range were slightly lower 
(max. 0.8) when adjusted for diet, physical activity and alcohol use (not shown). 
Excluding the first 2 years of follow-up (n=106) did not change the shape of any of the 
BMI-mortality curves meaningfully, although the exclusion did result in a small (0.2 to 0.6 
kg/m2) reduction in the estimated nadir of the BMI-mortality curve.
Excluding people with chronic diseases at baseline (n=542) again did not change the results 
meaningfully. Except for CVD mortality, where the increased mortality risk at lower BMI’s 
disappeared and the curve was replaced by an almost monotonic increasing risk, while the 
association was no longer significant (p=0.39) (Figure 3.3).
Figure 3.2 Sensitivity analyses of multivariate adjusted Cox models: basic model (n=1,788) compared 
to model with physical activity, diet and alcohol use (n=1,788) added as extra covariates to the model 
for all-cause (A) and cardiovascular mortality (B) in older adults aged 70–77y. All models were adjusted 
for sex, smoking and education level.
Figure 3.3 Sensitivity analyses of multivariate adjusted Cox models: basic model compared to model 
with baseline diseases excluded for all-cause (A) and cardiovascular mortality (B) in older adults aged 
70–77y. All models were adjusted for sex, smoking and education level.
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In people who had never smoked (n=1,042), the BMI mortality curves for all-cause and CVD 
mortality shifted to the left and showed a flattening of the risk on the left hand side of the 
curve (Figure 3.4). In contrast, the curve for other mortality (not shown) shifted somewhat 
to the right. 
In all sensitivity analyses, the risk of respiratory mortality decreased with higher BMIs, 
although this association was not significant.
Discussion
This study shows that in older adults aged 70–77 years, BMI is associated with all-cause 
mortality when BMI is analysed as a continuous variable. The lowest all-cause mortality 
risk was found around 27 kg/m2, and this risk was significantly increased above 31 kg/
m2 and below 21 kg/m2. BMI was also associated with CVD mortality and mortality from 
other causes, but not with cancer or respiratory mortality during 10 years of follow-up. The 
increased all-cause mortality risk seemed to be mostly driven by an increased CVD risk. For 
CVD mortality risk, the lowest risk was found around 25.6 kg/m2; this mortality risk increased 
significantly above BMI 30.9 kg/m2. 
Our findings of the associations between BMI (continuous) and mortality and their nadirs 
seem to be stable when looking at the sensitivity analyses. In general, the sensitivity analyses 
did not change the HRs substantially. However, excluding people with chronic diseases 
(CVD, cancer and respiratory diseases) at baseline (resulting in a considerably smaller study 
Figure 3.4 Sensitivity analyses of multivariate adjusted Cox models: basic model compared to 
model with never-smokers for all-cause (A) and cardiovascular mortality (B) in older adults aged 
70–77y. All models were adjusted for sex and education level and the basic model was also adjusted 
for smoking status.
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population) mainly affected the association between BMI and CVD mortality risk, which 
resulted in lower CVD mortality risks in the lower BMI range. This might be due to a loss of 
power in the analyses, but could also have resulted from less influence of susceptibility for 
illness and death in the lower BMI ranges. In our main analyses, we did not exclude people 
with chronic diseases at baseline, because (given the high prevalence of CVD at the age of 
70 years and the association of BMI with CVD morbidity15 this would have underestimated 
the mortality risk of a high BMI. Additionally, we analysed a subgroup of never-smokers, 
because of potential residual confounding by smoking.16 This resulted in BMI nadirs shifting 
to the left within the 20–25 kg/m2 range for all-cause and CVD mortality. The shift to the 
left was similar to the results of a recent study including 1.46 million White adults, although 
they also excluded people with chronic diseases.17 
Some limitations of our study should be noted. First, the response rate was low and we had 
to exclude participants from our analyses. From a bias assessment study, it was shown that 
non-participants may have been less active and healthy than the participants.18 However, 
with mortality as an outcome measure and from our results of the sensitivity analyses, this 
would probably not influence our results substantially. Also, the 420 people who were 
excluded from the study were somewhat older and heavier and had a higher mortality rate 
than the study population. This may have resulted in an underestimation of the relative 
mortality risk in the higher BMI range. However, when we included a part of the excluded 
people, namely the participants of the three excluded study centres (Monor, Burgdorf and 
Bellinzona), in the analyses for all-cause mortality, the nadir and the HRs over the whole 
BMI range did not change meaningfully. Secondly, no cause of death could be retrieved 
for 23.7% of the total number of deaths, which might have limited the power to study 
cause-specific deaths. However, for these cases, the death certificates were randomly not 
available. Therefore, we do not expect that the unknown cases would affect our findings 
of the associations between BMI and cause-specific mortality. Also, there was a high level 
of standardization in our study: one medical doctor coded all causes of death from death 
certificates. Thirdly, the age-related decline in height among the elderly may induce a false 
BMI increase of about 2.0 kg/m2.19 Because of loss of lean body mass and redistribution 
of fat inside the body with ageing, BMI in elderly people could be an underestimation of 
the adiposity.20 Measures that take into account the distribution of fat mass, such as waist 
circumference, may be more appropriate in the elderly.20 However, BMI as a measurement 
is often used in clinical practice, which makes it important to examine the association 
between BMI, as a measure of adiposity, and mortality, in the elderly. Finally, the relatively 
small numbers of persons and deaths in the lower BMI range (<20 kg/m2), and the small 
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number of deaths from respiratory diseases led to a limited statistical power for establishing 
the lower end of the BMI range and for studying the association between BMI and the 
mortality of respiratory diseases.
Our results are nonetheless comparable with other studies including Western elderly people 
with regard to several aspects. First, we did not find an increased all-cause mortality risk 
associated with the BMI categories of overweight and obesity, which is comparable with 
other studies among the elderly.2,6,21-23 Results for cause-specific mortality are also much in 
line with others.7,24-26 There are few studies that have used BMI as a continuous variable to 
assess the association with mortality. Previous studies showed increased relative risks of 
cardiovascular diseases and mortality in the association with continuous BMI in persons aged 
70 years and older,27,28 although the relative risks were lower than those found in younger 
persons. Two other studies estimated the BMI associated with the lowest all-cause mortality 
rate among older persons.3,29 Engeland and colleagues found BMI nadirs 1.5–3 kg/m2 lower 
compared to our estimate, depending on sex.29 This might be explained by differences in 
methodology, i.e. 1/BMI was used as a proxy for BMI. However, in this study, Engeland and 
colleagues found an increased BMI nadir with increasing age in their population.29 The 
other study by Flicker and colleagues3 found similar U-shaped associations and nadirs for 
all-cause and cause-specific mortality risks, although in contrast to our results, they did find 
a significant association for cancer and respiratory diseases. This might be explained by the 
limited power in our study population, especially in the lower BMI range.
In conclusion, our results show that in people of older age, weight status is still associated 
with mortality and seems to be mostly driven by CVD. The minimum mortality risks in 
our study were between 25 and 27 kg/m2 and the BMI range at which the cause-specific 
mortality risk was increased by less than 10%, was between 24 and 30 kg/m2, indicating 
that the mortality risk was lowest in the overweight category. Therefore, the WHO cut-off 
point of 25 kg/m2 for defining overweight might be too low for older people as well as the 
cut-off point of 18.5 kg/m2 or 20 kg/ m2 for defining underweight. Finally, more studies are 
needed to define specific cut-off points for BMI measurements in the elderly. In addition 
to mortality, these studies should also focus on morbidity.
57
BM
I and m
ortality in old age
Chapter 3
References
1.  Branca F, Nikogosian H, Lobstein T. The challenge of obesity in the WHO European Region and the 
strategies for response. Denmark: World Health Organization, 2007.
2. Janssen I, Mark AE. Elevated body mass index and mortality risk in the elderly. Obes Rev. 
2007;8(1):41–59.
3. Flicker L, McCaul KA, Hankey GJ, Jamrozik K, Brown WJ, Byles JE, et al. Body mass index and 
survival in men and women aged 70 to 75. J Am Geriatr Soc. 2010;58(2):234–241.
4. Heiat A, Vaccarino V, Krumholz HM. An evidence-based assessment of federal guidelines for 
overweight and obesity as they apply to elderly persons. Arch Intern Med. 2001;161(9):1194–
1203.
5. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, et al. Overweight, 
obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 
2006;355(8):763–778.
6. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, 
overweight, and obesity. Jama. 2005;293(15):1861–1867.
7. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with 
underweight, overweight, and obesity. JAMA. 2007;298(17):2028–2037.
8. Van ‘t Hof MA, Hautvast JG, Schroll M, Vlachonikolis IG. Design, methods and participation. 
Euronut SENECA investigators. Eur J Clin Nutr. 1991;45 Suppl 3:5–22.
9. De Groot C, Van Staveren W. Nutrition and the elderly: manual of operations. (Report 11): 
Wageningen, the Netherlands, 1988.
10. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and 
survival in a Greek population. N Engl J Med. 2003;348(26):2599–2608.
11. Knoops KT, de Groot LC, Kromhout D, Perrin AE, Moreiras-Varela O, Menotti A, et al. Mediterranean 
diet, lifestyle factors, and 10-year mortality in elderly European men and women: the HALE 
project. Jama. 2004;292(12):1433–1439.
12. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity 
questionnaire for the elderly. Med Sci Sports Exerc. 1991;23(8):974–979.
13. International Classification of Diseases, Ninth Revision (ICD-9). Geneva: World Health Organization, 
1977.
14. Kivimaki M, Ferrie JE, Batty GD, Davey Smith G, Elovainio M, Marmot MG, et al. Optimal form of 
operationalizing BMI in relation to all-cause and cause-specific mortality: the original Whitehall 
study. Obesity (Silver Spring). 2008;16(8):1926–1932.
15. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Rosner B, Monson RR, et al. A prospective study 
of obesity and risk of coronary heart disease in women. N Engl J Med. 1990;322(13):882–889.
16. Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med. 1999;341(6):427–
434.
58
BMI and mortality in old ageChapter 3
17. Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, et al. Body-mass 
index and mortality among 1.46 million white adults. N Engl J Med. 2010;363(23):2211–2219.
18. van’t Hof MA, Burema J. Assessment of bias in the SENECA study. Eur J Clin Nutr. 1996;50 Suppl 
2:S4–8.
19. Sorkin JD, Muller DC, Andres R. Longitudinal change in height of men and women: implications 
for interpretation of the body mass index: the Baltimore Longitudinal Study of Aging. Am J 
Epidemiol. 1999;150(9):969–977.
20. Zamboni M, Mazzali G, Zoico E, Harris TB, Meigs JB, Di Francesco V, et al. Health consequences of 
obesity in the elderly: a review of four unresolved questions. Int J Obes (Lond). 2005;29(9):1011–
1029.
21. Al Snih S, Ottenbacher KJ, Markides KS, Kuo YF, Eschbach K, Goodwin JS. The effect of obesity 
on disability vs mortality in older Americans. Arch Intern Med. 2007;167(8):774–780.
22. Locher JL, Roth DL, Ritchie CS, Cox K, Sawyer P, Bodner EV, et al. Body mass index, weight loss, 
and mortality in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2007;62(12):1389–
1392.
23. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Decreased muscle mass and increased 
central adiposity are independently related to mortality in older men. Am J Clin Nutr. 
2007;86(5):1339–1346.
24. Baik I, Ascherio A, Rimm EB, Giovannucci E, Spiegelman D, Stampfer MJ, et al. Adiposity and 
mortality in men. Am J Epidemiol. 2000;152(3):264–271.
25. Breeze E, Clarke R, Shipley MJ, Marmot MG, Fletcher AE. Cause-specific mortality in old age in 
relation to body mass index in middle age and in old age: follow-up of the Whitehall cohort of 
male civil servants. Int J Epidemiol. 2006;35(1):169–178.
26. Dyer AR, Stamler J, Garside DB, Greenland P. Long-term consequences of body mass index for 
cardiovascular mortality: the Chicago Heart Association Detection Project in Industry study. 
Ann Epidemiol. 2004;14(2):101–108.
27. Ni Mhurchu C, Rodgers A, Pan WH, Gu DF, Woodward M. Body mass index and cardiovascular 
disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants. 
Int J Epidemiol. 2004;33(4):751–758.
28. Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, et al. Body-mass index and 
cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. 
Lancet. 2009;373(9669):1083–1096.
29. Engeland A, Bjorge T, Selmer RM, Tverdal A. Height and body mass index in relation to total 
mortality. Epidemiology. 2003;14(3):293–299.
Int J Epidemiol. 2012;41(3):805–817.
The association between waist 
circumference and risk of mortality 
considering body mass index in 65- to 
74-year-olds: a meta-analysis of 29 
cohorts involving more than 58,000 
elderly persons
Ellen L de Hollander, Wanda JE Bemelmans, Hendriek C Boshuizen,  Nele Friedrich, 
Henri Wallaschofski, Pilar Guallar-Castillón, Stefan Walter, M Carola Zillikens, 
Annika Rosengren, Lauren Lissner, Julie K Bassett, Graham G Giles, Nicola Orsini, 
Noor Heim, Marjolein Visser, Lisette CPGM de Groot, for the WC elderly collaborators
4
60
Waist circumference and mortality in old ageChapter 4
Abstract
Background: For the elderly, the association between waist circumference (WC) and 
mortality considering body mass index (BMI) remains unclear, and thereby also the 
evidence base for using these anthropometric measures in clinical practice. This meta-
analysis examined the association between WC categories and (cause-specific) mortality 
within BMI categories. Furthermore, the association of continuous WC with lowest and 
increased mortality risks was examined. 
Methods: Age- and smoking-adjusted relative risks (RRs) of mortality associated with 
WC-BMI categories and continuous WC (including WC and WC2) were calculated by the 
investigators and pooled by means of random-effects models. 
Results: During a 5-year-follow-up of 32,678 men and 25,931 women, we ascertained 
3,318 and 1,480 deaths, respectively. A large WC (men: ≥102 cm, women: ≥88 cm) was 
associated with increased all-cause mortality RRs for those in the ‘healthy’ weight {1.7 
[95% confidence interval (CI): 1.2–2.2], 1.7 (95%CI: 1.3–2.3)}, overweight [1.1 (95%CI: 
1.0–1.3), 1.4 (95%: 1.1–1.7)] and obese [1.1 (95%CI: 1.0–1.3), 1.6 (95%CI: 1.3–1.9)] BMI 
category compared with the ‘healthy’ weight (20–24.9 kg/m2) and a small WC (<94 cm, 
men; <80 cm, women) category. Underweight was associated with highest all-cause 
mortality RRs in men [2.2 (95%CI: 1.8–2.8)] and women [2.3 (95%CI: 1.8–3.1]. We found a 
J-shaped association for continuous WC with all-cause, cardiovascular (CVD) and cancer, 
and a U-shaped association with respiratory disease mortality (p<0.05). An all-cause 
(CVD) mortality RR of 2.0 was associated with a WC of 132 cm (123 cm) in men and 116 
cm (105 cm) in women. 
Conclusions: Our results showed increased mortality risks for elderly people with 
an increased WC – even across BMI categories – and for those who were classified as 
‘underweight’ using BMI. The results provide a solid basis for re-evaluation of WC cut-
points in ageing populations. 
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Introduction
The prevalence of overweight has increased for all age groups over the past decades in the 
Western world, including the elderly.1,2 For adults, overweight is known to be associated 
with many health problems and decreases in life expectancy,1,3 but for the elderly the 
association is less clear.4–7 
In clinical practice, body mass index (BMI) and to a lesser extent waist circumference (WC) 
are widely used measures to assess an individual’s health risk. However, WC might be a 
better measure than BMI, given its relationship with harmful visceral adiposity.8 This might 
be particularly important for the elderly since they have more visceral adipose tissue than 
younger adults for a given WC.7,8 Several studies have examined the association between 
WC and mortality risks in elderly people, but findings are inconsistent.5,6,9–14 
For WC, three categories (men: <94 cm, 94–101 cm and ≥102 cm, women: <80 cm, 80–87 
cm and ≥88 cm)15 have been defined to indicate the increasing health risk with increasing 
WC.16,17 However, associations between these WC categories and mortality have not been 
studied extensively in the elderly. One study reported in never smoking men aged ≥55 years 
an elevated all-cause mortality risk in the upper two categories (94–101 cm and ≥102 cm) 
compared with the reference category (79–93 cm).18 
Furthermore, since BMI is the most commonly used anthropometric measure, it is important 
to assess mortality risks associated with WC categories, within BMI categories. By studying 
combined categories, a more complete picture of risks becomes available and insight 
is gained on the magnitude of relative risks with increasing WC or with increasing BMI 
categories, keeping the other measurement the same. This has previously been studied, 
but not by stratifying for all combinations of WC and BMI categories, and in a smaller 
population of elderly.6,12
Given the unclear association between WC and mortality in the elderly, especially when 
also considering BMI, and the ageing of the population, more research in a large elderly 
population is needed. This would provide an evidence base for application of these 
anthropometric indicators. To our knowledge, only data from single cohort studies with 
limited generalizability have previously studied this association. Therefore, the aims of this 
meta-analysis, which included over 58,000 people aged 65–74 years, were twofold. The first 
aim was to examine the association between internationally defined WC categories and 
all-cause and cause-specific mortality risks, within standard BMI categories. The second aim 
was to examine the association of WC as a continuous variable with lowest and increased 
mortality risks.
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Methods
Data sources and searches
Studies were identified by a PubMed search from 1984 until 1 November 2010, by examining 
the reference lists of identified reviews, and by suggestions from colleagues. The following 
search strategy was used: waist, or WC, or abdominal adiposity in the abstract, title or in 
the Medical Subject Heading (MeSH), and mortality in the abstract, title or mortality in 
MeSH, plus either prospective or cohort. This search resulted in 202 abstracts. Additionally, 
all investigators from a previous collaboration were contacted,19 and we searched on the 
website of the United States National Institute of Aging for eligible studies. 
Study selection
Eligible studies were prospective cohort studies conducted in predominantly Caucasian 
populations. The studies had to include at least 400 people in the age range of 65–74 
years at baseline, this ensured smaller studies were also included. WC, BMI and all-cause 
mortality had to be available. Additionally, it had to be possible to calculate hazard ratios 
[relative risks (RRs)] for a follow-up period of 5–8 years (preferably closest to 5 years). This 
follow-up range was chosen to ensure most subjects were still alive during follow-up, since 
life expectancy is about 80 years,20 and also to reduce heterogeneity between studies. Also, 
baseline conditions tend to change considerably over a longer follow-up period. 
In Appendix 1 (available at http://ije.oxfordjournals.org/content/41/3/805/suppl/DC1), 
a flowchart of the identified studies is presented. We identified 100 studies as possibly 
eligible for inclusion in our meta-analysis. The investigators of these studies received an 
e-mail with an explanation of the purpose of the study, an invitation for participation and 
a request to ensure their study would meet the inclusion criteria. No financial support was 
offered to participate in this meta-analysis.
We could not find valid e-mail addresses for four investigators, thus 96 investigators were 
contacted by e-mail of whom 60 responded. Eighteen of these declined because the data 
did not fully meet the inclusion criteria. Fourteen investigators declined for financial reasons, 
due to lack of time or interest, or lost contact after initial response. Finally, 28 investigators 
responded from whom 29 cohort studies were included in the meta-analysis.
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Data extraction
The investigators who agreed to participate were requested to perform Cox regression 
analyses to calculate RRs of mortality for WC as a categorical and continuous variable 
following a protocol with instruction. All analyses were stratified by sex. 
For the combined WC-BMI categories, WC categories defined by Lean and colleagues and 
used in practice15–17 (i.e. <94, 94–101, ≥102 cm in men; <80, 80–87, ≥88 cm in women) and 
BMI categories underweight (<20 kg/m2), ‘healthy’ weight (20–24.9 kg/m2), overweight 
(25–29.9 kg/m2) and obese (≥30 kg/m2) were used. The investigators used a model to 
assess mortality risks for the 11 combined WC-BMI categories compared with the reference 
category (‘healthy weight’ and small waist) (Table 4.1). This model was adjusted for age and 
smoking status [current, former and never smokers (reference)].
Since previous studies have shown a U-shaped relation between WC and mortality,10,11,21,22 
the investigators used a model with WC as a continuous variable, including the linear and 
quadratic term of WC (WC and WC2). The models were first only adjusted for age and smoking 
status, and subsequently for BMI as well. All analyses were performed over a follow-up 
period of ~5 years for all-cause mortality and, if available, for mortality from cardiovascular 
disease (CVD), cancer and respiratory disease (see Table 4.2 for definitions). 
Additional analyses were performed for the models with WC as a categorical variable and 
WC as a continuous variable (with adjustment for BMI) for the following subgroups: subjects 
aged 65–69 years and 70–74 years; subjects aged 65–74 years; excluding mortality during 
the first 2 years of follow-up; excluding those with major chronic diseases (i.e. CVD, cancer 
and respiratory disease) at baseline; and only including never smokers. 
Table 4.1 Sex-specific combinations of waist circumference (WC) and body mass index (BMI) 
categories used in the analyses
WC categories (men/women)
BMI categories Small waist Medium waist Large waist
Underweight <20kg/m2 <94cm/<80cm 94–101cm/80–87cm ≥102cm/≥88cm
‘Healthy’ weight 20–24.9kg/m2 <94cm/<80cm (ref ) 94–101cm/80–87cm ≥102cm/≥88cm
Overweight 25–29.9kg/m2 <94cm/<80cm 94–101cm/80–87cm ≥102cm/≥88cm
Obese >30 kg/m2 <94cm/<80cm 94–101cm/80–87cm ≥102cm/≥88cm
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The investigators were not asked to test the proportional hazard assumption for each 
requested analysis because it was considered too onerous. Nevertheless, the proportional 
hazard assumption was tested for each analysis in eight cohort studies and no violations 
were found [(global) test of Schoenfeld p>0.05]. 
Descriptive statistics for each cohort (e.g. mean age, BMI and WC, number of subjects, total 
deaths, deaths from CVD, cancer and respiratory disease and percentage never smokers) 
were provided by the investigators. 
Data synthesis and analysis
First, heterogeneity of the pooled RRs for the combined WC–BMI categories (received 
from the investigators) was tested by calculating the Cochran’s chi-square, its p-value and 
the I2 (percentage of variation across studies).23 Heterogeneity in the continuous analyses 
was tested by a chi-squared test from the random effects model.24 To account for any 
heterogeneity, a random-effects model was used for all models to pool the log RRs. For 
the combined WC–BMI categories, the log RR for each WC–BMI category was pooled by a 
univariate meta-analysis.24 For the continuous analyses, we used a bivariate meta-analysis 
to pool the log RRs with the variance of each term and the covariance between terms.25 To 
assess the association between continuous WC and mortality, we tested if the regression 
coefficients for both terms were equal to 0. To plot a parabolic function between WC and 
mortality, the lowest risk was calculated by -EstimateWC/(2*EstimateWC2) which was the 
reference point (RR=1.0) for the function. The RRs associated with the commonly used 
cut-points of 102 cm in men and 88 cm in women were reported. Also, the values of WC 
associated with a RR of 2.0 which we consider a clinically relevant increased mortality risk as 
supported by the National Cancer Institute.26 For the continuous analyses without and with 
adjustment for BMI, we tested the effect of BMI by means of a meta-regression analysis.24 
Results
The 29 cohort studies included 32,678 men and 25,931 women aged 65–74 years of whom, 
respectively, 3,318 and 1,480 died. Table 4.2 shows the characteristics of the included 
cohorts by sex.
For the cohort studies where the cause of death was known (n=24), the proportion of deaths 
assigned to CVD was 40.7% for men and 33.3% for women, the corresponding proportions 
for cancer were 38.7% and 45.1% and for respiratory diseases, 6.8% and 4.0%. 
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In general, there was no substantial heterogeneity in the analyses regarding the combined 
WC-BMI categories resulting in an I2<17.5% (p=0.22, for the chi-squared test) (Appendix 
4, Figure 4.1, 4.2 available at http://ije.oxfordjournals.org/content/41/3/805/suppl/DC1). 
Similarly, no substantial heterogeneity was found in the continuous analyses (p=0.05 for 
the chi-squared test from the random-effects model (Appendix 4, Table 4.1 available at 
http://ije.oxfordjournals.org/content/41/3/805/suppl/DC1).
Associations between combined WC–BMI categories and mortality
For men and women, a large WC (≥102 cm, men; ≥88 cm, women) was associated with increased 
all-cause mortality RRs for those in the ‘healthy’ weight, overweight and obese BMI category 
compared with those classified as ‘healthy’ weight (20–24.9 kg/m2) with a small WC (<94 cm, 
men; <80 cm, women) (Table 4.3). Overall, we observed a tendency for lower all-cause and CVD 
mortality risks in the overweight category compared with the ‘healthy’ weight category within 
WC categories for both men and women (men: pall-cause=0.02, pCVD=0.03; women: pall-cause=0.18, 
pCVD=0.36), although the RR for overweight men with a small WC in the association with CVD 
mortality was higher compared with ‘healthy’ weight men with a small waist (Table 4.3). 
The risks of all-cause, CVD and cancer mortality were (although not statistically tested) 
higher for those with a large WC compared with those having a medium WC, except within 
the obese category in the association with all-cause and CVD mortality, and for women 
within the ‘healthy’ weight category in the association with cancer mortality (Table 4.3).
Underweight was associated with highest all-cause mortality RRs in men {2.2 [95% 
confidence interval (95%CI): 1.8–2.8]} and women [2.3 (95%CI: 1.8–3.1)]. The RRs for cancer 
mortality were of the same magnitude. For CVD, an increased risk was found for men [RR=2.9 
(95%CI: 2.0–4.2)], but in women the RR was lower [RR=1.5 (95%CI: 0.8–2.8)] (Table 4.3).  
Associations between WC as a continuous variable and mortality
All-cause mortality
We observed a J-shaped association between WC and all-cause mortality adjusted for 
age and smoking status (p<0.01) with the lowest risk at 94 cm and 77 cm for men and 
women, respectively (Figure 4.1a). The cut-points of 102 cm in men and 88 cm in women 
were associated with all-cause mortality RRs of 1.03 (95%CI: 1.00–1.07) and 1.06 (95%CI: 
0.97–1.15), respectively. An RR of 2.0 was associated with a WC of 132 cm in men and 116 
cm in women (Figure 4.1a). 
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Cause-specifi c mortality 
Mortality from CVD, cancer and respiratory diseases were all associated with WC adjusted 
for age and smoking status in both men and women (p≤0.03) (Figure 4.1b–d). For CVD 
mortality, the lowest risk was at 89 cm and 63 cm for men and women, respectively. For men 
with a WC of 102 cm, the risk of CVD mortality was 1.11 (95%CI: 0.99–1.26) and for women 
with a WC of 88 cm this was 1.28 (95%CI: 0.92–1.77). An RR of 2.0 was associated with a 
WC of 123 cm in men and 105 cm in women (Figure 4.1b). For cancer mortality, the lowest 
risk was at 73 cm and 74 cm for men and women, respectively. For men with a WC of 102 
cm, the risk of cancer mortality was 1.13 (95%CI: 0.74–1.71) and for women with a WC of 
88 cm this was 1.07 (95%CI: 0.90–1.27) (Figure 4.1c). We observed a U-shaped relationship 
between WC and mortality from respiratory disease for both men and women. The lowest 
risk was at 104 cm for men and 99 cm for women. For men with a WC of 102 cm, the risk of 
mortality from respiratory diseases was 1.00 (95%CI: 0.98–1.03) and for women with a WC 
of 88 cm this was 1.15 (95%CI: 0.85–1.57) (Figure 4.1d).
Associations between WC as a continuous variable and mortality with ad-
justment for BMI
After adjusting for BMI, WC remained associated with mortality from all causes, CVD and 
cancer in both sexes, and with respiratory diseases in men but not in women. The curves for 
CVD mortality were similar to those that were not adjusted for BMI (pmen=0.99; pwomen=0.62), 
but the curves for mortality from all causes (pmen<0.01; pwomen<0.01) and respiratory diseases 
(pmen<0.01; pwomen=0.40) were shifted to the left for both sexes, and for cancer only in women 
(p=0.15). Thus, the lowest risks were at lower values of WC, and the RRs associated with a 
similar WC were higher after adjusting for BMI compared with the analyses unadjusted for 
BMI (Figures 4.1a–d). The curve of cancer mortality in men became linear after adjustment 
for BMI (Figure 4.1c).
Additional analyses
We restricted our additional analyses to the four most relevant categories (i.e. underweight 
with a small WC, ‘healthy’ weight, overweight and obese combined with a large WC), 
because these categories gave the most consistent and strongest RRs in the main analyses. 
The associations between the WC-BMI categories and all-cause and CVD mortality did not 
differ by age group (Appendix 2, Table 2.1, 2.2 available at http://ije.oxfordjournals.org/
content/41/3/805/suppl/DC1). Excluding the first 2 years of follow-up, or major chronic 
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Figure 4.1 Relative risks of mortality from all causes (A), cardiovascular diseases (B), cancer (C), 
and respiratory disease (D) in men(I) and women(II) aged 65–74 years for waist circumference as a 
continuous variable. All models were adjusted for age and smoking. In panel A–D solid lines indicate 
relative risks and dashed lines indicate 95% confidence intervals. The black lines indicate the analyses 
unadjusted for body mass index and the grey lines indicate the analyses with the adjustment for body 
mass index. aIn this figure, for the analysis adjusted for body mass index, a minimum of 94 cm was 
used, because there was no longer a parabolic association.
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diseases at baseline, or only including never smokers did not change the interpretation 
of our findings (Appendix 3, Table 3.1, Figure 3.1 available at http://ije.oxfordjournals.org/
content/41/3/805/suppl/DC1).
We found some differences between the main analyses and additional analyses. After 
excluding the first 2 years of follow-up, we observed an RR of 1.6 (95%CI: 0.8–3.2) for CVD 
mortality risk in women with a ‘healthy’ weight and a large WC, compared with an RR of 2.2 
(95%CI: 1.3–3.8) including all subjects. However, the additional analyses confirmed that for 
those with a large WC being in the ‘healthy’ weight category is associated with a higher RR 
(1.6) than the overweight category [RR=1.3; (95%CI: 0.8–2.0)]. Furthermore, the analyses 
for continuous WC showed a similar pattern for all-cause mortality (Appendix 3, Table 3.1, 
Figure 3.1 available at http://ije.oxfordjournals.org/content/41/3/805/suppl/DC1). 
After exclusion of major chronic diseases at baseline, the RR for CVD mortality in underweight 
men was 2.5 (95%CI: 0.8–7.7) compared with an RR of 3.3 (95%CI: 1.5–7.3) including all 
men, but still this confirms that underweight is associated with CVD mortality with an RR 
of at least 2.0 (Appendix 3, Table 3.1, Figure 3.1 available at http://ije.oxfordjournals.org/
content/41/3/805/suppl/DC1). 
Results for never smokers were comparable to the total population, except for the CVD 
mortality risks in men with a large WC and overweight/obesity, which were higher among 
never smoking men (RR=2.2) than for the total population [RR=1.3 (overweight+large WC]; 
RR=1.5 (obesity+large WC)]. In women, the patterns of the curves for the continuous analyses 
of WC were similar, but in men the steepness of the curves differed. As a consequence, in 
never smoking men, higher WC levels were accompanied by lower RRs for all-cause mortality 
compared with the RRs in all men (Appendix 3, Table 3.1, Figure 3.1 available at http://ije.
oxfordjournals.org/content/41/3/805/suppl/DC1).
Discussion
This meta-analysis of 29 cohort studies, which included a total of 58,609 elderly people 
of whom 4,798 died during 5 years of follow up, showed that both an increased WC and 
underweight according to BMI) were associated with an increased risk of all-cause, CVD 
and cancer mortality risk.
Consistent with our study, others have reported stronger associations between WC (as a 
continuous variable) and mortality after adjustment for BMI.5,6,11,14,21,53 We also found that the 
RR of mortality in persons with a ‘healthy’ weight combined with a large waist was generally 
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higher than for those with overweight and a large waist. These findings might be explained 
by body fat composition, in particular the proportion of hazardous visceral abdominal 
fat.54 In contrast to other studies, we also found strong associations with increased risks of 
mortality, particularly from all causes and CVD, but also from cancer, without adjustment 
for BMI.5,6,9,12,13 For respiratory diseases, a U-shaped association was observed between WC 
and mortality, whereas other studies reported an inverse association.9,12 
Our results of the combined categories are difficult to compare with other studies as they 
have used different combined WC-BMI categories, reference categories, study groups or 
other outcome measures.6,12,55 However, these studies also found that underweight was 
associated with higher risks of coronary heart disease in adults,55 and all-cause and CVD 
mortality in the elderly.12 
In our study, all analyses were conducted in a similar manner by the original investigators 
addressing the specific age-range of 65–74 years. This may be the reason that in general 
there appeared to be no substantial heterogeneity between studies. We included two cohort 
studies, one restricted to only men, the other only women, which excluded participants 
with cancer at baseline in the original data and used self-reported data of WC and BMI. 
However, excluding these studies from the analyses did not change our results meaningfully 
(data not shown).
Another strength of the included studies is that no overrepresentation of higher estimates 
of RR among studies with low precision (i.e. small studies) was detected in our data 
suggesting no substantial selection bias (Appendix 4 available at http://ije.oxfordjournals.
org/content/41/3/805/suppl/DC1). We had a low response, only 28 out of 100 investigators 
participated but reasons for non-participation depended primarily on lack of time or 
financial sources. We included cohort studies according to their study characteristics rather 
than the published analyses. This meta-analysis was conducted according to a specific 
analysis protocol, requiring new analyses for each cohort; the exact information (required 
for this study) was not available in the literature already. Therefore, we do not think there 
is any participation bias in our study. Also, the additional analyses excluding the first 2 
years, excluding major chronic diseases at baseline and including only never smokers did 
not affect our main conclusions.
To keep all analyses as similar as possible, we did not adjust for covariates, such as diet, 
physical activity and socio-economic status. These variables differ between studies in 
operationalization, and are often self-reported and thereby less accurate. Furthermore, 
two studies showed no major differences between the crude and adjusted risks (for these 
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covariates) of mortality associated with WC.11,14 However, this might not have been the case if 
more precise measures were included. Sui and colleagues reported an association between 
abdominal obesity (≥102 cm, ≥88 cm) and all-cause mortality in adults ≥60 years [RR: 1.3 
(95%CI: 1.0–1.6)], similar to our results, but this association attenuated after adjustment for 
cardiorespiratory fitness [RR: 1.0 (95%CI: 0.8–1.3)].56 This would imply that WC might not be 
independently associated with all-cause mortality and that cardiorespiratory fitness may 
be considered as an indicator instead. More research is needed to confirm these findings 
of Sui and colleagues, and to add evidence to underpin practical application. Finally, our 
analyses did not account for weight loss or weight gain prior to baseline, which both can be 
predictive of mortality risk,57 possibly due to underlying illnesses. However, the additional 
analysis when excluding major chronic diseases at baseline, did not affect the interpretation 
of our findings. 
Another methodological issue is that the adjustment for BMI in the continuous analyses 
might have caused multicollinearity resulting in a less precise estimate with wide confidence 
intervals. However, in our analyses, the CIs were not substantially wider, which is supported 
by the lack of a near perfect correlation between BMI and WC (rho<0.95) and the variance 
inflation factor did not exceed 5. 
In our study, underweight was associated with a high RR of mortality, which is commonly 
explained by underlying diseases or smoking. After excluding those with chronic diseases 
at baseline, or the first 2 years of follow-up, or including only never smokers this association 
persisted. This might be explained by the association of low BMI with malnutrition58 and 
sarcopenia59 which are in turn both associated with higher mortality risks.60,61 In addition, 
elderly people with underweight may have low-grade inflammation,62 and might be frailer.63 
These mechanisms might contribute to the vulnerability for external hazards which can 
lead to death. More research into possible mechanisms is necessary to give more insight 
into the risk of mortality in underweight persons and give suitable recommendations for 
the treatment of the elderly.
Interestingly, we found lower all-cause and CVD mortality risks in the overweight category 
compared with the ‘healthy’ weight category within WC categories for both men and 
women, but only in men accompanied by a p<0.05, probably because women had wider 
CIs. The lower risks within the overweight category are congruent with other studies which 
found that the lowest mortality risk was associated with overweight and an increased risk 
was in the ‘healthy’ weight category, indicating that the ‘healthy’ weight category might 
not be appropriate for the elderly.12,64–67 An explanation for this finding could be the age-
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related decline in height among the elderly which might induce a false increase in BMI.7 
Furthermore, as mentioned above for underweight, these elderly persons with low BMI 
are prone to external hazards, whereas overweight might provide a metabolic buffer for 
diseases as previously reported in older people with chronic conditions.68 Therefore, the 
cut-point of 25 kg/m2 to indicate excess adiposity might not be appropriate for the elderly. 
We found that a large waist (≥102 cm, men; ≥88 cm, women) was consistently associated 
with all-cause and CVD mortality within the ‘healthy’ weight, overweight and obese BMI 
category. This finding was supported by our continuous analyses, which showed that an 
increased risk was associated with an increased WC either with or without adjustment for 
BMI. Furthermore, our results provide a solid basis for re-evaluation of currently defined 
cut-points for WC, which are based on adults aged 20–74 years.15 From our continuous 
analysis, we found no relevant elevated mortality risks between the value of the lowest risk 
and the standard WC cut-points of 102 cm for men and 88 cm for women. This suggests 
that cut-points for the elderly should be defined at higher WC values. For CVD mortality, 
a twofold increased risk was seen at WC levels of 123 cm for men and 105 cm for women, 
which can be considered as clinically relevant (almost) beyond discussion. However, we 
do not suggest that these levels should be the new WC cut-points. Thresholds to be used 
in (clinical) guidelines should be based on opinions and consensus about the relevance of 
increased risks – as found in epidemiological studies – which can differ. For example, Heim 
and colleagues69 suggested new WC cut-points of between 100 cm and 106 cm in men and 
99 cm in women based on several health outcomes,69 which especially in women is indeed 
higher than the currently advocated cut-points.16,17 In addition, when defining cut-points 
to be used in clinical guidelines, the absolute prevalence rates need to be considered for 
practical reasons. We performed additional analyses in seven cohorts (data not shown in 
the article) to illustrate this issue, which revealed that the prevalence rates sharply increased 
between a WC level of 123 cm (1–2%) and 102 cm (12–48%) in men, with a similar pattern 
in women. So, a level of WC in between would include a large part of the population that 
is at risk and needs to be treated according to clinical guidelines.
In conclusion, in this elderly population, we found increased mortality risks associated with 
an increased WC – even across BMI categories – and also with being underweight according 
to BMI. Clinicians should be made aware of the usefulness of WC to measure adiposity in 
order to determine mortality risk in the elderly. This meta-analysis provides a solid basis 
for re-evaluation of WC cut-points in ageing populations.
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Abstract
Objectives: In elderly individuals, little is known about changes in different anthropo-
metric measure with respect to mortality. We examined the association between changes 
in eight anthropometric measures and mortality in an elderly population. 
Design: Longitudinal study including baseline measurements in 1988–1990 and 
repeated measures in 1993. 
Setting: European towns. 
Participants: A total of 1,061 older adults born in 1913–1918 from the Survey in Europe 
on Nutrition and the Elderly: a concerted action study were included in this study. 
Measurements: Weight, body mass index, waist circumference, waist-hip ratio, waist-
height ratio, mid-upper arm circumference (MUAC), triceps-skinfold and corrected arm 
muscle area were taken during both measurements. 
Results: A Cox regression model was used to examine the association between 
anthropometric changes (divided into quintiles, smallest change = reference category) 
and all-cause and cardiovascular disease (CVD) mortality over approximately 6 years 
of follow-up, adjusted for baseline measurement of application, age, sex, smoking, 
education, physical activity and major chronic diseases. A decrease in weight (≥3.2 
kg), waist circumference (≥3.1 cm), and MUAC (≥1.6 cm and 0.6–1.6 cm) were (near) 
significantly associated with an all-cause mortality risk of 1.48 (95%CI: 0.99–2.20), 1.52 
(95%CI: 1.01–2.31), 1.81 (95%CI: 1.17–2.79) and 1.66 (95%CI: 1.10–2.49), respectively. 
Also for MUAC, an increase (≥1.3 cm) was significantly associated with an increased all-
cause and CVD mortality risk [HR: 1.52 (95%CI: 1.00–2.31) and 1.94 (95%CI: 1.00–3.75)], 
respectively. 
Conclusions: Associations were observed for decreases in only 3 out of 8 anthropometric 
measures and all-cause mortality. Decreases in MUAC had the strongest associations 
with mortality and was the only measure in which also an increase was associated with 
mortality. This suggests a role for MUAC in the prediction of mortality in the elderly. 
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Introduction
The association between measures of body composition and mortality in elderly persons 
has been examined in many studies.1-5 Body mass index (BMI), a measure of overall body 
fat, is commonly used in practice as a predictor for morbidity and mortality. However, 
abdominal adiposity measures, such as, waist circumference (WC), waist-hip ratio (WHR) 
and waist-height ratio (WHtR) have been shown to be better predictors for cardiovascular 
events and mortality in adults than BMI.6-8 For elderly people, BMI might not be the strongest 
predictor of mortality, since body composition changes with increasing age, e.g. muscle 
mass reduces, height decreases, and fat mass increases, which is redistributed to the 
stomach area.9 Nevertheless, for elderly persons an association with mortality has been 
reported for a high BMI, as well as for a high WC.1,10 But for an increased WC, adjusted for 
BMI an increased mortality risk was reported,1,11,12 while for an increased BMI, adjusted for 
WC an inverse association was reported.11,12 Thus, abdominal adiposity measures need to 
be considered for the elderly in the use of predicting mortality risks with regard to excess 
body fat.13 
Other anthropometric measures like the triceps skinfold thickness (TSF), mid-upper arm 
circumference (MUAC), and corrected arm muscle area (CAMA, calculated from TSF and 
MUAC) are generally used to assess nutritional status and also body fat. TSF reflects the 
subcutaneous fat mass, whereas MUAC reflects the muscle mass as well as fat mass, and 
CAMA reflects only the muscle mass. Several studies found that a low value in these measures 
was associated with an increased mortality risk in elderly persons.2,4,5,14 These measures 
can be valuable for clinical practice; in elderly people problems can occur with standing in 
an upright position because of frailty or a kyphotic posture, as well as with errors in body 
weight caused by fluid status (dehydration or oedema). 
Next to baseline anthropometric measures, weight changes can be used as predictors for 
mortality. In elderly persons, especially weight loss was found to be associated with an 
increased mortality risk, but for weight gain, these findings were less consistent.15-17
Because changes in weight can depend on several factors (e.g. changes in body fluid 
or muscle mass) and the body composition in old age has changed, it is important to 
examine whether changes of several different anthropometric measures within one elderly 
population are predictive for mortality. To our knowledge this has not been done before; 
therefore we examined in a 70–77 year old European population the association between 
changes in eight anthropometric measures (weight, BMI, WC, WHR, WHtR, MUAC, TSF and 
CAMA) and all-cause and cardiovascular disease (CVD) mortality.
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Methods
Study population
The SENECA (Survey in Europe on Nutrition and the Elderly, a Concerted Action) study started 
in 1988. Elderly persons born between 1913 and 1918 were eligible to participate in the 
study. The only exclusion criteria were: living in a psycho-geriatric nursing home, not being 
fluent in the country’s language, and not being able to answer questions independently. 
Participants were selected at baseline from an age- and sex-stratified sample of inhabitants 
from 19 European towns. The median participation rate of the 19 towns was 51%.18 Of 
these towns, Hamme, Belgium; Roskilde, Denmark; Haguenau, France; Romans, France; 
Padua, Italy; Culemborg, the Netherlands; Vila Franca de Xira, Portugal; Betanzos, Spain; 
Yverdon, Switzerland; Marki, Poland also participated in the second survey in 1993. All 
participants gave their written informed consent. Approval of the study was obtained from 
the participating SENECA centers.
Anthropometric measures
Weight, height, WC, hip circumference (HC), MUAC and TSF were measured in the first and 
second survey by a trained fieldworker, as described previously.19 BMI (kg/m2), WHR (WC/HC) 
and WHtR (WC/m) were calculated. CAMA was calculated for men and women separately 
by using MUAC and TSF in the equation developed by Heymsfield and collegaues:20
CAMA = [(MUAC – π x (TSF / 10)2) / (4 x π)] – i; 
i = 10 for men, and 6.5 for women.
Changes in weight, BMI, WC, WHR, WHtR, MUAC, TSF and CAMA were calculated by 
subtracting the baseline value from the value at the second survey over a mean interval 
of 4 years (range: 3–6 years). Changes in anthropometric measures were subsequently 
divided into quintiles. The quintile with the smallest change, including a change of zero, 
was defined as the reference category.
Covariates
Information on smoking habits, physical activity, education level and chronic diseases 
at baseline were obtained by questionnaires. Smoking habits were divided into three 
categories: never smoker, former smoker and current smoker. Physical activity consisted 
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of household, sports and leisure-time activities, which were estimated using a validated 
questionnaire.21 The three categories of physical activity were defined by sex specific tertiles. 
High education level was defined as secondary or higher education and low education level 
as primary education only or illiteracy. Chronic diseases (i.e. diabetes, ischemic heart disease, 
stroke, malignancy and respiratory disease) were measured at baseline with a questionnaire 
in which having a specific disease could be answered with yes or no.
Mortality
Information on vital status and causes of death was collected in 1999–2000. The follow-up 
period on which mortality was calculated lasted from the second survey in 1993 until April 
30th 1999. Cause of death was obtained through death certificates collected at the local 
government offices in towns where death had occurred or, if this data was not available, via 
a medical doctor or first-degree relatives. Cause of death was coded by one experienced 
clinical epidemiologist using the 9th revision of the World Health Organization International 
Classification of Disease (ICD-9).22 Mortality caused by CVD was defined by using ICD-9 
codes: 390–459.
Statistical analysis
From the 2,080 participants, 246 participants (12%) died before the second survey and 
640 (31%) participants were lost to follow-up, who could therefore not be included in 
the analysis. One hundred and thirty three participants (6%) had missing values on all 
anthropometric measures at baseline and second survey, or on one of the covariates 
and were therefore excluded from the analysis. In total, 1,061 subjects remained left for 
the analysis with data available at both baseline and the second survey of at least one 
anthropometric measure. Dependent on the anthropometric measure, the final number 
of subjects in the analyses varied between 976 and 1,053. Finally, five subjects had one 
or two anthropometric measure(s) with a very unlikely value, which were set as a missing 
value, but were not excluded. 
Characteristics of the study population are presented as frequencies and percentages or 
mean and standard deviation. To check for participation or selection bias, we compared 
the excluded group, without the ones who died before 1993 (n=773), with the included 
group by means of a Chi-square test for categorical variables and an independent samples 
t-test for continuous variables. The same tests were used to compare the characteristics 
between men and women from the included group.
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A Cox regression analysis was used to examine the association between the anthropometric 
changes and all-cause and CVD mortality over a follow-up period of approximately 6 years. 
The analyses were adjusted for anthropometric measurement of application, age, sex, 
education level, smoking habits, physical activity, study centre and having diabetes, ischemic 
heart disease, stroke, malignancy or respiratory disease at baseline. The proportional 
hazard assumption was tested for all models and no major violations of the assumption 
were found (p>0.05).
Linear and quadratic trends were tested for the exposure variables by using median values of 
the quintiles in the Cox regression model. Interactions between anthropometric changes and 
sex were examined to check for possible differences between men and women. In addition, 
sensitivity analyses were performed by excluding subjects with major chronic diseases (i.e. 
diabetes, ischemic heart disease, stroke, malignancy or respiratory disease) at baseline. 
Data were analysed using SAS System for Windows version 9.2 (SAS Institute Inc., Cary, 
North Carolina, USA) and statistical significance was established at p<0.05. 
Results
The baseline characteristics of the included and excluded participants are presented in Table 
5.1. The group of excluded participants were 0.2 years older and consisted of more women 
than the group of included participants (p<0.05, Table 5.1). The excluded participants with 
data on baseline anthropometrics and demographics had a higher BMI (0.5 kg/m2), WC (1.3 
cm), WHtR (1.1), MUAC (0.4 cm) and TSF (1 mm) and consisted of more participants with 
a low education level and low physical activity level (p<0.05, Table 5.1) than the included 
participants. Finally, excluded participants had a shorter survival time (0.6 years, p<0.01) 
than the included participants (Table 5.1). 
From the included participants under study, the percentage of persons with a high 
education, former and current smokers, and persons with respiratory diseases was higher 
in men than in women. Women had on average a lower weight, WC, WHR, WHtR, CAMA 
and a higher TSF (Table 5.1).
All-cause mortality
The hazard ratios (HRs) for all-cause mortality per quintile for the eight anthropometric 
measures are presented in Table 5.2. For changes in BMI, WHR, WHtR, TSF and CAMA, no 
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Table 5.1 Baseline characteristics of included study participants by sex and baseline characteristics 
of excluded participants
Variable Totalincluded
n=1,061
Menincluded
n=516
Womenincluded
n=545
p-valuesex* Totalexcluded 
n=773
p-valueincl vs excl*
Sex, nmen (%) 516 (49) 337 (44) 0.03
Age, mean (SD), years 72.9 (1.8) 72.9 (1.8) 72.9 (1.7) 0.70 73.1(2.0) 0.01
Weight, mean (SD), kg 69.2 (12.5) 74.3(11.1) 64.4 (11.9) <0.001 69.9 (12.5) 0.27
BMI, mean (SD), kg/m2 26.5 (4.1) 26.5 (3.5) 26.6 (4.6) 0.58 27.0 (4.3) 0.02
WC, mean (SD), cm 92.2 (11.6) 96.9 (9.7) 87.7 (11.5) <0.001 93.4 (11.5) 0.03
WHR, mean (SD) 0.91 (0.08) 0.96 (0.06) 0.86 (0.07) <0.001 0.91 (0.08) 0.99
WHtR, mean (SD) 57.1 (6.9) 57.9 (5.9) 56.4 (7.6) <0.001 58.3 (7.2) 0.002
MUAC, mean (SD), cm 29.2 (3.3) 29.2 (2.8) 29.1 (3.6) 0.51 29.5 (3.4) 0.03
TSF, mean (SD), mm 16.5 (7.5) 11.9 (5.2) 21.0 (6.7) <0.001 17.5 (7.7) 0.01
CAMA, mean (SD), cm2 38.1 (10.5) 42.1 (9.7) 34.2 (9.9) <0.001 38.6 (10.8) 0.38
Education, n (%)
Illiteracy/ Primary
Secondary/ Higher
681 (64)
380 (36)
293 (57)
223 (43)
388 (71)
157 (29)
<0.001
537 (70) 
231 (30)
0.01
Smoking status, n (%)
Never smoker
Former smoker
Current smoker
574 (54)
310 (29)
177 (17)
116 (22)
261 (51)
139 (27)
458 (84)
49 (9)
38 (7)
<0.001
436 (56)
205 (27)
132 (17)
0.44
Physical activity, n (%)
Low
Moderate
High
287 (27)
382 (36)
392 (37)
139 (27)
183 (35)
194 (38)
148 (27)
199 (37)
198 (36)
0.90
283 (37)
249 (33)
234 (31)
<0.001
Chronic diseases, n (%)
Diabetes
Ischemic heart disease
Stroke
Malignancy
Respiratory diseases
One or more disease(s)
73 (7)
167 (16)
20 (2)
17 (2)
97 (9)
314 (30)
32 (6)
88 (17)
13 (3)
7 (1)
65 (13)
131 (25)
41 (8)
79 (15)
7 (1)
10 (2)
32 (6)
119 (22)
0.40
0.25
0.14
0.54
<0.001
0.17
61 (8)
121 (16)
16 (2)
17 (2)
81 (10)
246 (32)
0.41
0.97
0.78
0.35
0.34
0.31
SD: standard deviation, BMI: body mass index, WC: waist circumference, WHR: waist to hip ratio, WHtR: Waist to 
height ratio, MUAC: mid-upper arm circumference, TSF: triceps skinfold thickness, CAMA: corrected arm muscle 
area. *Chi-square test was used for categorical variables and a Student’s t-test was used for continuous variables. 
Statistical difference: p<0.05.
associations with all-cause mortality were found, except for an increase in WC between 0.8 
and 3.0 cm [1.61 (95%CI: 1.08–2.39)] and a decrease in TSF between 1.3 and 4.1 mm [0.61 
(95%CI: 0.41–0.93)].
For a decrease in weight (≥3.2 kg) and WC (≥3.1 cm), increased all-cause mortality risks of 
1.48 (95%CI: 0.99–2.20) and 1.52 (95%CI: 1.01–2.31) were observed.
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For MUAC, a decrease of ≥1.6 cm and a decrease between 0.6 and 1.6 cm were associated 
with all-cause mortality risks of 1.81 (95%CI: 1.17–2.79) and 1.66 (95%CI: 1.10–2.49), 
respectively. Also, an increase in MUAC of ≥1.3 cm was associated with an increased all-
cause mortality risk of 1.52 (95%CI: 1.00–2.31). These findings were accompanied with a 
significant quadratic trend (pquadratic=0.05).
Cardiovascular disease mortality
The HRs for CVD mortality are presented in Table 5.3. No associations were observed for 
anthropometric changes and CVD mortality, except for a decrease in WHR between 0.01 
and 0.04 [0.45 (95%CI: 0. 22–0.93)], an increase in WHtR between 2.2 and 4.6 [0.41 (95%CI: 
0.18–0.92)] and a decrease in TSF between 4.1 and 1.3 mm [0.43 (95%CI: 0.21–0.86)]. In 
addition, an increase in MUAC of ≥1.3 cm was associated with an increased CVD mortality 
risk of 1.94 (95%CI: 1.00–3.75). 
Interactions between anthropometric changes and sex
We observed no significant interactions (p>0.05) between anthropometric changes and 
sex in the association with all-cause and CVD mortality for BMI, WHR, WHtR, TSF and CAMA 
(data not shown). For weight and WC, we only observed a nearly significant interaction 
with sex for a decrease in WC of ≥3.1 cm (p=0.07) and an increase in WC between 3.1 and 
6.9 cm (p=0.04). The risks for all-cause mortality for these categories were lower in women 
(Appendix A, Table 4a,b; see publication: http://www.sciencedirect.com/science/article/pii/
S1525861012003465). For MUAC, no interactions with sex were observed (p≥0.09). The risks 
for all-cause mortality for a decrease in MUAC (≥1.6 cm and 0.6–1.6 cm) and the risks for 
all-cause and CVD mortality for an increase in MUAC (≥1.3 cm) were in the same (positive) 
direction for men and women (Appendix A, Table 4c and 5; see publication: http://www.
sciencedirect.com/science/article/pii/S1525861012003465). 
Sensitivity analyses
Our main findings of positive associations for changes in weight, WC and MUAC with all-
cause and CVD mortality were still present when excluding subjects with major chronic 
diseases at baseline, although some associations became weaker (Appendix B; see 
publication: http://www.sciencedirect.com/science/article/pii/S1525861012003465).
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Discussion
In this study of European elderly persons aged 70 to 77 years, we found no consistent 
associations with all-cause and CVD mortality for changes in 5 out of 8 anthropometric 
measures. Decreases in 3 anthropometric measures were associated with increased all-cause 
mortality risks. MUAC showed the most consistent associations with all-cause mortality 
and was the only measure from which an increase was associated with all-cause and CVD 
mortality.  
The SENECA study provided information from a geographically broad elderly population 
who were selected according to a standardized methodology to provide a representative 
sample of the population born in 1913–1918 from 19 towns.18 This has the advantage to 
generalize our results on a broader scale than just one country. Although, measurements 
were taken in different centres, these were carried out by a standardized protocol and 
thereby controlling for variation. This was supported by no consistent significant interactions 
between anthropometric changes and centres (data not shown). Nevertheless, we adjusted 
for centre to rule out any possible confounding. Furthermore, we were able to adjust for 
many potential confounders.
In our study, we could not distinguish between intentional and unintentional weight loss. 
This may have important implications in the evaluation of weight loss effects on mortality, 
since unintentional weight loss may reflect underlying diseases that lead to increased 
mortality.9,23 However, measuring intentionality might be prone to bias as it is often 
measured after the weight loss period.24 Studies with intentionality measured before the 
weight loss period showed increased mortality risks regardless of the intention, suggesting 
underlying mechanisms that can lead to increased long-term mortality, although weight 
loss was intended.24 
During the second survey (1993), only 10 towns kept participating in the study and the 
participants’ health had changed, which led to drop out.25 This resulted in a healthier 
population than had originally entered the study.25 Therefore, we expected that 
anthropometric changes might have been larger in the sample that was lost to follow-up. 
However, our population did not differ consistently on all baseline anthropometrics from 
the ones that were lost to follow-up, and the differences were relatively small, although 
some were statistically significant. Because of the relatively good health of our population, 
the observed changes could be considered to reflect changes due to ageing, rather than 
underlying diseases. This was supported by our sensitivity analysis with the exclusion of 
persons with chronic diseases at baseline that did not affect our main findings as presented 
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in the results section. Furthermore, we carried out two extra analyses in which persons 
who died during the first two years of follow-up were excluded and in which we adjusted 
for having a chronic disease at baseline or the second survey, to account for diseases that 
might have developed between the two measurements. These extra analyses did not affect 
our main findings (data not shown).
We found no consistent associations for 5 out of 8 anthropometric (BMI, WHR, WHtR, TSF 
and CAMA) measures. There were some associations for WHR, WHtR and TSF with mortality, 
but these were more likely to be caused by chance than can be explained by biological 
factors or population characteristics. Most of these measures were calculated from two 
measures, which probably introduce more measuring errors than when it consists of one 
single measure. BMI and WHtR both include height, which in elderly persons decreases with 
age, and thus introduces inaccuracy and an overestimation of the body fat measure. This 
is important since BMI is still a commonly used measure of body fat. TSF can be difficult to 
measure in elderly people which was demonstrated by the discrepancy that occurred in 
the measurements by different observers in Roskilde, Denmark.19 This might explain why 
we did not find an association with mortality for these measures. 
Our result of an increased risk for a weight loss of ≥3.2 kg was similar to previous findings in 
an elderly population.15,17,26-28 In contrast to other studies,17,27,28 we did not find an increased 
mortality risk associated with weight gain. This might be explained by the use of methods, 
e.g. the statistical analysis, definition of weight change and especially the period on 
which weight gain was calculated. Weight gain in the longer term might be more strongly 
associated with an increased mortality risk than weight gain during a short period, as 
suggested by Bamia and collegaues.17 
Because of the redistribution of fat in elderly persons, we expected to find associations 
between changes in WC and mortality. However, we only found an association between a 
decrease of ≥3.1 cm in WC and all-cause mortality, which is comparable with the finding of 
weight loss. The association between changes in WC and mortality was previously studied in 
a middle-aged population, in which a positive linear association between WC changes (per 
5 cm) and mortality was found after adjustment for changes in BMI.29 We did not combine 
two measures in our analyses, because the interpretation and application for clinical practice 
would be difficult. When we adjusted the analyses for changes in WC and all-cause mortality 
for changes in BMI or weight, an increase of ≥3.1 cm was (near) significantly associated with 
all-cause mortality [HR: 1.59 (95%CI: 0.96–2.61) and 1.75 (95%CI: 1.07–2.88, respectively)]. 
These results might be explained by a better reflection of the gain in hazardous abdominal 
fat, when changes in BMI are fixed.
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MUAC was the only measure in which decreases (≤-1.6 cm and -0.6 to -1.6 cm) as well as an 
increase (≥1.3 cm) were associated with all-cause mortality and in which an increase (≥1.3 
cm) was associated with CVD mortality. Our results of an increased all-cause mortality risk 
associated with a decrease in MUAC is corresponding with previous literature reporting 
higher mortality risks for a low MUAC.2,5 The decrease in MUAC probably indicates a 
decrease in muscle mass, reflecting sarcopenia that is associated with disability, frailty 
and mortality,30 but could also reflect a decrease in (subcutaneous) fat that might indicate 
a lost of metabolic or nutritional buffer to survive a disease.31 The associations between 
an increase in MUAC and all-cause and CVD mortality are more difficult to explain. The 
increase in MUAC probably reflects a gain in subcutaneous fat mass. Subcutaneous fat 
mass might not be particularly hazardous for the elderly, but MUAC might give a better 
reflection of changes in overall fat mass since it is less prone to measuring errors and has 
an exceptionally good reproducibility (intraclass correlation (ICC)=0.98 between observers, 
ICC=0.99 within observers).32 In addition, this measure is very practical to use in the elderly 
as it can be measured in a standing and sitting position.32 Furthermore, the strength of our 
findings for MUAC were enforced when we observed that the associations with mortality 
remained present after adjusting for changes in other anthropometric measures during 
additional analyses (data not shown). 
Conclusion
In this European elderly population of 70–77 years old, we found no consistent associations 
for changes in 5 out of 8 anthropometric measures. Decreases in three single anthropometric 
measures were associated with all-cause mortality. This again stresses the importance of 
preventing weight loss in elderly persons, as reported more often in the elderly literature. 
Associations between decreases in MUAC and all-cause mortality were the strongest of all 
single measures and seemed to have better discriminative power as associations for both 
decrement quintiles were observed. In addition, MUAC was the only measure in which 
also an increase was associated with all-cause and CVD mortality. Therefore, this highly 
applicable anthropometric measure can be recommended for clinical practice to observe 
body compositional changes in elderly people in order to prevent diseases and mortality. 
Nevertheless, since we are the first examining changes in this anthropometric measure, 
more research is recommended to confirm these findings in other elderly populations. 
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Abstract
Background: The cross-sectional association between obesity and a lower health-related 
quality of life (HRQL) is clear. However, less is known about the association between 
changes in weight and HRQL. We examined the association between weight changes 
and changes in HRQL in a population-based sample of 2,005 men and 2,130 women 
aged 26 to 70 years. 
Methods: Weight was measured 2 or 3 times with 5-year intervals between 1995 and 
2009; and was categorized as stable (change ≤2kg, 40%), weight loss (19%), or weight 
gain 2.1–4.0 kg, 4.1–6.0 kg, or >6 kg (41%). Changes in HRQL (SF36 questionnaire, 
including physical and mental scales) per weight change category were compared with 
a stable weight using generalized estimating equations. 
Results: Weight gain was associated with declines of up to 5 points on five mainly 
physical scales and holds for different age categories. Especially for women, a dose-
response relationship was observed, i.e. larger weight gain was associated with larger 
declines in HRQL. Changes in HRQL for those with weight loss were small, but particularly 
on the mental scales, changes were in the negative direction compared to a stable 
weight. 
Conclusions: Both weight gain and weight loss were associated with unfavourable 
changes in HRQL compared to a stable weight. For weight gain, this was most 
pronounced on the physical scales and for weight loss, although less consistent, on 
the mental scales. 
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Introduction
Overweight, and in particular severe overweight (obesity), is associated with reduced health-
related quality of life (HRQL), because of its link with several diseases.1,2 But, also without 
apparent morbidity, obesity may impair HRQL, e.g. due to mild physical impairments, 
negative perceptions of body weight, and stigmatization.3,4 
The cross-sectional relation between obesity, and to a lesser extent overweight, and 
impaired HRQL has consistently been shown, especially for the physical scales of HRQL.1,2 
In addition, from surgical and lifestyle intervention studies it is known that intentional 
weight loss in obese people can lead to substantial improvements in HRQL after 0.5 to 5 
years follow-up.2,4,5 
Less is known on the relation between weight changes and changes in HRQL in the general 
population over longer periods. A few studies reported associations of weight gain with 
larger declines,6-9 lower attained scores on the physical scales and the vitality scale of HRQL at 
the end of a follow-up period,10-12 or a higher odds for poor physical functioning13 compared 
to stable weight. However, most of these studies did not include all HRQL scales,6,8,11-13 only 
used self-reported data on changes in weight,6,7,12 and/or relatively short periods of 2–5 
years for weight change.6-10,12 Results on the association between weight loss and changes 
in HRQL in a general population are even more scarce and inconsistent.6,7,9,10
Previous research has shown that HRQL scores are dependent on sex and age, with men on 
average scoring higher on all HRQL scales, and HRQL scores decreasing with age particularly 
on the physical scales in the older age categories.14,15 Thus, we expect that the impact of 
weight change on HRQL differs by age and sex, e.g. due to differences in perceptions of 
body weight, differences in the occurrence of morbidity/impairments, and differences in 
the reason(s) for weight change (intentional or unintentional). This emphasizes the need for 
age and sex stratified analyses when examining associations between weight change and 
change in HRQL. Insight in these age and sex specific associations may be used to assess 
public health needs and target public health interventions to specific groups.16
The aim of this study was to evaluate the relation between weight change and changes 
in HRQL in the population-based sample of the Doetinchem Cohort Study over two 
consecutive 5-year periods, for men and women separately. In addition, we evaluated 
whether this relation differs between individuals in different age groups.
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Methods
Study population
The Doetinchem Cohort Study is a population-based longitudinal study, which currently 
has four measurement rounds completed and a fifth round in progress.17 The first round 
took place from 1987 to 1991 as part of the Monitoring Project on Cardiovascular Disease 
Risk factors (Peilstations project). In that period, 12,405 inhabitants of Doetinchem (a rural 
area in the eastern part the Netherlands), aged 20–59 years, were examined (response rate 
62%; Figure 6.1). A random sample of 7,769 participants were re-invited for the second 
Figure 6.1 Flowchart of data collection in the Doetinchem Cohort Study.
Round 1 
1987–1991
Invited = 20,155
Response rate = 62%
Par?cipated = 12,405
Round 2 
1993–1997
Invited = 7769
Response rate = 79%
Par?cipated = 6,118
Round 3 
1998–2002
Invited = 6579
Response rate = 75%
Par?cipated = 4,917
Round 4 
2003–2007
Invited = 5784
Response rate = 78%
Par?cipated = 4,523
Round 5 
2008–2012
Invited = In progress
Response rate = -
Par?cipated = -
Original measurement rounds Rounds for analyses
Round N1 
1995–1999
n=5,727
Round N2 
2000–2004
n=4,742
Round N3 
2005–2009
n=4,312
Complete data on 
change
N1->N2
n=4,135
Complete data on 
change
N2->N3
n=3,545
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round between 1993 and 1998 (MORGEN project). These participants were then re-invited 
for an examination five, ten and fifteen years later. Participants who actively refused to 
participate at any time were not invited again. The response rate for the second, third, and 
fourth measurement round was ≥75%. 
The study was approved according to the guidelines of the Helsinki Declaration by the 
external Medical Ethics Committee of the Netherlands Organization of Applied Scientific 
Research Institute and of the University of Utrecht (5th round). All participants gave written 
informed consent.
For the present study, data were available until 2009. Data on HRQL have been collected 
since 1995. Thus, for our analyses the first round (baseline) are the data collected between 
1995 and 1999 (N1), data collected between 2000 and 2004 represent the first follow-up 
(N2) and data collected between 2005 and 2009 as the second follow-up (N3) (Figure 6.1).
If participants were pregnant at the time of data collection, data for that round were 
excluded for the analyses (n=39). Data on HRQL, weight, demographic, and lifestyle variables 
were available for 4,135 individuals. 
Measures
Change in Health-Related Quality of Life (HRQL).
HRQL was evaluated with the Dutch RAND-36 questionnaire,18 which was adapted from the 
standardized SF-36 Health Survey.19 The RAND-36 includes one question on health change 
in the past year and 35 items on eight scales of HRQL: 
1. physical functioning
2. role limitations due to physical problems
3. bodily pain 
4. general health perceptions 
5. vitality 
6. social functioning 
7. general mental health
8. role limitations due to emotional problems 
In this paper, we consider the first four scales to reflect the ‘physical scales’, and the last 
four the ‘mental scales’.
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For each scale, the crude score was converted to a 0–100 scale, according to international (SF-
36) methodology; with higher scores indicating better HRQL.19 The main outcome variable 
was change in HRQL over 5 years, for each scale; which could thus range from -100 to 100.
Weight and weight change
All anthropometric measurements were carried out by trained personnel. Subjects wore 
light clothes with emptied pockets, and without shoes. Height was measured on a wall-
mounted stadiometer to the nearest 0.5 cm. Body weight was measured with a calibrated 
scale to the nearest 100g. 
The main independent variable was weight change over 5y, which was categorized into 
five classes: 
1: Weight loss >2 kg 
2: Stable (≤2 kg change; reference category) 
3: Weight gain 2.1–4.0 kg 
4: Weight gain 4.1–6.0 kg 
5: Weight gain >6 kg 
Demographic, health, and lifestyle characteristics were assessed using self-administered 
questionnaires that were completed at home preceding the medical examination.17 
Information on chronic diseases was obtained from self-report for cardiovascular diseases, 
diabetes (type 1 and 2), asthma, and cancer.
Body-mass index (BMI) and BMI category
Before calculating BMI, 1 kg was subtracted from the weight to adjust for clothing. BMI was 
calculated as weight divided by height squared (kg/m2). Based on BMI participants were 
defined as normal weight (BMI <25.0 kg/m2), overweight (BMI 25.0–29.9 kg/m2) or obese 
BMI ≥30.0 kg/m2).
Physical activity
Physical activity was estimated with the validated physical activity questionnaire for 
the “European prospective investigation into cancer and nutrition” (EPIC questionnaire), 
extended with questions on sports and other strenuous leisure activities in the preceding 
year. All activities were categorized as light, moderate, or vigorous based on the metabolic 
equivalent value (MET) as reported by Ainsworth and colleagues.20 Cutoff points for light, 
moderate, and vigorous were <4.0, 4.0–6.4, and ≥6.5 MET, respectively. Subsequently, the 
average time spent on low, moderate, and high-intensity activities was used to classify 
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individuals as inactive (<0.5h per week), semi active (0.5–3.4h per week) and norm active 
(≥3.5 h per week).
Smoking 
Smoking status (current, ex or never smoker) was obtained from questions on past and 
present cigarette use. Individuals were defined as smoker if they reported smoking at least 
one cigarette per month.
Alcohol
Alcohol use was also classified as heavy (mean intake ≥3 drinks per day for men, and ≥2 
drinks per day for women), moderate (mean intake 0–2 drinks per day for men, and 0–1 
drinks per day for women), ex, or never. 
Education
Educational level was defined as the highest completed education, and was classified 
into four categories: primary education or less, low or intermediate secondary education, 
higher secondary education or intermediate vocational education, and higher vocational 
education or university.
Job status
Job status was defined as having a paid job (including salaried employment and self-
employment) or not having a paid job (including those who reported not to have a job, 
housewife, retired, unable to work, and other).
Household composition
Household composition was defined as living alone or not living alone (living with a partner, 
children, parents, or other adults).
Statistical analyses
To study the relationship between changes in weight and changes in HRQL over two 
consecutive 5-year periods, we used generalized estimating equations (GEE). (Proc 
GENMOD in SAS, with distribution=normal, link function=identity, and correlation 
structure=autoregressive; SAS Institute Inc., Cary, North Carolina, USA). The mean change in 
HRQL for each weight change category was estimated using the least squares means option 
after adjustment for age, smoking, physical activity, alcohol use, educational level, job status, 
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household composition, HRQL score, and BMI at the preceding measurement. Then, the 
change in HRQL per weight change group was compared with the change in HRQL of the 
reference group, stable weight. All analyses were performed for men and women separately. 
To assess how changes in weight affect HRQL in individuals in different age groups, we 
performed analyses stratified for age category (≤40, 41–50, 51–60, >60 years). Furthermore, 
we explored the association between weight changes and changes in HRQL for different 
BMI categories by stratifying for preceding BMI category. 
To evaluate the associations between changes in weight and HRQL independently of 
the development of severe chronic diseases, we performed additional analyses after the 
exclusion of individuals with self-reported cardiovascular diseases, diabetes, asthma, or 
cancer at baseline and/or in one of the subsequent two measurement rounds. 
Results
Baseline population characteristics and changes in weight and HRQL
The study population consisted of 2,005 men and 2,130 women aged 26 to 70 years 
at baseline (1995–1999) (Table 6.1). At this time, 50% of the participating men was 
(moderately) overweight and 10% obese. For women, these percentages were 34% and 12% 
respectively.
Table 6.1 Baselinea characteristics of the study population by sex
Men (n=2,005) Women (n=2,130)
Body-mass index (BMI, kg/m2) 25.9 ± 3.14c 25.2 ± 4.14
Normal weight (BMI <25 kg/m2) 41 54
Overweight (BMI 25–29.9kg/m2) 50 34
Obese (BMI >30 kg/m2) 10 12
Waist circumference (cm) 96 ± 10 87 ± 11
Weight (kg) 84.5 ± 11.1 70.9 ± 11.8
5-year weight change (kg)b 1.3 ± 4.4 1.4 ± 4.9
5-year weight change category (%)b
Lost >2 kg 18 19
Stable (change ≤2 kg) 41 39
Gain 2.1–4.0 kg 19 18
Gain 4.1–6.0 kg 10 10
Gain >6 kg 12 13
Table 6.1 continues on next page
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Table 6.1 Continued
Men (n=2,005) Women (n=2,130)
Age (%)
≤40 years 25 30
41–50 years 36 35
51–60 years 26 24
>60 years 13 11
Educational level (%)
Low 42 59
Moderate 32 24
High 27 18
Smoking (%)
Current 27 28
Ex 43 34
Never 30 38
Alcohol use (%)d
Heavy 17 8
Moderate 78 77
Ex 2 1
Never 4 14
Leisure time physical activity level (%)
Inactive (<0.5 h/wk) 4 2
Semi active (0.5–3.4 h/wk) 18 17
Active (>3.5 h/wk) 78 81
Cohabiting status (%)
Living alone 10 11
Job status (%)
Paid job 77 49
Perceived health (%)
Good/excellent 31 25
Intermediate 60 63
Reasonably/poor 10 12
HRQL (score with range 0–100)
Physical functioning 91 ± 14 87 ± 17
Role limitations due to physical problems 86 ± 28 80 ± 34
Bodily pain 83 ± 21 77 ± 22
General health perceptions 68 ± 17 67 ± 17
Vitality 70 ± 16 65 ± 17
Social functioning 89 ± 18 84 ± 21
Role limitations due to emotional problems 89 ± 26 85 ± 31
General mental health 79 ± 14 74 ± 15
 a Measurement between 1995 and 1999 (N1); b Change between 1995–1999 and 2000–2004 (N1–N2) and 
2000–2004 and 2005–2009 (N2–N3) combined (3,733 observations for men and 3,947 observations for women). 
c Mean ± standard deviation; all such values. d Heavy: ≥3 drinks per day for men, ≥2 drinks per day for women; 
moderate: 0–2 drinks per day for men, 0–1 drinks per day for women.
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Association between weight change and change in HRQL
Men and women who had a stable weight (40% of the study population) had small changes 
(declines as well as improvements) ranging from -2 to + 3 on all scales of HRQL (Figure 6.2a,b).
Both men and women who gained weight (41% of the population) had declines in physical 
functioning, role limitations due to physical problems, pain, general health perceptions, and 
vitality (Figure 6.2a,b). For these scales, a dose-response relation was apparent, especially 
in women, i.e. with an increase in weight gain, an increase in the decline in HRQL was 
Figure 6.2 Mean changea in quality of life score by weight change category in men (A) and women 
(B). a 5-year change in score (0–100) with 100 representing excellent health; Adjusted for preceding 
age, educational level (low, medium, high), smoking (current, ex, never), alcohol intake (never, ex, 
moderate, heavy), physical activity category (<0.5h, 0.5–3.4h, >3.5h moderate-to vigorous intensity 
activity per week), job status (paid job yes/no), cohabiting status (living alone yes/no), quality of life 
score (0–100) and BMI (kg/m2). * Significantly different from stable weight.
-7.0
-5.0
-3.0
-1.0
1.0
3.0
5.0
Lost >2.0 kg
Stable
Gain 2.1–4.0 kg
Gain 4.1–6.0 kg
Gain >6.0 kg
*
*
*
*
*
*
* * *
*
*
A
-7.0
-5.0
-3.0
-1.0
1.0
3.0
5.0
Lost >2.0 kg
Stable
Gain 2.1–4.0 kg
Gain 4.1–6.0 kg
Gain >6.0 kg
*
*
*
*
*
*
*
*
*
*
* *
*
*
B
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observed. Individuals who gained more than 6 kg had declines in HRQL scores that were 
statistically significantly different by 1–5 points in the negative direction from the change 
in HRQL of individuals with a stable weight. Except for physical functioning, and general 
health perceptions in women, the statistically significant differences from the stable weight 
group were limited to the highest weight gain categories (4.1–6.0 kg or >6 kg). 
Individuals who lost more than 2 kg over 5 years (19% of the study population) had stable 
scores or small declines for social functioning, mental health, and role limitations due to 
emotional problems whereas individuals with a stable weight had small improvements on 
these HRQL scales. Thus, the statistically significant differences from those with a stable 
weight were in the negative direction.
Stratifi cation by age group
Both in men and women within all age groups, weight gain >6 kg was associated with 
declines on most physical HRQL scales (Appendix 6.1, Table A6.1a,b).  
For women, this was observed across all ages, but women older than 60 years had the 
largest declines on the physical scales of up to 15 points. 
Men older than 60 years in general had improvements in HRQL, except for those who gained 
weight for physical functioning and pain. Improvements in HRQL were thus also observed 
for those who lost weight, but these improvements were smaller than for men in this age 
category with a stable weight. 
Stratifi cation by BMI category 
Both in men and women with normal weight, overweight and obesity, weight gain larger 
than 6 kg over 5 years was associated with declines in HRQL, particularly on the physical 
scales (Appendix 6.1, Table A6.2a,b). The largest declines were found in obese individuals.
Exclusion of chronic diseases
Exclusion of individuals with chronic diseases at baseline, and/or who developed one or 
more of these diseases during follow-up did not affect our main findings (data not shown). 
Observed score differences with individuals with a stable weight changed with less than 
1 point, except for role limitations due to physical problems in men, where the difference 
decreased with up to 1.6 points, and role limitations due to emotional problems in both 
men and women, where the score difference increased with up to 1.1 points.
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Discussion
In this population-based sample, weight gain over two consecutive 5-year periods was 
associated with declines in physical functioning, role limitations due to physical problems, 
pain, general health perceptions, and vitality. For these HRQL scales, dose-response 
relations between the amount of weight gain and the decline in HRQL were observed, 
especially for women. Among all age categories, weight gain was associated with declines 
on the physical scales of HRQL. Changes in HRQL for individuals who lost weight did not 
show a consistent direction, but the difference with individuals with a stable weight was 
unfavourable, especially for men older than 60 years and the scores on the mental scales.
Comparison with previous research
Consistent with the cross-sectional associations between overweight/obesity and HRQL, 
weight gain coincided with declines in scores on the physical scales.2 As compared to studies 
examining (almost) all dimensions of HRQL, our findings of associations between weight 
gain and declines in scores on in particular the physical scales of HRQL were similar.6,7,9 
These findings were more marked in women than in men. 
However, in contrary to results from interventions,2,4,5 weight loss in our study did not 
lead to improvements. In our population-based study, we observed that weight loss was 
associated with less favourable changes on the mental scales as compared to a stable weight. 
This was more or less in agreement with the study by Leon-Munoz and colleagues among 
elderly men and women.7 They found larger declines on the mental scales as compared 
to our results, which might be explained by their measurement of weight change. In this 
study,7 weight change was not measured, but only investigated with a questions “whether 
individuals noticed important changes in weight over the past 2 years”, which may affect 
the associations by perception. A negative perception of your weight, either weight gain 
or loss might negatively influence your perception of HRQL.
Moreover, Fine and colleagues6 reported that the results for weight loss were dependent on 
age and baseline BMI. Women younger than 65 years with obesity and weight loss (>9 kg) 
had larger improvements in physical functioning, pain and vitality than their counterparts 
with a stable weight. We could not stratify for both age and BMI simultaneously due to the 
lower number of participants in our study (n=4,135) as compared to Fine and colleagues6 
(n=40,098). In addition, the weight losses in their population were larger, in combination 
with obesity, this might be due to voluntary weight loss attempts that may have a greater 
and positive impact on HRQL.
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Strengths and limitations
Strengths of our study include the large, population-based sample, and 10 years of follow-
up, which allowed us to investigate the relation between changes in HRQL with the ‘normal 
course’ of weight change in the general population. Weight change was not self-reported but 
measured by trained personnel. Data on weight, all scales of HRQL, and several demographic 
and lifestyle characteristics were available for two or three measurements per person, thus 
we could adjust for preceding BMI, HRQL and other important characteristics.
Limitations of our study were that we did not know whether the weight change (particularly 
weight loss) was intentional (dieting) or unintentional. The fact that weight loss for some 
individuals may have been unintentional and that weight loss in our population was 
relatively small (e.g. in our population mean weight loss for obese individuals was 7 kg (SD: 
5 kg) over 5 years) may explain why we did not find improvements in HRQL with weight loss. 
Weight loss interventions, especially surgical interventions, among obese people resulted 
in large weight losses of 33–55 kg and large improvements in HRQL.2,4,5 In addition, larger 
improvements in intervention studies may be expected because obese individuals who seek 
treatment are more (physically) impaired than those who are not trying to lose weight.2,4,5
Another limitation was that the period between measurements was relatively long (5 
years), thus there may be changes in-between measurements of weight and HRQL that 
were not captured. 
Finally, there may have been selective participation and loss to follow up. Individuals who 
dropped out on average had lower HRQL scores at baseline, were more often obese, and 
were more often in the highest age category than individuals who remained in the study 
(results not shown). In addition, it can be assumed that individuals who have large declines 
in HRQL, are more likely to drop out. If there is selective loss to follow up related to changes 
in HRQL, this may lead to bias in the estimated associations between changes in weight 
and changes in HRQL.
Implications for public health
Individuals who gained more than 6 kg over 5 years had declines in HRQL of 1 to 5 points. 
The stratified analyses showed that these declines are larger in some groups, e.g. obese 
individuals and older women these declines were larger (up to 15 points). Compared to 
the changes in HRQL of individuals in the stable group, the difference was up to 10 points. 
Changes of 3 to 5 points in HRQL are considered clinically relevant.21 However, this applies 
to intra-individual changes in clinical samples, while we examined ‘healthy’ participants 
in a population-based study. In population-based samples smaller differences can impact 
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public health.22 For the interpretation of our results, it should be kept in mind that we 
cannot assume that the changes in HRQL are caused by the changes in weight, because 
the opposite relation of changes in HRQL leading to weight change may also be present.8
The declines on the physical scales, associated with weight gain were larger in women 
than in men. Men older than 60 years in general had improvements in HRQL, whereas 
women in this age group had the largest declines on the physical scales. This suggests 
that prevention of weight gain is particularly important for women, and up to higher age 
than in men. Further research is needed to confirm this difference and/or to establish the 
reasons behind this difference (e.g. differences in selective dropout or in perceptions of 
weight change and HRQL between men and women).
Exclusion of individuals with a serious chronic illness (cardiovascular diseases, diabetes, asthma 
or cancer) did not affect our main findings. This shows that the association between weight 
change and change in HRQL is partially independent of development of these conditions. 
Conclusion
In conclusion, in this population-based sample weight gain over two consecutive 5-year 
periods was associated with clinically relevant declines in HRQL, particularly for the physical 
scales. This was observed in all age groups. Nevertheless, older women who gained more 
than 6 kilograms had the largest declines on the physical scales of HRQL. This stresses 
again the importance of prevention of weight gain among adults across all ages in order 
to maintain physical functioning in daily life, especially in women.
The results for weight loss were less consistent, but for the mental scales, we observed that 
individuals who had a stable weight were better off than those who lost weight, which was 
most pronounced in men older than 60 years. More research is needed on weight loss in a 
general population with a distinction between unintentional and intentional weight loss 
to gain further insight in the impact on HRQL. 
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Appendix 6.1
Mean change in quality of life score by weight change category, stratifi ed 
for age and BMI
Table A6.1a Mean change‡ in quality of life score by weight change category in men after 
stratification for age category (n=3,733 observations for 2,005 men)
QoL scale
Weight change 
category
26–40y 41–50y 51–60y >60y
Mean SE Mean SE Mean SE Mean SE
Physical 
functioning
 
Lost >2 kg -1.1 1.3 0.4 0.9 -0.2 0.8 -3.2bc* 1.2
Stable (change ≤2 kg) 0.2 0.7 -0.3 0.5 -0.2 0.5 -0.3 0.9
Gain 2.1–4.0 kg -0.5a 0.7 -1.3b 0.6 -0.4ab 0.8 -1.9ab 1.5
Gain 4.1–6.0 kg 0.9 0.7 -2.9a* 1.1 -1.1 1.2 -1.9 2.2
Gain >6 kg -1.0 0.9 -4.5a* 1.2 -6.2a* 1.6 -4.5 2.5
Role limitations 
physical
 
Lost >2 kg -3.6 2.7 -4.0 2.2 0.3 1.6 2.2* 2.7
Stable (change ≤2 kg) -0.7a 1.6 -1.8a 1.2 0.5a 1.2 9.8b 1.8
Gain 2.1–4.0 kg 0.9 1.9 -1.0 1.5 1.7 2.0 8.5abc 2.8
Gain 4.1–6.0 kg -2.9 2.5 -8.0* 2.6 2.6b 3.0 10.1ab 4.6
Gain >6 kg -0.3 2.1 -6.7 2.5 -4.3 3.1 7.4b 5.0
Bodily pain Lost >2 kg -1.0 1.5 -1.2 1.4 -0.0 1.1 1.2 1.4
Stable (change ≤2 kg) -2.9 1.2 -2.3 0.8 -1.0 0.7 1.7abc 1.2
Gain 2.1–4.0 kg -0.5 1.3 -2.2 1.1 1.1b 1.3 1.8b 1.7
Gain 4.1–6.0 kg -3.7 1.7 -4.0 1.4 -0.9 2.2 -3.7 3.1
Gain >6 kg -1.3 1.4 -6.3a* 1.6 -3.9 2.1 -2.4 2.8
General health 
perceptions
Lost >2 kg -1.0 1.6 1.8 1.2 2.6 1.0 3.0* 1.3
Stable (change ≤2 kg) -1.9 1.1 0.4 0.7 1.0a 0.7 5.8abc 1.0
Gain 2.1–4.0 kg -2.8 1.2 -0.4 0.8 2.5ab 1.0 6.3abc 1.4
Gain 4.1–6.0 kg -3.9 1.3 -3.0* 1.0 -0.2 1.8 5.2abc 1.8
Gain >6 kg -4.8 1.1 -2.3* 1.2 -3.6* 1.6 6.0abc 2.2
Vitality Lost >2 kg -1.4 1.2 0.4 1.2 3.0a 0.9 2.1a 1.1
Stable (change ≤2 kg) -0.4 0.9 -0.1 0.6 3.3ab 0.5 4.2ab 0.9
Gain 2.1–4.0 kg 0.1 1.1 0.3 0.8 4.3ab 1.0 3.7ab 1.3
Gain 4.1–6.0 kg -2.4 1.2 -1.8 1.2 1.9a 1.6 -0.4* 1.8
Gain >6 kg -1.8 1.3 -2.2 1.2 -0.3* 1.4 1.9 2.8
Social 
functioning
Lost >2 kg -1.7 1.9 -1.3 1.5 0.6 1.1 1.0* 1.5
Stable (change ≤2 kg) 1.2 0.9 -1.0a 0.7 1.3b 0.7 4.4abc 1.1
Gain 2.1–4.0 kg -0.1 1.3 -0.5 1.0 2.6b 1.0 5.9ab 1.4
Gain 4.1–6.0 kg -4.6* 1.5 -2.3 1.4 1.5a 1.9 7.7abc 1.9
Gain >6 kg -2.0* 1.4 -3.1 1.5 -1.5 1.7 9.3abc 2.8
Table A6.1a continues on next page
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Table A6.1a Continued
QoL scale
Weight change 
category
26–40y 41–50y 51–60y >60y
Mean SE Mean SE Mean SE Mean SE
General mental 
health
Lost >2 kg -2.6* 1.3 -0.4 1.0 1.2a 0.8 1.5a* 0.9
Stable (change ≤2 kg) 0.6 0.7 -0.2 0.5 1.4b* 0.5 3.9abc 0.7
Gain 2.1–4.0 kg -0.2 0.9 0.8 0.7a 3.5ab 0.7 2.4 1.2
Gain 4.1–6.0 kg -1.8* 1.0 -0.2 0.9 2.6a 1.2 3.5ab 1.4
Gain >6 kg 0.1 1.0 -1.0 1.0 2.8b 1.2 1.2 1.9
Role limitations 
emotional
Lost >2 kg -0.2 2.4 -1.0 2.0 -0.1 1.7 3.5* 2.0
Stable (change ≤2 kg) 1.8 1.4 -2.7a 1.2 1.8b 1.0 9.0abc 1.4
Gain 2.1–4.0 kg 1.1 1.8 0.5 1.5 4.6b 1.3 8.9abc 1.7
Gain 4.1–6.0 kg -4.5* 2.5 -4.9 2.4 2.5 2.9 6.0ab 3.4
Gain >6 kg -0.3 2.0 -3.3 2.4 0.5 2.7 11.1abc 3.6
a p<0.05 for difference with age 26–40y; b p<0.05 for difference with age 41–50y; c p<0.05 for difference with age 51–60y. 
* p<0.05 for difference with stable weight. ‡ 5-year change in score (0–100) with 100 representing excellent health; 
Adjusted for preceding educational level (low, medium, high), smoking (current, ex, never), alcohol intake (never, 
ex, moderate, heavy), physical activity category (<0.5h, 0.5–3.4.h, ≥3.5h moderate-to vigorous intensity activity 
per week), job status (paid job yes/no), cohabiting status (living alone yes/no), quality of life score (0–100) and 
BMI (kg/m2).
117
Changes in w
eight and quality of life in an ageing population
Chapter 6
Table A6.1b Mean change‡ in quality of life score by weight change category in women after 
stratification for age category (n=3,947 observations for 2,130 women)
QoL scale
Weight change 
category
26–40y  41–50y 51–60y  >60y 
Mean SE Mean SE Mean SE Mean SE
Physical 
functioning
 
Lost >2 kg 1.6 1.1 1.2 0.9 -1.1 1.0 -4.3ab 1.4
Stable (change ≤2 kg) 0.8 0.6 -0.4 0.6 -0.3 0.6 -5.3abc 0.9
Gain 2.1–4.0 kg 0.2 0.9 -2.1 0.9 -3.8a* 1.1 -3.8a 1.6
Gain 4.1–6.0 kg 0.3 1.1 -2.1 1.0 -3.8a* 1.4 -9.1ab 3.0
Gain >6 kg -2.7* 1.2 -2.6 1.0 -6.8ab* 1.3 -15.1abc* 3.1
Role 
limitations 
physical
 
Lost >2 kg 3.7 2.7 -0.9 2.2 2.4 2.0 -3.4 3.1
Stable (change ≤2 kg) 2.9 1.7 1.7 1.4 2.7 1.4 -4.4abc 2.1
Gain 2.1–4.0 kg 3.0 2.2 -2.4 2.1 0.5 2.3 -1.8 3.4
Gain 4.1–6.0 kg -1.7 3.0 -1.6 2.7 -2.4 3.6 -11.7 6.2
Gain >6 kg -3.4 2.9 -1.1 2.3 -7.9* 3.5 -10.9 6.7
Bodily pain Lost >2 kg 0.9 1.7 0.2 1.4 -0.2 1.4 -2.5 1.7
  Stable (change ≤2 kg) 2.5 1.0 -0.7a 0.8 -0.3a 0.8 -4.7abc 1.1
  Gain 2.1–4.0 kg -1.3* 1.3 -2.8 1.3 -1.8 1.4 -0.8 2.0
  Gain 4.1–6.0 kg -0.6 1.8 -1.2 1.6 -3.6 2.0 -3.2 2.9
  Gain >6 kg -2.5* 1.5 -1.8 1.4 -4.4 2.0 -11.6abc* 2.9
General 
health 
perceptions
Lost >2 kg -1.2 1.3 1.7 1.0 3.1a 1.0 1.8 1.3
Stable (change ≤2 kg) -1.2 0.9 1.8a 0.7 3.4a 0.7 4.0a 1.0
Gain 2.1–4.0 kg -3.8* 1.1 -1.5* 1.0 2.3ab 1.1 1.1a 1.7
Gain 4.1–6.0 kg -5.5* 1.3 -2.0a* 1.0 2.2ab 1.5 -0.9* 2.3
Gain >6 kg -5.7* 1.1 -2.8* 1.0 -1.4a* 1.6 -1.0* 2.2
Vitality Lost >2 kg 0.6 1.3 0.4 0.9 1.8 0.9 -2.0c* 1.1
  Stable (change ≤2 kg) 0.9 0.8 1.4 0.6 2.3 0.6 1.4 0.8
  Gain 2.1–4.0 kg -0.7 0.9 0.3 1.0 1.5 1.0 3.1a 1.3
  Gain 4.1–6.0 kg -0.6 1.4 -0.8 1.1 3.0b 1.4 -0.4 2.0
  Gain >6 kg -1.0 1.1 -1.0* 1.0 0.9 1.3 -1.3 2.2
Social 
functioning
Lost >2 kg 0.2 1.8 1.8 1.3 -0.7* 1.3 -1.7 1.6
Stable (change ≤2 kg) 1.4 1.1 1.3 0.8 3.6b 0.7 0.5c 1.1
Gain 2.1–4.0 kg 1.5 1.3 0.9 1.2 3.1 1.1 2.9 1.9
Gain 4.1–6.0 kg 0.8 1.6 -0.9 1.5 1.9 1.7 -3.1 3.2
Gain >6 kg -1.5 1.6 1.0 1.3 1.8 1.9 -4.3 3.9
General 
mental 
health
Lost >2 kg -0.5 1.2 0.9 0.8 0.1 0.8 -1.6 1.1
Stable (change ≤2 kg) 1.0 0.7 1.2 0.5 1.3 0.5 0.6 0.6
Gain 2.1–4.0 kg 1.1 0.8 1.5 0.7 2.0 0.9 1.0 1.1
Gain 4.1–6.0 kg 1.0 1.2 1.4 1.0 2.3 1.1 -0.8 2.0
Gain >6 kg 1.6 0.9 1.3 0.9 2.0 1.2 -0.0 2.5
Table A6.1b continues on next page
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Table A6.1b Continued
QoL scale
Weight change 
category
26–40y  41–50y 51–60y  >60y 
Mean SE Mean SE Mean SE Mean SE
Role 
limitations 
emotional
Lost >2 kg -2.4* 2.6 -0.0 2.0 1.3 1.9 -3.3 2.9
Stable (change ≤2 kg) 3.4 1.5 1.3 1.3 5.6b 1.1 2.9 1.6
Gain 2.1–4.0 kg -3.2* 2.4 1.8 1.8 1.0* 2.1 3.4 2.9
Gain 4.1–6.0 kg -0.3 2.6 -0.7 2.4 5.1 2.8 -1.6 4.1
Gain >6 kg -1.1 2.5 1.3 2.1 -0.4 3.0 3.2 5.3
a p<0.05 for difference with age 26–40y; b p<0.05 for difference with age 41–50y; c p<0.05 for difference with age 51–60y. 
* p<0.05 for difference with stable weight. ‡ 5-year change in score (0–100) with 100 representing excellent health; 
Adjusted for preceding educational level (low, medium, high), smoking (current, ex, never), alcohol intake (never, 
ex, moderate, heavy), physical activity category (<0.5h, 0.5–3.4.h, ≥3.5h moderate-to vigorous intensity activity 
per week), job status (paid job yes/no), cohabiting status (living alone yes/no), quality of life score (0–100) and 
BMI (kg/m2).
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Table A6.2a Mean change‡ in quality of life score by weight change category in men after 
stratification for preceding BMI category (n=3,733 observations for 2,005 men)
QoL scale
Weight change 
category
BMI 
<25 kg/m2
BMI 
25–29.9 kg/m2 
BMI 
>30 kg/m2 
Mean SE Mean SE Mean SE
Physical functioning Lost >2 kg -1.8 1.1 -0.3 0.6 -2.5 1.6
  Stable (change ≤2 kg) -0.0 0.4 -0.1 0.4 0.4 1.1
  Gain 2.1–4.0 kg -0.2 0.6 -1.2 0.5 -3.7 1.9
  Gain 4.1–6.0 kg -1.4 0.7 -1.3 1.0 -2.9 1.8
  Gain >6 kg -3.1*§ 0.9 -3.0* 0.9 -9.9ab* 2.1
Role limitations physical Lost >2 kg -2.3 2.0 -2.5* 1.4 1.8 2.6
  Stable (change ≤2 kg) 1.2 1.0 1.0 1.0 3.2 2.3
  Gain 2.1–4.0 kg 2.4 1.3 1.5 1.3 2.0 3.3
  Gain 4.1–6.0 kg -2.9 2.4 -1.3 2.2 1.9 3.6
  Gain >6 kg -0.8 2.1 0.4 2.0 -10.1ab* 4.1
Bodily pain Lost >2 kg -0.5 1.2 -0.2 0.8 -1.5 1.8
  Stable (change ≤2 kg) -0.7 0.7 -1.7 0.6 0.5 1.5
  Gain 2.1–4.0 kg -0.5 1.0 -0.5 0.9 1.8 2.3
  Gain 4.1–6.0 kg -2.9 1.4 -3.3 1.4 -2.8 2.6
  Gain >6 kg -1.4 1.4 -3.2 1.4 -9.4ab* 2.3
General health perceptions Lost >2 kg 0.6 1.2 2.1 0.8 -1.3b 1.5
  Stable (change ≤2 kg) 2.2 0.7b 0.4a 0.6 0.5 1.4
  Gain 2.1–4.0 kg 1.4 1.4 0.9 0.7 2.1 1.7
  Gain 4.1–6.0 kg -0.9* 1.1 -1.1 1.0 -0.8 1.9
  Gain >6 kg -0.7* 1.1 -2.1* 1.0 -2.5 2.1
Vitality Lost >2 kg 1.1 1.1 0.8 0.7 1.3 1.2
  Stable (change ≤2 kg) 2.2 0.5 1.1 0.4 2.8 1.1
  Gain 2.1–4.0 kg 2.1 0.7 2.0 0.7 1.7 1.8
  Gain 4.1–6.0 kg -0.9* 1.1 -1.0* 0.9 1.6 1.7
  Gain >6 kg 0.1 1.2 0.4 1.0 -5.6ab* 2.1
Social functioning Lost >2 kg -1.1 1.5 -1.0 0.9 0.6 1.6
  Stable (change ≤2 kg) 1.8 0.6 0.7 0.5 0.3 1.4
  Gain 2.1–4.0 kg 2.5 0.8 0.7 0.8 2.8 1.9
  Gain 4.1–6.0 kg -1.9* 1.3 0.5 1.2 0.4 2.1
  Gain >6 kg -0.3 1.3 1.1 1.2 -6.0ab* 2.5
General mental health Lost >2 kg 0.0 0.9 -0.3 0.6 0.3 1.1
  Stable (change ≤2 kg) 1.5 0.4 1.0 0.4 0.5 1.0
  Gain 2.1–4.0 kg 1.8 0.6 1.7 0.6 0.8 1.5
  Gain 4.1–6.0 kg 0.5 0.9 0.3 0.8 3.1 1.5
  Gain >6 kg 1.5 0.9 1.7 0.8 -2.8ab 1.8
Table A6.2a continues on next page
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Table A6.2a Continued
QoL scale
Weight change 
category
BMI 
<25 kg/m2
BMI 
25–29.9 kg/m2
BMI 
>30 kg/m2 
Mean SE Mean SE Mean SE
Role limitations emotional Lost >2 kg -0.6 1.9 -0.3 1.3 0.3 2.4
  Stable (change ≤2 kg) 2.2 0.8 0.9 0.8 2.6 1.9
  Gain 2.1–4.0 kg 3.5 1.2 3.5* 1.1 1.0 2.8
  Gain 4.1–6.0 kg -3.3* 2.3 0.2 1.9 0.3 3.7
  Gain >6 kg 1.5 2.1 2.2 1.8 -3.7 3.6
a p<0.05 for difference with BMI<25 kg/m2; b p<0.05 for difference with BMI 25–29.9 kg/m2. * p<0.05 for difference 
with stable weight. ‡ 5-year change in score (0–100) with 100 representing excellent health; Adjusted for age, and 
preceding educational level (low, medium, high), smoking (current, ex, never), alcohol intake (never, ex, moderate, 
heavy), physical activity category (<0.5h, 0.5–3.4.h, ≥3.5h moderate-to vigorous intensity activity per week), job 
status (paid job yes/no), cohabiting status (living alone yes/no), quality of life score (0–100).
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Table A6.2b Mean change‡ in quality of life score by weight change category in women after 
stratification for preceding BMI category (n=3,947 observations for 2,130 women)
QoL scale
Weight change 
category
BMI 
<25 kg/m2 
BMI 
25–29.9 kg/m2
BMI 
>30 kg/m2 
Mean SE Mean SE Mean SE
Physical functioning Lost >2 kg -0.5 0.8 -0.3 0.8 -1.5 1.2
  Stable (change ≤2 kg) 0.8 0.4 -2.0a 0.6 -3.6a 1.2
  Gain 2.1–4.0 kg -1.8* 0.6 -1.7 1.0 -5.3 2.0
  Gain 4.1–6.0 kg -1.6* 0.8 -2.5 1.0 -9.5ab* 2.6
  Gain >6 kg -3.3* 0.9 -6.3a* 1.2 -8.9a* 1.9
Role limitations physical Lost >2 kg -0.3 2.0 0.9 1.8 0.3 2.7
  Stable (change ≤2 kg) 2.7 1.0 1.4 1.3 -5.7ab 2.9
  Gain 2.1–4.0 kg 0.3 1.6 -1.2 2.1 -0.2 3.4
  Gain 4.1–6.0 kg -2.8* 2.4 -1.4 2.7 -11.5 5.4
  Gain >6 kg -3.4* 2.3 -6.1* 2.7 -5.6 3.6
Bodily pain Lost >2 kg -0.6 1.2 -0.2 1.1 -0.9* 1.6
  Stable (change ≤2 kg) 0.6 0.6 -0.4 0.8 -5.9ab 1.6
  Gain 2.1–4.0 kg -1.5 0.9 -1.4 1.3 -5.2 2.3
  Gain 4.1–6.0 kg -1.6 1.3 -1.5 1.7 -5.2 3.2
  Gain >6 kg -1.6 1.2 -5.8a* 1.6 -6.4 2.3
General health perceptions Lost >2 kg 1.8 0.9 0.3 0.9 0.3 1.1
  Stable (change ≤2 kg) 2.9 0.6 1.3 0.7 -0.9a 1.3
  Gain 2.1–4.0 kg -0.0* 0.8 0.4 1.0 -4.8ab* 1.7
  Gain 4.1–6.0 kg -0.8* 1.0 -1.7* 1.1 -4.7 1.9
  Gain >6 kg -2.3* 0.9 -1.7* 1.1 -6.3ab* 1.8
Vitality Lost >2 kg 0.7 0.8 -0.0 0.8 -0.7 1.1
  Stable (change ≤2 kg) 2.2 0.4 1.2 0.6 -0.5a 1.1
  Gain 2.1–4.0 kg 1.4 0.7 -0.1 1.0 0.9 1.3
  Gain 4.1–6.0 kg 0.9 1.0 -0.3 1.1 -1.1 2.2
  Gain >6 kg -0.4* 0.9 -1.0 1.1 -0.0 1.4
Social functioning Lost >2 kg -0.2* 1.1 0.4 1.1 -0.3 1.8
  Stable (change ≤2 kg) 2.4 0.5 1.6 0.8 0.1 1.6
  Gain 2.1–4.0 kg 2.2 0.9 1.4 1.2 1.8 2.1
  Gain 4.1–6.0 kg 0.7 1.3 -0.5 1.4 -1.3 2.7
  Gain >6 kg -0.7* 1.3 0.3 1.4 1.0 2.0
General mental health Lost >2 kg -0.2 0.7 -0.1 0.7 0.7 1.0
  Stable (change ≤2 kg) 1.2 0.4 1.4 0.5 -0.3 1.1
  Gain 2.1–4.0 kg 1.1 0.6 1.5 0.7 3.0 1.0
  Gain 4.1–6.0 kg 2.2 0.8 0.3 1.0 -0.3 2.0
  Gain >6 kg 1.0 0.8 1.2 0.9 3.2 1.2
Table A6.2b continues on next page
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Table A6.2b Continued
QoL scale
Weight change 
category
BMI 
<25 kg/m2 
BMI 
25–29.9 kg/m2
BMI 
>30 kg/m2 
Mean SE Mean SE Mean SE
Role limitations emotional Lost >2 kg -1.7* 1.8 1.0 1.7 -3.4 2.7
  Stable (change ≤2 kg) 4.5 0.8 2.1 1.3 -0.7 2.4
  Gain 2.1–4.0 kg 1.5 1.5 -2.0 2.1 3.7a 2.4
  Gain 4.1–6.0 kg 0.7 2.0 1.1 2.2 -0.3 3.9
  Gain >6 kg -1.5* 2.1 0.5 2.2 6.4a* 2.4
a p<0.05 for difference with BMI<25 kg/m2; b p<0.05 for difference with BMI 25–29.9 kg/m2. * p<0.05 for difference 
with stable weight. ‡ 5-year change in score (0–100) with 100 representing excellent health; Adjusted for age, and 
preceding educational level (low, medium, high), smoking (current, ex, never), alcohol intake (never, ex, moderate, 
heavy), physical activity category (<0.5h, 0.5–3.4.h, ≥3.5h moderate-to vigorous intensity activity per week), job 
status (paid job yes/no), cohabiting status (living alone yes/no), quality of life score (0–100).
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Abstract
Overweight is associated with a reduced health-related quality of life (QOL), but less 
is known about the impact of long-term body mass index [BMI, calculated as weight 
(kg)/height (m)2] patterns on QOL in adults. In the Dutch Doetinchem Cohort Study 
(1989–2009) that included 1,677 men and 1,731 women aged 20–66 years, 6 BMI 
patterns were defined by using 4 measurements over a 15-year period: 1) persistent 
healthy weight (18.5–24.9, reference pattern); 2) persistent overweight (25.0–29.9); 3) 
persistent obesity (≥30.0); 4) developing overweight; 5) developing obesity; and 6) 
switching between BMI categories. For each BMI pattern, adjusted QOL (measured on 
a 0–100 scale) was estimated at the end of this period. The lowest QOL was observed 
for persistent obesity of all BMI patterns. It was 5.0 points (p=0.02) lower for 1 mental 
dimension in men and 6.2–11.6 points (p<0.05) lower for 5 (mainly physical) dimensions 
in women. Developing overweight or obesity scored 1.8–6.3 points (p<0.05) lower 
on 2–5 (mainly physical) dimensions. Persistent overweight hardly differed from a 
persistent healthy weight. In women, switching between BMI categories resulted in a 
lower QOL on the mental dimensions. Studying long-term BMI patterns over a 15-year 
period showed that persistent obesity, developing overweight, and developing obesity 
resulted in a lower QOL – particularly on the physical dimensions – compared with a 
persistent healthy weight. 
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Introduction
Overweight and obesity are known to be associated with a shorter life expectancy, many 
chronic diseases, and lower quality of life.1-5 Health-related quality of life (QOL), often 
measured with the standardized 36-item Short-Form Health Survey (SF-36) that includes 
8 dimensions regarding physical and mental aspects of health,6 is considered a more 
general health indicator than mortality or disease rates7 and therefore a relevant indicator 
for healthy ageing.
The association between weight status and QOL has been explored by both cross-sectional 
and longitudinal studies. Cross-sectional studies showed that obesity (≥30.0 kg/m2) was 
associated with lower QOL scores compared with a healthy weight (18.5–24.9 kg/m2), even 
without apparent diseases.3,5 However, an important aspect for healthy ageing is the impact 
of overweight and obesity determined on the longer term. So far, longitudinal studies 
showed that gaining weight {within body mass index [BMI, calculated as weight (kg)/
height (m)2] categories} over time was associated with a lower QOL or with larger declines 
in QOL than having a stable weight.8-12 However, these studies on longitudinal associations 
between weight and QOL were based on relatively short periods of 2–6 years and/or used 
self-reported weight.8-12 Thus, the impact of (measured) overweight or obesity over long 
periods of time on QOL is not known.
One study examined the association between QOL and changing BMI categories over 
a longer period, that is, 20 years.13 They found that persons who remained obese or 
developed overweight or obesity had a lower QOL on the physical domain, but not on the 
mental domain, than persons who remained a healthy weight.13 However, in this study, 
only two measurements were used to classify persons into long-term BMI patterns, and 
no information was available on (changes in) BMI between these measurements.13 To 
gain insight into long-term BMI patterns, more measurements are needed. In addition, a 
number of studies9-13 failed to examine the association between weight and QOL for men 
and women separately, although previous studies showed differences in QOL between 
the sexes14,15 and/or did not include all dimensions of QOL. Therefore, we studied, for both 
men and women, the impact of long-term BMI patterns, that is, over a period of 15 years, 
on all 8 dimensions of QOL at the end of this period, by using 4 measurements with 5-year 
intervals.
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Methods
Population and measurement rounds
The Doetinchem Cohort Study is a Dutch prospective population-based study. The baseline 
measurement was carried out between 1987 and 1991 involving 12,405 respondents from 
Doetinchem (initial response of the invitees: 62%). For the second measurement round 
(1993–1997), a random sample of 7,769 men and women was invited and reinvited for the 
third (1998–2002) and fourth (2003–2007) rounds. Response rates of the second, third, 
and fourth rounds were 79%, 75%, and 78%, respectively. The fifth round started in 2008 
and was finished at the end of 2012. The Doetinchem Cohort Study is described in detail 
elsewhere.16 Assessment of QOL has been available since 1995; therefore, for the current 
paper, measurement rounds were shifted into the following 4 consecutive analysis rounds: 
1989–1994 (baseline, round A), 1995–1999 (round B), 2000–2004 (round C), and 2005–2009 
(round D) (Figure 7.1).
The study was approved by the external Medical Ethics Committee of the Netherlands 
Organization of Applied Scientific Research Institute and the University of Utrecht according 
to the guidelines of the Helsinki Declaration. All participants gave written, informed consent.
Body mass index
Trained staff measured body weight and height. The participants wore light clothing and 
no shoes and had empty pockets. Body weight was measured with a calibrated scale to 
the nearest 100 g. To adjust for clothing, 1 kg was subtracted from the weight before 
calculating the BMI. The participants were classified into 4 BMI categories: 1) underweight 
(<18.5 kg/m2), 2) healthy weight (18.5–24.9 kg/m2), 3) overweight (25–29.9 kg/m2), and 4) 
obesity (≥30.0 kg/m2).
Health-related quality of life (Short-Form 36)
Health-related quality of life was not measured at baseline (round A). Therefore, we used QOL 
data from round B to adjust for previous QOL. QOL was evaluated with the Dutch RAND-
36 questionnaire,17 which is an adapted version of the standardized SF-36.6 The RAND-36 
includes 8 dimensions of QOL: 1) physical functioning, 2) role limitations due to physical 
health problems (role, physical), 3) bodily pain, 4) general health perceptions, 5) vitality, 6) 
social functioning, 7) role limitations due to emotional problems (role, emotional), and 8) 
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mental health. The first four dimensions are considered to reflect the “physical dimensions,” 
and the last four dimensions, the “mental dimensions.” The crude score of each dimension 
was converted to a 0–100 scale, according to international (SF-36) methodology, with higher 
scores indicating better QOL.6
Round 1 
1987–1991
Invited = 20,155
Response rate = 62%
Par?cipated = 12,405
Round 2 
1993–1997
Invited = 7769
Response rate = 79%
Par?cipated = 6,118
Round 3 
1998–2002
Invited = 6579
Response rate = 75%
Par?cipated = 4,917
Round 4 
2003–2007
Invited = 5784
Response rate = 78%
Par?cipated = 4,523
Round 5 
2008–2012
Invited = In progress
Response rate = -
Par?cipated = -
Original measurement rounds Analysis measurement rounds
Round A 
1989–1994
Par?cipated = 9,702
Round B 
1995–1999
Par?cipated = 5,727
Round C 
2000–2004
Par?cipated = 4,742
Round D 
2005–2009
Par?cipated = 4,312
Round A-D
Par?cipated = 3,796 
Missing data = 158 
Complete cases = 3,638
Further exclusions:
Pregnant women = 87
Underweight = 59
Persons loosing weight = 84
Study popula?on = 3,408 
Figure 7.1 Flow chart of the shifted rounds, the Doetinchem Cohort Study, the Netherlands, 
1989–2009.
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Potential confounders
Data from round D were used to evaluate potential confounders, because attained levels 
of a confounder or risk factor are suggested to be more relevant for a health outcome 
than initial levels.18,19 Smoking status was categorized as never smoker, former smoker, 
and current smoker, on the basis of questions referring to past and present cigarette use. 
Educational level was defined as the highest completed education and was classified into 
three categories: 1) intermediate secondary education or less, 2) intermediate vocational 
or higher secondary education, and 3) higher vocational education or university. Work 
status was defined as having a job or not. Household composition was defined as living 
alone or not living alone (i.e., living with a partner, child(ren), a parent(s) or other adult(s)). 
Physical activity was assessed with the validated physical activity questionnaire developed 
for the European Prospective Investigation into Cancer and Nutrition (EPIC), extended with 
questions on sports and other strenuous leisure-time activities in the preceding year.20 All 
activities were categorized as light, moderate, or vigorous on the basis of the metabolic 
equivalent value of task (MET) as reported by Ainsworth and colleagues.21 Cutoff points 
for light, moderate, and vigorous activities were <4.0 METs, 4.0–6.5 METs, and >6.5 METs, 
respectively. Subsequently, the average time spent on moderate and vigorous intensity 
activities was used to classify persons as inactive (<0.5 hour/week), semiactive (0.5–3.4 
hours/week), and normal active (≥3.5 hours/week). Alcohol use was classified as current, 
former, or never. Current alcohol users were classified as heavy users (mean intake: ≥3 
drinks/day for men and ≥2 drinks/day for women), and moderate users (mean intake: 0–2 
drinks/day for men and 0–1 drink/day for women).
Statistical analyses
As we carried out a complete case analysis, data had to be available on BMI at all four rounds, 
demographics and lifestyle variables at round D, and QOL at rounds B and D (n=3,638). In 
total, 4,131 respondents were excluded, mainly due to nonresponse at follow-up (Figure 7.1). 
The proportion of men did not differ between the excluded respondents and the included 
respondents (p=0.14). However, the excluded respondents were slightly older by 0.9 years 
(p<0.01) and had a higher BMI of 0.7 kg/m2 (p<0.01) at baseline (round A). Women who 
were pregnant (n=87) and underweight persons (n=59) at one of the measurement rounds 
were excluded from analyses. The number of underweight participants at one of the four 
measurements was too low (n=59) to classify them in a separate pattern, and they could 
not be combined with those with a persistent healthy weight as from exploratory analysis 
we observed structurally lower QOL scores (data not shown).
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The remaining participants (n=3,492) were classified in one of the following BMI patterns 
by using the BMI status of each round: “persistent healthy weight,” “developing overweight,” 
“persistent overweight,” “developing obesity,” “persistent obesity,” “switching between 
categories,” “becoming healthy weight,” and “becoming overweight” (Figure 7.2). The latter 
Overweight Overweight Overweight Overweight
Overweight Healthy weight Overweight Overweight
Overweight Overweight Healthy weight Overweight
Overweight Obesity Overweight Overweight
Overweight Overweight Obesity Overweight
Healthy weight Healthy weight Healthy weight Healthy weight
Healthy weight Overweight Healthy weight Healthy weight
Healthy weight Healthy weight Overweight Healthy weight
Healthy weight Healthy weight Healthy weight Obesity
Healthy weight Healthy weight Obesity Obesity
Healthy weight Overweight Overweight Obesity
Healthy weight Overweight Obesity Obesity
Healthy weight Obesity Obesity Obesity
Overweight Overweight Overweight Obesity
Overweight Overweight Obesity Obesity
Overweight Obesity Obesity Obesity
Obesity Obesity Obesity Obesity
Obesity Overweight Obesity Obesity
Obesity Obesity Overweight Obesity
Round A Round B Round C Round D
Persistent
healthy weight
n=1,173
Developing
overweight
n=716
Switching 
between 
categories
n=147
Persistent 
obesity
n=198
Developing
obesity
n=374
Persistent
overweight 
n=800
Included BMI pa?erns
Healthy weight Healthy weight Healthy weight Overweight
Healthy weight Healthy weight Overweight Overweight
Healthy weight Overweight Overweight Overweight
Any other combina?on of body mass index categories that is not included in the pa?erns above or in the 
excluded pa?erns below.
Excluded pa?erns
Becoming
healthy weight
n=69
Becoming
overweight
n=15
Overweight Healthy weight Healthy weight Healthy weight
Overweight Overweight Healthy weight Healthy weight
Overweight Overweight Overweight Healthy weight
Obesity Overweight Overweight Overweight
Obesity Obesity Overweight Overweight
Obesity Obesity Obesity Overweight
Figure 7.2 Defined long-term body mass index (BMI) patterns, the Doetinchem Cohort Study, the 
Netherlands, 1989–2009.
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two patterns with participants losing weight were excluded from the analysis because of 
the low number of participants (n=69 and n=15, respectively). In all, we analysed the data 
of 3,408 participants who were classified into six long-term BMI patterns.
Descriptive statistics were carried out for study characteristics and QOL, and the differences 
between sexes were examined with an independent-samples t test for continuous variables 
and a χ2 test for categorical variables.
To examine the differences between the reference BMI pattern “persistent healthy weight” and 
the other five BMI patterns in QOL at round D, we carried out multivariable linear regression 
analyses. We used generalized estimated equations with the estimation of robust standard 
errors to account for the skewed distribution of QOL. The least-squares-means method was 
used to estimate the adjusted mean of QOL for each BMI pattern. Adjustments were made 
for age, smoking status, educational level, physical activity, alcohol use, work status, and 
household composition at round D and for QOL at round B (SAS, version 9.2, software; SAS 
Institute, Inc., Cary, North Carolina; 2-tailed p-values are reported for all analyses).
Interaction terms between age (<60 years and ≥60 years at round D) and BMI patterns were 
entered into the model to test for interaction (significant at p≤0.05 (2 sided)), since age was 
expected to be highly associated with (changes in) QOL.22,23
Sensitivity analyses were carried out by repeating the analyses by further adjusting for the 
presence of a chronic disease at each round and by excluding persons who had a chronic 
disease at ≥1 measurement round(s). These chronic diseases were self-reported at each 
measurement round and included diabetes, myocardial infarction, stroke, cancer, and 
asthma. 
Results
A persistent healthy weight was found more often among women (40.8%) than among 
men (27.8%), while persistent overweight was found more often among men (31.2%) than 
among women (16.0%) (Table 7.1). Men had higher scores on all eight QOL dimensions 
assessed at round B than women did (p<0.05) (Table 7.1). Furthermore, men differed from 
women in all study characteristics assessed at round D (p<0.01), except for physical activity 
(p=0.57) (Table 7.1).
The following results are reported as score differences from the mean score of the reference 
BMI pattern, “a persistent healthy weight” (for men and women separately). In general, 
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Table 7.1 Study characteristics, the Doetinchem Cohort Study, the Netherlands, 1989–2009
Men (n=1,677) Women (n=1,731)
p-value*% Mean (SD) % Mean (SD)
BMI patterns <0.01
Persistent healthy weight 27.8 40.8
Developing overweight 22.9 19.2
Persistent overweight 31.2 16.0
Developing obesity 10.0 11.9
Persistent obesity 5.0 6.6
Switching between categories 3.1 5.5
8 dimensions of QOL at round B
Physical functioning 91.1 (13.9) 87.6 (16.7) <0.01
Role, physical 86.2 (28.0) 81.4 (32.9) <0.01
Bodily pain 83.5 (20.2) 77.9 (22.1) <0.01
General health perceptions 68.4 (16.8) 67.3 (16.9) 0.04
Vitality 70.1 (16.2) 65.3 (16.7) <0.01
Social functioning 89.4 (17.6) 84.3 (20.8) <0.01
Role, emotional 89.9 (25.0) 85.7 (30.9) <0.01
Mental health 79.3 (14.0) 74.9 (14.8) <0.01
Agea 57.8 (10.0) 57.2 (9.9) 0.09
Smoking statusa <0.01
Current smoker 17.6 19.4
Former smoker 50.9 40.1
Never smoker 31.5 40.6
Educational level <0.01
Low 32.3 49.6
Moderate 36.8 27.6
High 31.0 22.8
Physical activitya 0.57
Inactive 3.6 3.0
Semiactive 15.9 16.4
Normal active 80.4 80.7
Alcohol usea <0.01
Never drinker 4.7 14.7
Former drinker 2.2 1.7
Moderate use 80.0 76.1
Heavy use 13.2 7.5
Joba <0.01
No 39.2 51.4
Yes 60.8 48.6
Living alonea <0.01
No 89.4 85.0
Yes 10.6 15.0
BMI, body mass index; QOL, health-related quality of life; SD, standard deviation. 
* p<0.05 (2 sided). a Study characteristics were displayed for round D (2005–2009), because our analyses were 
adjusted for these variables at round D.
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persistently obese adults had the lowest scores on all QOL dimensions, and this was most 
marked for the physical dimensions, especially in women (Web Figure 1 available at http://
aje.oxfordjournals.org/). Persistently obese women had statistically significant lower scores 
(p<0.05) on physical functioning (9.2 points), role limitations due to physical health problems 
(11.6 points), general health perceptions (6.6 points), vitality (6.2 points), and role limitations 
due to emotional problems (6.8 points) (Table 7.2; Web Figure 1A). Persistently obese men 
had lower scores on all QOL dimensions, but the difference was statistically significant only 
for social functioning (5.0 points; p=0.02) and borderline statistically significant (p≤0.10) 
for physical functioning (3.4 points) and general health perceptions (3.4 points) (Table 7.3; 
Web Figure 1B).
Also, adults who developed obesity had lower scores on the physical dimensions, and this 
was more pronounced in women than in men. Women who developed obesity scored 
from 3.9 to 6.3 points lower on the physical dimensions (p<0.05) and 3.2 points lower on 
vitality (p<0.01) (Table 7.2; Web Figure 1A). Men who developed obesity scored statistically 
significant lower (p<0.05) on physical functioning (3.5 points), general health perceptions 
(3.2 points), and borderline statistically significant lower on bodily pain (3.0 points) (p=0.08) 
(Table 7.3; Web Figure 1B).
Persistently overweight adults did not score statistically significant lower on QOL, except 
for a 3.2-points-lower mean score on physical functioning in women (p<0.01) (Tables 7.2 
and 7.3; Web Figure 1).
For developing overweight, lower scores on some of the QOL dimensions were observed. 
Women who developed overweight had statistically significant lower scores (p<0.05) on 
physical functioning (2.8 points), general health perceptions (3.1 points), vitality (2.4 points), 
and role limitations due to emotional problems (3.9 points) (Table 7.2; Web Figure 1A). 
For men who developed overweight, statistically significant lower scores (p<0.05) were 
observed only on physical functioning (1.8 points) and general health perceptions (3.3 
points) (Table 7.3; Web Figure 1B).
Women who switched between BMI categories had statistically significant lower scores 
(3.6–9.8 points) on the four mental dimensions (p<0.05) (Table 7.2; Web Figure 1A). In men, 
higher scores were observed on physical role limitations (6.5 points) (p=0.03) (Table 7.3; 
Web Figure 1B).
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Interaction between age and BMI patterns
We found no overall interactions between age and BMI patterns in the association with 
QOL, with the exception of women and general health perceptions (p=0.02) and role, 
emotional (p=0.04). However, in persistently obese women aged ≥60 years, we observed 
consistently (larger) negative differences in QOL scores compared with their persistently 
healthy weight peers than in women aged <60 years. For physical functioning, role, physical, 
bodily pain, vitality, social functioning, role, emotional, and mental health, this difference 
for women aged ≥60 years was -12.5, -16.4, -6.6, -7.7, -3.0, -12.2, and -1.9, while for women 
aged <60 years this difference was -6.4, -7.2, 0, -3.9, -2.0, 1.1, and 0.4, respectively. For men, 
no consistent differences between age groups were found (data not shown).
Sensitivity analyses
Adjustment for the presence of a chronic disease did not affect our main findings (data not 
shown). After exclusion of persons with a chronic disease, most observed score differences 
changed with a decrease in score difference of up to 1.6 points, and with an increase in score 
difference of up to 2.2 points. A larger change was found for persistently obese women and 
emotional role limitations, which decreased by 4.5 points.
Discussion
Persistently obese men and women had the lowest scores on almost all QOL dimensions 
compared with other long-term BMI patterns. Men and women who developed obesity or 
overweight had lower scores on mainly the physical QOL dimensions than did those with a 
persistent healthy weight. These findings were most pronounced in women. Women who 
switched between BMI categories had lower scores on the mental QOL dimensions than 
persistently healthy weight women.
Our findings of an association between long-term BMI patterns and the physical dimensions 
of QOL were comparable to the findings by Kozak and colleagues.13 They examined the 
association between six BMI patterns and QOL, comparable to our patterns, over a 20-year 
period by using the change in BMI category from two measurements.13 In contrast to Kozak and 
colleagues,13 we also found an association between lower scores on mental dimensions (one in 
men and two in women). This might be explained by the difference in population (i.e., younger, 
other country) and applied methods (e.g., defining patterns by only two measurements and 
adjusting for different variables, such as general health instead of an earlier QOL score). Our 
136
Long-term BMI patterns and quality of life in an ageing populationChapter 7
results as to developing overweight or obesity were also in agreement with studies that found 
an association between weight gain and a lower QOL on the physical dimensions compared 
with a stable weight.10-12 In addition, in women, we found consistent associations between 
the switching BMI pattern and lower scores on the mental dimensions compared with a 
persistent healthy weight. These associations have not been examined before.
The differences in QOL between a persistent healthy weight and other BMI patterns were 
strikingly larger in women than in men and were in agreement with previous cross-sectional 
and longitudinal studies.22,24,25 The sex difference was largest for the switching BMI pattern. 
An explanation for the sex difference regarding the mental dimensions might be that, 
compared with men, women have a greater drive to look thin because of external pressure 
(e.g., media) and the stigmatization of obesity is more pronounced.26-28 Thus, women are 
more likely to try to lose weight through dieting and, when dieting fails, their self-esteem 
and body image may get negatively affected.26,27
In addition to the factors mentioned for the mental dimensions, the sex difference for 
the physical dimensions might also be explained by men being physically stronger than 
women, with men being more likely to recover from disabilities, with the possibility that 
men have more muscle mass than women for the same BMI, and the tendency by men to 
underreport health problems.29-31
Strengths of our study include the large, population-based sample that allowed us to investigate 
the relation between six long-term BMI patterns and QOL in the general population. Trained 
personnel measured the participants’ weight and height. We had data on all eight dimensions of 
QOL at several measurement rounds, as well as data on demographics and lifestyle. Therefore, 
we were able to adjust for important characteristics and an earlier score of QOL.
A limitation of our study is the loss to follow-up that resulted in a relatively healthy 
population that remained in the Doetinchem Cohort Study.32 Because of the higher BMI at 
baseline in the excluded respondents, as presented in Materials and Methods, we examined 
whether the cross-sectional associations (at round B) between BMI status and QOL were 
different for included and excluded persons by examining the interaction between inclusion 
and BMI. We found only small and mostly insignificant differences, which suggest that the 
lack of data for the excluded respondents had little effect on our findings.
Our study did not have data on stressful life events, which have been shown to be associated 
with weight gain33 and could be an explanatory factor for the finding of the lower scores on 
the mental dimension of QOL in women who switched between BMI categories. However, 
illness-related life events have been shown to be an important predictor of BMI in a British 
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population.34 We accounted for the presence of chronic diseases at each round, which did 
not affect our main findings.
Because of the observational nature of our study, we cannot establish the underlying pathway 
or direction of the association between the BMI patterns and QOL. A recent study by Cameron 
and colleagues22 found associations between baseline BMI and changes in QOL and between 
baseline QOL and changes in BMI over 5 years, which suggests a bidirectional relationship 
between BMI and QOL. However, for the physical dimensions, a clear dose-response 
relationship between baseline BMI and changes in QOL was observed, while for baseline QOL 
and changes in BMI, this was not observed.22 We also observed a dose-response relationship 
between the BMI patterns (excluding switching pattern) in women especially and QOL on 
the physical dimensions. With each increasing pattern, thus from becoming overweight to 
having persistent obesity, the QOL at the end of the 15-year period became lower, and thus 
the difference with those who had a persistent healthy weight became larger (Web Figure 1).
In our study, the period between measurements was 5 years, which can be assumed to be 
more accurate than an interval of 20 years. However, the amount of measurements needed 
to capture relevant BMI changes in order to explain the impact on health is unknown. In 
addition, the definition of our BMI patterns was not overly restrictive (Figure 7.2). We allowed, 
for example, one deviation to another BMI category at round B or C in the persistent weight 
patterns. In preliminary analyses, we also examined other definitions of persistent weight 
patterns in which no deviation was allowed, or of developing patterns in which progression 
to a higher BMI category that occurred at the final round was not allowed. This did not change 
our results substantially, indicating that our results are robust. Therefore, we think that we 
captured the global changes in BMI during the life course that give a good indication of the 
consequences of exposure or developments of overweight or obesity on the longer term.
Differences in the eight QOL dimensions are considered clinically important if between 
3 and 5 points.35 However, this applies to clinical samples, while we examined “healthy” 
participants in a population-based study. In population-based samples, smaller differences 
can impact public health.36 Therefore, our results of several BMI patterns scoring at least 
3 points lower compared with a persistent healthy weight may be of importance for 
public health. Moreover, in persistently obese women aged ≥60 years, we observed larger 
negative differences in QOL scores compared with their persistently healthy weight peers 
than in women aged <60 years. This might be explained by a longer exposure to obesity 
in the elder group. This stresses again the importance of prevention of overweight and 
especially obesity and implies that prevention should be implemented early in adulthood. 
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Furthermore, women who switched between BMI categories had lower scores on the mental 
dimensions, ranging from -4 to -10, than persistently healthy weight women. This indicates 
that prevention of weight cycling is especially relevant for women.
Only persistently overweight persons did not show lower scores on QOL than persistently 
healthy weight persons, except for women. This suggests that, to retain a good QOL in later 
life for persons who are overweight, they do not necessarily have to lose weight, although 
they should avoid the development of obesity.
In conclusion, in this population-based study, adults who developed overweight or 
obesity or who were persistently obese over 15 years had lower QOL scores – particularly 
on the physical dimensions – compared with those who were persistently of healthy 
weight. Women who switched between BMI categories had lower scores on the mental 
dimensions of QOL than did persistently healthy weight women. Thus, in particular for 
women, prevention of developing overweight and especially obesity is important not only 
for preventing specific diseases but also for QOL in general. 
Acknowledgements
The Doetinchem Cohort Study was financially supported by the Ministry of Health, Welfare, 
and Sport of the Netherlands and the National Institute of Public Health and the Environment. 
The authors thank the epidemiologists and field workers of the Municipal Health Service in 
Doetinchem for their contribution to the data collection for this study. Project director is Dr. 
W. M. M. Verschuren. Logistic management was provided by J. Steenbrink and P. Vissink, and 
administrative support was supplied by E. P. van der Wolf. Data management was provided 
by A. Blokstra, A. W. D. van Kessel, and P. E. Steinberger.
References
1.  Bjorge T, Engeland A, Tverdal A, et al. Body mass index in adolescence in relation to cause-specific 
mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol. 2008;168(1):30–37.
2.  Branca F, Nikogosian H, Lobstein T, eds. The Challenge of Obesity in the WHO European Region 
and the Strategies for Response. Copenhagen, Denmark: World Health Organization; 2007:1–12.
3.  Jia H, Lubetkin EI. The impact of obesity on health-related quality-of-life in the general adult 
US population. J Public Health (Oxf). 2005;27(2):156–164.
4.  Lean ME, Han TS, Seidell JC. Impairment of health and quality of life using new US federal 
guidelines for the identifi cation of obesity. Arch Intern Med. 1999;159(8):837–843.
139
Long-term
 BM
I patterns and quality of life in an ageing population
Chapter 7
5.  Yan LL, Daviglus ML, Liu K, et al. BMI and health-related quality of life in adults 65 years and 
older. Obes Res. 2004;12(1):69–76.
6.  Ware JJ, Sherbourne C. The MOS 36-item short-form health survey (SF-36). I. Conceptual 
framework and item selection. Med Care. 1992;30(6):473–483.
7.  Hennessy CH, Moriarty DG, Zack MM, et al. Measuring health-related quality of life for public 
health surveillance. Public Health Rep. 1994;109(5):665–672.
8.  Burns CM, Tijhuis MA, Seidell JC. The relationship between quality of life and perceived 
body weight and dieting history in Dutch men and women. Int J Obes Relat Metab Disord. 
2001;25(9):1386–1392.
9.  Fine JT, Colditz GA, Coakley EH, et al. A prospective study of weight change and health-related 
quality of life in women. JAMA. 1999;282(22):2136–2142.
10.  Staff ord M, Hemingway H, Marmot M. Current obesity, steady weight change and weight 
fl uctuation as predictors of physical functioning in middle aged offi  ce workers: the Whitehall 
II Study. Int J Obes Relat Metab Disord. 1998;22(1):23–31.
11.  Williams LT, Young AF, Brown WJ. Weight gained in two years by a population of mid-aged 
women: how much is too much? Int J Obes (Lond). 2006;30(8):1229–1233.
12.  Strandberg TE, Strandberg A, Salomaa VV, et al. Impact of midlife weight change on mortality 
and quality of life in old age. Prospective cohort study. Int J Obes Relat Metab Disord. 
2003;27(8):950–954.
13.  Kozak AT, Daviglus ML, Chan C, et al. Relationship of body mass index in young adulthood 
and health-related quality of life two decades later: the Coronary Artery Risk Development in 
Young Adults Study. Int J Obes (Lond). 2011;35(1):134–141.
14.  Garner RE, Feeny DH, Thompson A, et al. Bodyweight, gender, and quality of life: a population-
based longitudinal study. Qual Life Res. 2012;21(5):813–825.
15.  Orfi la F, Ferrer M, Lamarca R, et al. Gender diff erences in health-related quality of life among 
the elderly: the role of objective functional capacity and chronic conditions. Soc Sci Med. 
2006;63(9):2367–2380.
16.  Verschuren WMM, Blokstra A, Picavet HSJ, et al. Cohort profi le: the Doetinchem Cohort Study. 
Int J Epidemiol. 2008;37(6):1236–1241.
17.  van der Zee KI, Sanderman R. Measuring General Health Status with the RAND-36, a Manual [in 
Dutch]. Groningen, the Netherlands: Noordelijk Centrum voor Gezondheidsvraagstukken, 
Rijksuniversiteit Groningen; 1993.
18.  Gast GCM, Spijkerman AMW, van der A DL, et al. Five-year changes in biologic risk factors 
and risk of type 2 diabetes: Are attained but not initial risk factor levels of importance? Am J 
Epidemiol. 2012;176(8):720–725.
19.  Jacobs-van der Bruggen MAM, Spijkerman A, van Baal PHM, et al. Weight change and incident 
diabetes: addressing an unresolved issue. Am J Epidemiol. 2010;172(3):263–270.
20.  Pols MA, Peeters PH, Ocke MC, et al. Estimation of reproducibility and relative validity of the 
questions included in the EPIC Physical Activity Questionnaire. Int J Epidemiol. 1997;26(suppl 
1):S181–S189.
140
Long-term BMI patterns and quality of life in an ageing populationChapter 7
21.  Ainsworth BE, Haskell WL, Leon AS, et al. Compendium of physical activities: classifi cation of 
energy costs of human physical activities. Med Sci Sports Exerc. 1993;25(1):71–80.
22.  Cameron AJ, Magliano DJ, Dunstan DW, et al. A bi-directional relationship between obesity 
and health-related quality of life: evidence from the longitudinal AusDiab study. Int J Obes 
(Lond). 2012;36(2):295–303.
23.  Franco OH, Wong YL, Kandala NB, et al. Cross-cultural comparison of correlates of quality of life 
and health status: the Whitehall II Study (UK) and the Western New York Health Study (US). Eur 
J Epidemiol. 2012;27(4):255–265.
24.  Bentley TGK, Palta M, Paulsen AJ, et al. Race and gender associations between obesity and 
nine health-related quality-of-life measures. Qual Life Res. 2011;20(5):665–674.
25.  Wang R, Wu MJ, Ma XQ, et al. Body mass index and health-related quality of life in adults: a 
population based study in fi ve cities of China. Eur J Public Health. 2012;22(4):497–502.
26.  Grivetti L. Psychology and cultural aspects of energy. Nutr Rev. 2001;59(1 Pt 2):S5–S12.
27.  McCarthy M. The thin ideal, depression and eating disorders in women. Behav Res Ther. 
1990;28(3):205–215.
28.  Roehling MV, Roehling P, Pichler S. The relationship between body weight and perceived 
weight-related employment discrimination: the role of sex and race. J Vocat Behav. 
2007;71(2):300–318.
29.  Oksuzyan A, Juel K, Vaupel JW, et al. Men: good health and high mortality. Sex diff erences in 
health and aging. Aging Clin Exp Res. 2008;20(2):91–102.
30.  Walter S, Kunst A, Mackenbach J, et al. Mortality and disability: the eff ect of overweight and 
obesity. Int J Obes (Lond). 2009;33(12):1410–1418.
31.  Wong E, Stevenson C, Backholer K, et al. Adiposity measures as predictors of long-term 
physical disability. Ann Epidemiol. 2012;22(10):710–716.
32.  Blokstra A, Picavet HSJ, Verschuren WMM. De Doetinchem Cohort Studie 4e ronde 2003–2007 
Onderzoek naar volksgezondheid en veroudering (in Dutch). Bilthoven, the Netherlands: National 
Institute for Public Health and the Environment (RIVM); 2010.
33.  Block JP, He Y, Zaslavsky AM, et al. Psychosocial stress and change in weight among US adults. 
Am J Epidemiol. 2009;170(2):181–192.
34.  Stewart-Knox B, Duff y ME, Bunting B, et al. Associations between obesity (BMI and waist 
circumference) and socio-demographic factors, physical activity, dietary habits, life events, 
resilience, mood, perceived stress and hopelessness in healthy older Europeans. BMC Public 
Health. 2012;12:424.
35.  Samsa G, Edelman D, Rothman ML, et al. Determining clinically important diff erences in 
health status measures: a general approach with illustration to the Health Utilities Index Mark 
II. Pharmacoeconomics. 1999;15(2):141–155.
36.  Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001;30(3):427–432; discussion 
433–434.
General discussion
8
142
General discussionChapter 8
In this thesis, using several anthropometric measures and national and international cohort 
studies, we focused on the impact of weight status on coronary heart disease (CHD), all-
cause and cause-specific mortality, and quality of life (QoL) in old age and during ageing. 
This topic is important because underweight and overweight are important factors in 
healthy ageing and body composition changes during ageing.1-4 
First, we examined whether the association between body mass index (BMI) and CHD was 
consistent over time, and whether age of the population influenced this association. 
Secondly, we focused on anthropometric measures as predictors of mortality in elderly 
populations. 
Thirdly, we examined changes and developments in anthropometric measures and their 
association with mortality and QoL in old age and in an ageing population. 
In this chapter, the main findings (Table 8.1) on these topics are critically reviewed. We 
conclude with a discussion on the consequences for public health and clinical practice.
CHD risks associated with weight status consistent over 
calendar time but decreasing with increasing age 
We hypothesized that the risk of CHD in the association with body mass index (BMI) would 
be higher before 1985 (earlier studies) than after 1985 (later studies) because of improved 
health care procedures. However, from our meta-regression analysis, we found no consistent 
evidence for this hypothesis. When age of the population was added to the model, this 
appeared an important determinant, and the impact of calendar period on the association 
between BMI and CHD did not remain (Chapter 2). 
Our finding of no consistent evidence for the impact of calendar period on the association 
between BMI and CHD is in line with previous studies examining the impact of calendar 
period on the association between BMI and all-cause mortality.5-7 In our study as well as 
in previous studies,6,7 there was an overlap between the follow-up years (on which the 
mortality risk was calculated) of the earlier studies and the baseline years of the later studies. 
This makes it difficult to disentangle the influence of calendar period and the influence 
of follow-up period on the association between BMI and CHD, and thus to filter out the 
impact of calendar period.
We adjusted for health care procedures by indirect measures, i.e. baseline blood pressure, 
cholesterol, and physical activity; this did not alter our findings. A more optimal way would 
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have been to adjust – for example – for the use of medication, like in the Cancer Prevention 
Study II, where adjustments were made for aspirin use and no impact of calendar time was 
observed.5 However, data on medication use were not available in our study. 
On the basis of our results, we conclude that calendar period has no impact on 
the risk of CHD associated with BMI. 
From this meta-regression analysis, we found that mean age of the population strongly 
influenced the association between BMI and CHD. With increasing age of the population, 
the risk of CHD for a 5-BMI-unit increment and obesity decreased by 29% (95%CI: -55 to -5) 
and 31% (95%CI: -66 to 3), respectively. We were able to study this properly in the 31 studies, 
as the range of mean age of the population was 35–73 years. Previous studies that stratified 
their analyses to age found the lowest risk of mortality in the oldest age stratum; in other 
words, the risk of mortality associated with BMI decreased with increasing age.6,8-12 Thus, age 
is an important modifying factor in the association between BMI and CHD, and mortality. 
We conclude that the risk of CHD associated with BMI decreases with increasing 
age.
Body mass index and waist circumference are both as-
sociated with mortality in elderly individuals
It can be questioned whether cut-off points for BMI and waist circumference (WC) 
classifications should be age-specific, as it is evident that the mortality risk decreases with 
increasing age. Several factors might underlie this phenomenon, e.g. body compositional 
changes;1-4 the survival effect, i.e. individuals who are susceptible to the adverse effects 
of obesity have probably died before reaching old age; shorter exposure to obesity when 
obesity has developed at an old age;1 overweight (fat and lean mass) might provide a reserve 
when elderly individuals fall ill.13 Therefore, we examined the association between BMI and 
all-cause and cause-specific mortality among 1,970 70–77-year olds using both continuous 
and categorical measures for BMI (Chapter 3) and the association between continuous WC 
and mortality among approximately 58,000 65–74-year olds (Chapter 4).
In addition, we used a combination of commonly used WC categories and BMI categories 
(Table 8.2, Chapter 4) in line with the WHO guidelines based on the associated disease risks 
of increased abdominal fat relative to BMI.14 
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Body mass index as a single predictor of mortality
When we examined the standard BMI classifications, i.e. underweight, overweight, and 
obesity, as a predictor of all-cause and cause-specific mortality in the elderly, we found 
associations for underweight and obesity with all-cause and cause-specific mortality.  
With respect to underweight, we found high increased all-cause and cause-specific mortality 
risks; this is supported by previous studies.6,8,15,16 
For overweight, we found no association with all-cause and cause-specific mortality; this 
is in line with previous studies among the elderly.6,7,15,16 However, a meta-analysis including 
18 studies in old age (≥65 years) found an inverse association between overweight and 
all-cause mortality;17 this led to a discussion about whether overweight is protective for 
mortality or not.18 
Overweight might not be protective, but might be the wrong labelling for a high BMI 
associated with an increased mortality risk due to the above-described mechanisms. When 
we look at our results of a U-shaped association between BMI and all-cause mortality, and 
cause-specific mortality, the definition of cut-off points of the reference category seem 
very important. We observed the lowest all-cause and cause-specific mortality risks at 
higher BMI levels than the WHO reference category, i.e. between 25.6 and 27.4 kg/m2. 
This finding is supported not only by our results of the WC-BMI classifications, where we 
observed the lowest all-cause mortality risk within the overweight category across WC 
categories, but also by other studies among the elderly.19-21 Moreover, a 10% increased 
mortality risk can be considered as relevant since the absolute mortality is much higher 
among the elderly than in younger adults. In our study, ≥10% increased all-cause and 
Table 8.2 WC-BMI classification
WC (cm) categories (men/women)
BMI (kg/m2) categories Small: <94/<80 Medium: 94–101/80–87 Large: ≥102/≥88
Underweight: <20 Underweight n.a. n.a.
Healthy weight: 20–24.9 Reference Medium WC-Healthy weight Large WC-Healthy weight
Overweight: 25–29.9 Small WC-Overweight Medium WC-Overweight Large WC-Overweight
Obesity: ≥30 n.a. Medium WC-Obesity Large WC-Obesity
BMI: body mass index, WC: waist circumference. n.a.: not applicable. In our study, we did not find enough individuals 
with this body composition to calculate a relative risk of mortality for this classification.
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cause-specific mortality risks were observed at ≤24.2 and ≥30.1 kg/m2, respectively; this 
is similar to other studies among the elderly.7,19-21 Given this BMI range (24 kg/m2–30 kg/
m2), elderly individuals within the lower ranges of BMI at increased risk of mortality are 
included in the standard reference category (18.5–24.9 kg/m2, or 20–24.9 kg/m2). With 
respect to obesity, the definition of the reference category might also explain why findings 
of an association with mortality are inconsistent.6,7,15-17 Since we observed a 10% increased 
risk at the standard cut-off point for obesity (30 kg/m2), this might be an alternative for 
the current cut-off point of overweight.
Overall, we conclude that both high and low BMI levels are associated with 
all-cause and cause-specific mortality among the elderly. However, the WHO 
cut-off points to indicate underweight and overweight are too low and need to 
be reconsidered for the elderly. 
WC as a single predictor of mortality
For the WC classification, the cut-off points might also be different for the elderly than 
for younger adults. The association between a high WC and all-cause and CVD mortality 
is stronger among general adult populations (20–74 years)10,22,23 than among specifically 
elderly populations.24,25,26 In a Canadian elderly population, an inverse association was even 
observed with all-cause mortality.27 Our results for WC as a continuous variable showed 
strong J-shaped associations with all-cause mortality and CVD mortality. At the level of 
abdominal obesity (102 cm in men, 88 cm in women), the risks of all-cause and CVD mortality 
were only modestly increased, or the risks were not statistically significantly increased. At 
higher levels of WC, we observed significantly increased risks; this is in line with other studies 
for mortality and other health outcomes among elderly individuals.20,28 To be specific, we 
observed a two-fold increased all-cause and CVD mortality risk at 132 cm and 123 cm, 
respectively, in men and at 116 cm and 105 cm, respectively, in women. From exploratory 
analyses, the prevalence of these levels was found to be about 1–2%, and the prevalence 
of abdominal obesity was about 12–48% among populations. So, to target a large part of 
the population that is at risk, a WC level between 102 cm and 123 cm in men, and between 
88 cm and 105 cm in women, might be more appropriate for clinical guidelines.
We conclude that WC is associated with all-cause and cause-specific mortality, but 
the cut-off points for WC should be reconsidered for the elderly for the prediction 
of health risks.
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The combination of waist circumference and body mass index in the associa-
tion with mortality
A combination of WC and BMI might be a better proxy for body composition. By using WC 
as a single predictor, underweight is not considered. We found a J-shaped association for 
continuous WC with all-cause, CVD, and cancer mortality, and a U-shaped association with 
respiratory disease mortality (p<0.05). In our study, as well as in other studies, the association 
of WC with mortality became stronger after adjustment for BMI.10,23,29 In previous studies 
including elderly populations, the association changed from inverse or no association to an 
adverse association with mortality.24,27 This might be explained by body fat composition, in 
particular the proportion of hazardous visceral abdominal fat.30 In addition, the adjustment 
for BMI might attenuate the influence of underweight in the association between WC and 
mortality. This suggests that WC and BMI, although highly correlated, have a different role 
in the association with mortality.31 
The importance of a combination of WC and BMI manifested itself in our results of the 
WC-BMI classification and all-cause and CVD mortality. We observed that a large WC was 
associated with an increased all-cause and CVD mortality risk across BMI categories; this is 
in line with previous literature.10,22,23,29 For large WC-healthy weight, we observed the highest 
risk of all-cause and CVD mortality (about 2.0) of all BMI categories. This is not in line with 
the findings of two studies including younger American (30–55 years) and Canadian (18–74 
years) populations, in which the highest risk was found for large WC-obesity.22,23 However, 
these two studies included in general younger individuals who have a different body 
composition than elderly individuals.22,23 
The WHO guidelines14 indicate the highest disease risk for large WC-obesity and do not 
rigorously consider the health risk for persons with large WC-healthy weight. In the WHO 
guidelines, the following note is made: ‘Increased waist circumference can also be a marker 
for increased risk even in persons of normal weight.’ Although the prevalence for this 
specific elderly group may not be high, this group may need more attention because of 
the increased all-cause and CVD mortality risk. 
We conclude that, in elderly populations, a combination of WC and BMI can be 
recommended, since they complement each other in predicting mortality risks. 
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Developments in weight status are important for mortal-
ity and QoL in old age and in an ageing population
Mid-upper arm circumference as an anthropometric measure of changes in 
body composition in the elderly  
Among the elderly (70–77 years, Chapter 5), we found that a decrease in three out of eight 
anthropometric measures, i.e. weight, WC, and mid-upper arm circumference (MUAC), 
over an approximately four-year period was associated with increased all-cause mortality 
risks. For only one measure, i.e. MUAC, an increase was also associated with an increased 
all-cause and CVD mortality risk. 
Our findings for weight loss are consistent with previous literature.32-35 For changes in WC, 
we found an association for a decrease, but not for an increase, in WC. The latter finding 
is in line with a previous study.36 Adjustment for changes in BMI resulted in an increased 
mortality risk for an increment in WC.36 During exploratory analysis, we observed the same, 
which again suggests that a combination of WC and BMI would provide more information 
than WC or BMI alone. 
For MUAC, which to our knowledge has not been observed before, we found associations 
with all-cause and CVD mortality for both decreases (≥1.6 cm and 0.6–1.6 cm) and an 
increase of ≥1.3 cm. Decreases in MUAC probably reflect a loss of subcutaneous fat and 
muscle mass. A decrease in muscle mass might be a result of sarcopenia, which is a common 
problem among the elderly leading to frailty, functional disabilities, and mortality.37,38 
Even when in exploratory analyses MUAC was adjusted for changes in weight, BMI, or 
WC, the associations of decreases in MUAC with all-cause mortality remained, as well as 
the association between an increase in MUAC and all-cause and CVD mortality. When we 
further explored the association between an increase in MUAC and CVD mortality, we 
observed that this association was attenuated after excluding persons with ischemic heart 
disease and diabetes at baseline rather than persons with cancer and respiratory diseases. 
The results from the exploratory analyses may indicate that the increase in MUAC reflects 
an increase in oedema. 
On the basis of our findings, we conclude that MUAC as a single anthropometric 
measure and that WC and BMI, or WC and weight, as combined measures seem 
good body compositional predictors of mortality among the elderly. 
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Stable weight, provided it is not within the extreme ranges, is best for health 
maintenance among all ages 
Among the elderly (70–77 years), we found clear evidence that weight loss was associated 
with an increased mortality risk (Chapter 5). Among adults of 26–70 years of age (Chapter 
6), we observed that persons who lost weight were at a disadvantage in relation to changes 
in QoL compared with those who had a stable weight. This was most pronounced among 
men aged ≥60 years. These findings are in line with other longitudinal studies reporting 
associations between weight loss and adverse outcomes on mortality and QoL.32-34,39,40 
However, some studies have found a beneficial impact of weight loss on all-cause mortality 
risk and improvement in physical performance and bodily pain score of QoL for individuals. 
These studies included persons with a high or extremely high BMI and hypertension, in 
which substantial weight losses (3–5 BMI units/2 years, 1.6 kg/year, ≥9 kg/4 years) could be 
observed41-43 in contrast to our weight loss categories (Chapter 5: ≥3.1 kg/4 years; Chapter 
6: ≥2kg/5 years). This relates to the intentionality of weight loss, which has been shown 
to influence the association between weight loss and mortality specifically in unhealthy 
obese individuals.44,45 Thus, information on the intentionality of weight loss might influence 
the association between weight loss (among obese adults) and health. Our studies did not 
include many individuals with extreme levels of BMI and weight loss and thus could not 
detect a beneficial impact of weight loss among the obese, and no data were available on 
the intentionality of weight loss. In general, we conclude that weight loss, especially among 
the elderly, is associated with adverse health outcomes.
With regard to weight gain, we observed among the elderly no clear evidence for an 
association between weight gain and mortality (Chapter 5). In adults, previous studies 
observed an association with increased mortality risk and reduced odds of healthy survival 
only in cases of large weight gains over the long term (≥15 kg/20 years and ≥20 kg/32 
years).46,47 With regard to QoL, we observed consistent associations between weight gain 
and a decline in QoL (Chapter 6). Moreover, we found associations between developing 
overweight and developing obesity and a lower QoL compared with those who persistently 
had a healthy weight (Chapter 7). These findings are in line with other studies.33-35,40,41,48-52 The 
lack of a consistent association between weight gain and mortality but a clear association 
between weight gain and QoL might be explained by the difference between an objective 
measure (mortality) and a subjective measure (QoL). More time is required to expose the 
detrimental impact of weight gain on mortality, whereas the impact on QoL can be more 
directly detected as it is measured from the individual’s perspective. Therefore, we conclude 
that weight gain is adversely associated with mortality and quality of life. 
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Since weight loss and weight gain are associated with adverse health outcomes, it seems 
that a stable weight is the best prognosis for good health. However, this prognosis is less 
straightforward than it seems, as it appears to depend on the level of weight. In additional 
analyses, we found that women with a stable weight in the obese range had larger declines 
on the physical dimensions of QoL than those in the healthy weight range (Chapter 6). 
Furthermore, we found that persistently obese women and men had the lowest QoL scores 
on most dimensions of QoL of the six BMI patterns, i.e. persistent healthy weight, developing 
overweight, persistent overweight, developing obesity, persistent obesity, and switching 
between BMI categories. Moreover, women who switched between BMI categories had 
lower scores on all four mental dimensions of QoL (Chapter 7). Given all of our findings, a 
stable weight contributes to health maintenance, but a too low or too high body weight 
should be avoided. The exact ranges within which a stable weight should be maintained 
cannot be provided by our results. 
We conclude that a stable weight, provided it does not fall within the extreme 
ranges, over a person’s life course is important for health maintenance. 
Representativeness of the cohort studies
The representativeness of the cohort studies examined in this thesis is important for the 
translation of the findings to general populations. Therefore, we compared important 
study characteristics of the selected elderly individuals (70–77 years) from the Survey in 
Europe on Nutrition and the Elderly: a concerted action (SENECA study) at baseline, and 
the adults (20–66 years) from the Doetinchem Cohort Study (DCS) during the first round 
(1989–1994) with statistics gathered by the Eurostat,53-56 Statistics Netherlands (CBS),57-59 
and the foundation for public health and smoking (STIVORO).60 For the SENECA study, in 
some cases, the prevalence of study characteristics was compared with Eurostat data of 
65–84-year olds from the 11 individual European countries included in the SENECA study, 
hereafter called the Eurostat countries.
Survey in Europe on Nutrition and the Elderly: a concerted action
The prevalence of underweight, overweight, and obesity in the SENECA study was 4%, 
44%, and 21%, respectively. This seems comparable with the prevalence of underweight, 
overweight, and obesity for the Eurostat countries, i.e. 0.4–4%, 40–56%, 12–29% in 2002.53 
However, as BMI was self-reported, the prevalence of overweight and obesity in the general 
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European population is probably higher. The SENECA population included fewer current 
smokers (18%) as compared to the Eurostat countries (19–37%) in 2002.54 In addition, in 
the SENECA study, 58% of the population perceived their health as good or very good. In 
nine Eurostat countries, the population that perceived their health as good, or very good 
was lower (9–58%), whereas in two countries it was higher (65–78%) in 2002.55 Finally, 
more persons in the SENECA study were highly educated (8%) compared to 25–64-year 
olds in the European Union in 2011 (27%).56 Given that the proportion of highly educated 
persons increased over time and that it declines with increasing age,56 the proportion of 
highly educated persons in the SENECA study might be an underrepresentation for the 
current situation, but it is probably an overrepresentation for the time when the SENECA 
study started, i.e. in 1989.
Doetinchem Cohort Study
The prevalence of overweight and obesity in the DCS was 35% and 6%, respectively; this 
prevalence of overweight is somewhat higher than the prevalence in 1991 given by the 
CBS among persons aged 20 years and over (overweight: 29%, obese: 6%).57 However, BMI 
given by the CBS is self-reported, which means that the prevalence of overweight and 
obesity is an underestimation. The prevalence of current smokers in the DCS was lower 
(27%) than the prevalence reported by STIVORO in 1991 (34%).60 More people in the DCS 
perceived their health as good or very good (90%) than reported by the CBS among 20–64-
year olds (70–90%).58 The prevalence of highly educated persons is 27% in the DCS, which 
is similar to the prevalence of highly educated people according to the CBS data (28%).59 
Given that the prevalence of highly educated people has increased over the past decade 
(20% in 2001 to 28% in 2011),59 the prevalence among the DCS is higher than among the 
general Dutch population. 
Thus, the populations used in this thesis seem healthier and have a higher 
education than the general European and Dutch population; this is due to a 
selective loss to follow-up, mostly of individuals with an unfavourable lifestyle, 
or due to diseases.61,62 Given that the results of this thesis are based on a relatively 
healthy population, the associations may be underestimated, and the public 
health implications of our findings may be even larger.  
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Implications for clinical practice and public health
In an ageing population, weight status is an important factor to reach old age in good 
health. In this thesis, we found clear associations between weight status, measured with 
several anthropometrics, and health among all ages; this has implications for public health 
as well as clinical practice.
Public health implications
The prevalence of obesity and abdominal obesity has increased worldwide among all 
ages.63 Although the relative risks of mortality as a result of high BMI levels are lower among 
elderly individuals than among younger adults, the absolute mortality rates are much higher 
among the elderly. In 2008, among European 70–79-year olds, the number of all-cause and 
CVD deaths was 2,376,995 and 1,324,979, respectively, whereas among 30–44-year olds 
the number of deaths was 451,725 and 94,312, respectively.64 This indicates that the public 
health implications of obesity among the elderly remain high.
To gain insight into how many deaths among elderly individuals could have been prevented 
by proper weight management, i.e. by preventing obesity, the Population Attributable Risk% 
(PAR%) needs to be calculated. The PAR indicates the proportion of cases that would not 
occur if obesity were eliminated, on the assumption of a causal relationship. The PAR% is 
calculated using the prevalence of persons at risk, i.e. persons with obesity, and the relative 
risk of CVD mortality because of obesity. Since we observed evidence for an increased risk 
of mortality at a BMI level of 30 kg/m2, we use the RR of CVD mortality of 1.39 from our 
categorical analysis.   
If we consider a European elderly population with 21% obese individuals and a 39% 
increased CVD mortality risk based on our results, then the PAR% is 7.6%. This means that, 
yearly, 100,698 CVD deaths among 70–79-year olds could have been prevented Europe-wide. 
With regard to public health interventions, the results presented in this thesis underpin the 
importance across all ages of a stable weight, provided it is not within the extreme ranges. 
We know from intervention studies that weight loss among obese and high risk populations 
can have beneficial effects on QoL,65 the progression from IGT to type 2 diabetes, and CVD 
risk factors,66 thereby potentially reducing the chance of mortality. Since sarcopenia, i.e. loss 
in muscle mass and an age-related decrease in muscle function, and specifically sarcopenic 
obesity, could be present among the elderly,38,67,68 it is of great importance that weight loss 
programmes targeting these groups pay attention to exercise in order to maintain muscle 
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mass, more specifically resistance training, in addition to a healthy diet, including e.g. 
sufficient protein.67,69 Such an approach is in line with current recommendations aiming at 
a stable healthy weight by means of a healthy diet and physical activity.70
Clinical implications
This thesis underlines the need to reconsider the current WHO cut-off points for BMI and 
WC classifications for the elderly, so that treatment becomes tailored rather than generic 
or even misguided. Our results, as well as previous literature,19-21,28 showed that the current 
labelling of the categories ‘overweight’ and ‘abdominal obesity’ is not in agreement with the 
mortality risks among the elderly. The current labelling might tempt general practitioners to 
prescribe treatments that are not needed and may even result in disadvantageous effects. 
Furthermore, in this thesis we found specific groups among the elderly who are at a 
high all-cause or CVD mortality risk, i.e. a relative risk of 2.0. These groups, with different 
underlying conditions, were individuals with a WC of 123 cm in men and 105 cm in women, 
individuals with underweight (<20.0 kg/m2), and individuals with large WC-healthy weight, 
which can be identified by using a combination of WC and BMI. Clinicians need to have a 
raised awareness about these groups. 
A combination of WC and BMI can also be used to detect changes in body composition, 
but as a single measure, MUAC might be a good alternative. MUAC of eight different 
anthropometric measures was the most sensitive in detecting hazardous changes in body 
composition of which increased mortality risks approaching 2.0 were observed. These 
findings of MUAC need further confirmation prior to clinical practice use. 
Conclusion
BMI and WC can be used as single predictors of mortality for the elderly, but higher cut-
off points for BMI and WC to indicate underweight and excess fat should be considered. 
Moreover, a combination of these two anthropometric measures can be recommended, 
as that would provide more information on body composition than one anthropometric 
measure alone. With regard to assessing changes in body composition, MUAC might be a 
good alternative for the elderly. Furthermore, a stable weight is best for health maintenance 
among all ages provided it is not within the extreme values of weight. In all, our results 
underscore the value of anthropometric measures in the management of weight and the 
importance of maintaining a stable weight during ageing.
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De vergrijzing van de Westerse bevolking is toegenomen in de laatste decennia, en zal 
verder toenemen in de toekomst. Daarom is het van belang factoren te bestuderen die 
het ‘gezond ouder worden’ kunnen beïnvloeden. Dergelijke factoren zijn het gewicht 
van een persoon en de ontwikkeling daarvan in de loop der jaren (gewichtstoestand). 
De gewichtstoestand wordt vaak gemeten met antropometrische maten zoals de body 
mass index (BMI) en de middelomtrek. In de klinische praktijk en in het onderzoek wordt 
de BMI gebruikt om personen in te delen: ondergewicht (<18.5 kg/m2, of <20.0 kg/m2), 
normaal gewicht (18.5–24.9 kg/m2, of 20.0–24.9 kg/m2), overgewicht (25.0–29.9 kg/m2) 
en obesitas (≥30.0 kg/m2). Daarnaast wordt de middelomtrek gebruikt om personen in te 
delen: kleine middelomtrek (<94 cm ♂, 80 cm ♀), middelmatige middelomtrek (94–101 
cm ♂, 80–87 cm ♀), en een grote middelomtrek ofwel abdominale obesitas (≥102 cm ♂, 
≥88 cm ♀). Deze categorieën geven aan of iemand te veel buikvet heeft. Bij volwassenen 
is het verband tussen overgewicht, of obesitas en gezondheidsrisico’s duidelijk, maar bij 
ouderen (65 jaar en ouder) is dit niet het geval. Een onderliggende factor die hierbij een rol 
kan spelen is de verandering van de lichaamssamenstelling bij het ouder worden. Ouderen 
hebben ten opzichte van jongvolwassenen met eenzelfde BMI of middelomtrek een grotere 
vetmassa door het verlies van spiermassa; zij hebben meer inwendig vet doordat het vet 
zich herverdeelt en zij hebben een afname in lengte doordat de wervels slijten en de 
tussenwervelschijven inzakken. Gezien deze verandering van de lichaamssamenstelling is 
het de vraag of de huidige afkappunten voor ondergewicht, overgewicht, en (abdominale) 
obesitas wel toepasbaar zijn bij ouderen. 
Het doel van dit proefschrift is dan ook om de betekenis van de gewichtstoestand, gemeten 
met verschillende antropometrische maten, voor verschillende gezondheidsmaten op latere 
leeftijd en in een ouder wordende populatie te onderzoeken. Deze gezondheidsmaten 
zijn ziekten aan het hart waarbij de kransslagaders zijn vernauwd (coronaire hartziekten), 
sterfte en kwaliteit van leven. 
Om dit te onderzoeken is er gebruik gemaakt van databestanden van grote internationale 
en nationale studies. In het bijzonder zijn de Survey in Europe on Nutrition and the Elderly: a 
concerted action (SENECA) studie en de Doetinchem Cohort Studie (DCS) gebruikt. De SENECA 
populatie bestaat uit ouderen van 70–77 jaar en de DCS populatie uit volwassenen van 
20–66 jaar. Binnen beide studies zijn antropometrische maten zoals de BMI, middelomtrek 
en armomtrek om de 5 jaar gemeten over een periode van 5–15 jaar. Daarnaast zijn ziekten, 
sterfte en doodsoorzaak, en kwaliteit van leven vastgesteld, alsmede het moment van 
intreden van een ziekte of overlijden. Hierna wordt onderscheid gemaakt in totaal overlijden 
(overlijden aan allerlei doodsoorzaken), en overlijden aan een specifieke ziekte. Kwaliteit 
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van leven is gemeten met vragen over hoe men het handelen in het dagelijks leven ervaart, 
waarbij onderscheid gemaakt kan worden naar fysieke en mentale aspecten van kwaliteit 
van leven. Deze informatie is gebruikt om het verband tussen een antropometrische 
maat (gewicht, BMI, middelomtrek en armomtrek) en een gezondheidsmaat (coronaire 
hartziekten, overlijden, en kwaliteit van leven) te onderzoeken. 
Omdat de gezondheidszorg in de afgelopen decennia is verbeterd, is onderzocht of het 
risico op het krijgen van coronaire hartziekten en het overlijden aan coronaire hartziekten 
dat samenhangt met obesitas verschillend zou zijn voor en na 1985 (hoofdstuk 2), en 
of leeftijd van invloed zou zijn op dit risico. Voor het eerste is geen overtuigend bewijs 
gevonden. Leeftijd, echter, beïnvloedt dit risico sterk. Een toename van 10 jaar in leeftijd 
geeft een daling van 31% van het risico. Een 65-jarige heeft bijvoorbeeld ten opzichte van 
een 55-jarige met obesitas een 31% lager risico op het krijgen van coronaire hartziekten 
of het overlijden aan coronaire hartzieken.
In hoofdstuk 3 en 4 is het verband bij ouderen tussen BMI en het overlijden, en tussen 
middelomtrek en het overlijden beschreven. In hoofdstuk 3 is een verband gevonden 
tussen BMI en het totaal overlijden, tussen BMI en het overlijden aan hart- en vaatziekten 
(HVZ), en tussen BMI en het overlijden aan een andere oorzaak dan HVZ, kanker en ziekten 
aan de luchtwegen. Personen met een BMI lager dan 24 kg/m2 en hoger dan 30 kg/m2 
hadden een verhoogd overlijdensrisico van 10%. In hoofdstuk 4 is ook een sterk verband 
gevonden tussen middelomtrek en het totaal overlijden, en tussen middelomtrek en het 
overlijden aan HVZ, kanker, en ziekten aan de luchtwegen. Het overlijdensrisico bij een 
middelomtrek van 102 cm bij oudere mannen en 88 cm bij oudere vrouwen (het afkappunt 
voor abdominale obesitas) was desondanks niet substantieel verhoogd. Bij hogere waarden 
van de middelomtrek was het overlijdensrisico wel verhoogd en bleek dat een tweevoudig 
risico op het totale overlijdensrisico en het overlijdensrisico aan HVZ gepaard ging met een 
middelomtrek van 132 en 123 cm bij mannen, respectievelijk 116 en 105 cm bij vrouwen. 
In hoofdstuk 4 is tevens de combinatie van standaard BMI- en middelomtrekcategorieën, 
zoals gebruikt in de praktijk, en het verband met overlijden onderzocht. Ouderen met 
ondergewicht in combinatie met een kleine middelomtrek, en ouderen met normaal 
gewicht in combinatie met abdominale obesitas hadden een twee keer zo hoog totaal 
overlijdensrisico en overlijdensrisico aan HVZ ten opzichte van ouderen met een normaal 
gewicht en een kleine middelomtrek.
In hoofdstuk 5 is het verband tussen veranderingen in antropometrische maten over een 
periode van ongeveer 4 jaar en het overlijdensrisico bij ouderen beschreven. Veranderingen 
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in BMI toonden geen verband met het overlijdensrisico. Voor veranderingen in hun 
middelomtrek en gewicht werd alleen bij een afname van deze maten een verband 
gevonden met het totaal overlijdensrisico. De resultaten voor deze twee maten waren 
vergelijkbaar. Zo hadden ouderen met een afname in middelomtrek van ≥3.1 cm een 52% 
hoger totaal overlijdensrisico dan ouderen met een stabiele middelomtrek, en hadden 
ouderen met een afname van ≥3.2 kg in gewicht een 48% hoger totaal overlijdensrisico 
dan ouderen met een stabiel gewicht. Voor één antropometrische maat, de armomtrek, 
werd bij zowel een toename als een afname een verband met het totaal overlijdensrisico 
en het overlijdensrisico aan HVZ gevonden. Ouderen die een afname van ≥1.6 cm en 
tussen de 0.6 en 1.6 cm in armomtrek lieten zien, hadden een 81% en 66% hoger totaal 
overlijdensrisico dan ouderen met een stabiele armomtrek. Ouderen met een toename van 
≥1.3 cm in armomtrek hadden een 52% hoger totaal overlijdensrisico, en een 94% hoger 
overlijdensrisico aan HVZ dan ouderen met een stabiele armomtrek. 
In hoofdstuk 6 en 7 zijn de veranderingen in gewicht en BMI van een ouder wordende 
populatie in een tijdsbestek van 10–15 jaar bestudeerd. Daaruit bleek dat onder volwassenen 
met een gewichtstoename van >2 kg —met name onder volwassenen met een toename van 
>6 kg— de kwaliteit van leven voor wat betreft de fysieke aspecten verminderde in de loop 
van de jaren. Bij volwassenen met een gewichtsafname van >2 kg veranderde de kwaliteit 
van leven niet of nauwelijks. Ten opzichte van volwassenen met een stabiel gewicht trad 
er desondanks een ongunstige verandering op in kwaliteit van leven voor wat betreft de 
mentale aspecten. Dat komt doordat de kwaliteit van leven van volwassenen met een stabiel 
gewicht verbeterde in de loop van de jaren. Wanneer de BMI-patronen van volwassenen 
werden geanalyseerd over een periode van 15 jaar bleek dat volwassenen met stabiele 
obesitas de slechtste kwaliteit van leven hadden. Ten opzichte van volwassenen met een 
stabiel normaal gewicht hadden volwassenen die overgewicht ontwikkelden, volwassenen 
die obesitas ontwikkelden, en volwassenen die stabiel obees waren een slechtere kwaliteit 
van leven voor wat betreft de fysieke aspecten aan het einde van de periode van 15 jaar. 
Vrouwen die wisselden tussen BMI-categorieën hadden een slechtere kwaliteit van leven 
voor wat betreft de mentale aspecten, ten opzichte van vrouwen met een stabiel normaal 
gewicht. Als enige groep, verschilden volwassenen met stabiel overgewicht weinig van 
volwassenen met een stabiel ‘gezond gewicht’. De resultaten uit deze hoofdstukken waren 
consistent voor verschillende leeftijdsgroepen. 
Tenslotte zijn de belangrijkste bevindingen bediscussieerd en zijn de implicaties voor de 
volksgezondheid en de klinische praktijk besproken in hoofdstuk 8. Ondanks dat het risico 
op coronaire hartziekten of overlijden in samenhang met obesitas lager is bij ouderen dan 
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bij jongvolwassenen, werden er sterke verbanden gevonden tussen een hoge BMI en het 
overlijdensrisico en tussen middelomtrek en het overlijdensrisico. De absolute aantallen 
van overlijdensgevallen in samenhang met een hoge BMI onder de oudere bevolking zijn 
aanzienlijk. Het voorkomen van een hoge BMI door middel van preventieve interventies 
bij ouderen zou daarom een positief effect kunnen hebben op de volksgezondheid. 
Daarnaast blijkt uit dit proefschrift dat het behouden van een stabiel gewicht, mits dit 
niet in de extremen valt, van belang blijft om een goede gezondheid te behouden. 
Voor de klinische praktijk is het van belang dat de afkappunten voor ondergewicht, 
overgewicht, en abdominale obesitas worden heroverwogen en worden opgehoogd om 
ouderen met een verhoogd gezondheidsrisico te kunnen identificeren. Daarnaast kan 
een combinatie van BMI en middelomtrek worden aanbevolen zodat de specifieke groep 
met een zeer hoog (tweevoudig) risico kan worden geïdentificeerd. Een combinatie van 
antropometrische maten geeft mogelijk meer informatie over de lichaamssamenstelling dan 
elke maat afzonderlijk. Om veranderingen in gewichtstoestand bij ouderen te meten zou 
de armomtrek naast gewicht en middelomtrek overwogen kunnen worden. De resultaten 
van dit proefschrift onderschrijven de waarde van antropometrische maten in het bepalen 
van de gewichtstoestand en het belang van een stabiel gewicht gedurende het leven.
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